<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:unherd="https://www.unherd.com"
	>

	<channel>
		<title>Big Pharma - UnHerd</title>
		<atom:link href="https://stage.unherd.com/tag/big-pharma/feed/" rel="self" type="application/rss+xml" />
		<link>https://stage.unherd.com/tag/big-pharma/</link>
		<description>think again</description>
		<lastBuildDate>Thu, 01 Oct 2026 22:35:57 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>12</sy:updateFrequency>
		<generator>https://wordpress.org/?v=7.1.4</generator>

<image>
	<url>https://stage.unherd.com/wp-content/uploads/2019/09/cropped-favicon.jpg?w=32</url>
	<title>Big Pharma - UnHerd</title>
	<link>https://stage.unherd.com/tag/big-pharma/</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">241382538</site>				<item>
					<title>How MAHA grew up</title>
					<link>https://stage.unherd.com/2026/10/how-maha-grew-up/?edition=us</link>
											<comments>https://stage.unherd.com/2026/10/how-maha-grew-up/?edition=us#respond</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2026/10/GettyImages-2246396493.jpg?w=525</unherd:featured_image>
										<unherd:main_theme>Health</unherd:main_theme>
					<dc:creator>
						<![CDATA[James Billot]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2024/06/James-Bilot-Blue.jpg?w=96</unherd:creator_img>
																<unherd:article_ranking>3</unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[Health and Human Services Secretary Kennedy at the Official MAHA Summit earlier this week. Credit: Getty]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p>James Billot is UnHerd&#8217;s <strong>Newsroom editor.</strong></p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle>james_billot</unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[]]>
					</unherd:author_bio>
										<pubDate>Thu, 01 Oct 2026 23:00:47 +0000</pubDate>
					<updated>Thu, 01 Oct 2026 23:00:47 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[bryan johnson]]></category>
		<category><![CDATA[Corporations]]></category>
		<category><![CDATA[Food]]></category>
		<category><![CDATA[maha]]></category>
		<category><![CDATA[MAHA Summit]]></category>
		<category><![CDATA[RFK Jr.]]></category>
					<guid isPermaLink="false">https://stage.unherd.com/?p=1076836</guid>
																												<description>
								<![CDATA[‘Selling out’ is a sign of success]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p><span style="font-weight: 400;">Inside the Waldorf Astoria in Washington, DC, a colony of flamingos has gathered. Around 200 people are balancing on one leg with their eyes closed as they await further instruction. The instructor intones: “Hold it for five seconds… 10… 15… 30. Now put your foot down.” </span></p>
<p><span style="font-weight: 400;">The flamingos open their eyes and glance around. Suddenly, they remember that this is the second annual Make America Healthy Again (MAHA) summit, not a Maharishi Mahesh Yogi retreat. The instructor guiding them is, in fact, Bryan Johnson, the investor-cum-longevity influencer who has set himself the modest goal of becoming the first human to not die. “If your balance lasted between zero and seven seconds, your biological age is 60 to 80.” Several 40-somethings look distraught.</span></p>
<p><span style="font-weight: 400;">The scene was undeniably nutty. But behind the biohacking and balance tests, MAHA is becoming something much more serious: a political movement with money and institutional backing that is moving well beyond its activist roots.</span></p>
<p><span style="font-weight: 400;">Johnson might seem like an unlikely ambassador for MAHA. He is a Silicon Valley millionaire whose transhumanist worldview has little in common with the more quotidian concerns of MAHA’s crunchy moms. He </span><a href="https://x.com/bryan_johnson/status/1907163395381756065?s=20&amp;utm_source=Undercurrents&amp;utm_campaign=a4e163f21a-EMAIL_CAMPAIGN_2025_12_02_12_14_COPY_01&amp;utm_medium=email&amp;utm_term=0_-51d05f1b9f-" target="_blank" rel="noopener"><span style="font-weight: 400;">worries</span></a><span style="font-weight: 400;"> about the end of the human race; they fret about Red 40 in their kids’ cereal. </span></p>
<p><span style="font-weight: 400;">But this strange alliance is what makes MAHA one of the most dynamic and politically potent forces in the United States today. Having evolved from a populist insurgency into a viable electoral coalition, MAHA in 2026 looks very different from the movement that helped propel President Trump to victory in 2024. It now counts in its ranks biotech bros like Johnson, health-care CEOs, and world-famous athletes, all of whom appeared at this week’s summit. </span></p>
<a href="https://stage.unherd.com/2026/10/how-maha-grew-up/?edition=us?=refinnar"><div class="ref-ar"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2026/10/GettyImages-2246396493.jpg?w=300" /><div class="content"><span class="meta">More from this author</span><h5>How MAHA grew up</h5><p class="author"><span>By</span> James Billot</p></div></div></a>
<p><span style="font-weight: 400;">Some of MAHA’s original supporters view these additions less as a success than a hostile takeover. They </span><a href="https://x.com/JoinCrowdHealth/status/2099886535235547481?s=20" target="_blank" rel="noopener"><span style="font-weight: 400;">pointed</span></a><span style="font-weight: 400;"> to the summit’s corporate sponsors and its speaker list, which featured more CEOs than MAHA moms, as evidence that the movement has sold out or been captured. As one despairingly </span><a href="https://www.malone.news/p/the-capture-of-maha" target="_blank" rel="noopener"><span style="font-weight: 400;">wrote</span></a><span style="font-weight: 400;">: “It is a betrayal of what MAHA claimed to stand for.” </span></p>
<p><span style="font-weight: 400;">This is, however, a misread. That the movement is now working with figures it has long opposed should be seen as a victory, not defeat. The truth is that the only way to effect change in a country dominated by powerful pharmaceutical and corporate interests is to do so from within. That doesn’t mean MAHA should abandon its principles. But it does require resisting the temptation to frame every compromise as a betrayal, or allowing red lines to congeal into purity tests that leave it isolated from the institutions it is trying to change.</span></p>
<p><span style="font-weight: 400;">There was plenty of bad blood going into the summit. Days earlier, activists vented their fury online about the proliferation of</span><a href="https://www.mahasummit.com/sponsors" target="_blank" rel="noopener"> <span style="font-weight: 400;">corporate sponsors</span></a><span style="font-weight: 400;"> paying $300,000 for a seat at the table, while various “medical-freedom” stalwarts were left at home. Why, for example, was there no panel discussion on </span><a href="https://x.com/TonySeruga/status/2104601016343929118?s=20" target="_blank" rel="noopener"><span style="font-weight: 400;">vaccine injuries</span></a><span style="font-weight: 400;">? Why was a UnitedHealth representative </span><a href="https://x.com/HeathVeuleman/status/2104656944208167125?s=20" target="_blank" rel="noopener"><span style="font-weight: 400;">talking</span></a><span style="font-weight: 400;"> about affordable health care? Why were scientists who lost their career for </span><a href="https://x.com/TonySeruga/status/2104601016343929118?s=20" target="_blank" rel="noopener"><span style="font-weight: 400;">asking questions</span></a><span style="font-weight: 400;"> not given a hearing?</span></p>
<p><span style="font-weight: 400;">As one of a handful journalists allowed to report on the summit, I was curious to see if this anger filtered into the crowd. There were some familiar faces: celebrity chef Andre Rush, Del Bigtree, RFK’s former communications director, and Mark Gorton, MAHA Institute’s president, who once said that he was “the boldest anti-vaxxer in the anti-vax conference.” But they did not have any speaking role. In fact, most of the attendees looked as though they had just stumbled out of a boardroom meeting, with off-stage conversations revolving around advances in cancer research and </span><a href="https://www.ohalo.com/boosted-breeding" target="_blank" rel="noopener"><span style="font-weight: 400;">boosted breeding</span></a><span style="font-weight: 400;"> in potatoes. Despite a healthy showing of amber-lens glasses, peptide-grown muscles, and one “vaccine police” T-shirt, this was not a crowd of cranks.</span></p>
<div class="su-pullquote su-pullquote-align-left">“MAHA is growing up — and its followers should, too.”</div>
<p><span style="font-weight: 400;">Having </span><a href="https://stage.unherd.com/2024/04/the-growing-rfk-jr-coalition/?edition=us" target="_blank" rel="noopener"><span style="font-weight: 400;">covered</span></a><span style="font-weight: 400;"> RFK during his presidential campaign in 2024, I was struck by how much had changed. Back then, Kennedy’s supporters comprised a motley bunch of crusty hippies, vaccine skeptics, and disillusioned Bernie bros. It was, in many ways, an expression of what used to be called the California Left: a blend of serious and kooky critiques of big business’s role in America’s health crises. </span></p>
<p><span style="font-weight: 400;">Channeling that spirit, Kennedy was the ultimate outsider candidate, building his campaign around three core issues: ending the forever wars, cutting America’s debt, and fighting chronic disease. It was the last of these issues that really galvanized his campaign, as Kennedy </span><a href="https://www.realclearpolitics.com/video/2024/08/23/watch_live_independent_candidate_robert_f_kennedy_expected_to_exit_presidential_race_rumor_he_may_endorse_trump.html" target="_blank" rel="noopener"><span style="font-weight: 400;">railed</span></a><span style="font-weight: 400;"> against agencies like the Food and Drug Administration, The Department of Agriculture, and the Centers for Disease Control and Prevention. All, he charged, were “controlled by giant for-profit corporations,” and the uniparty was “in cahoots with the big food producers, Big Pharma and Big Ag.” Now, he’s in charge of those very agencies, with the Big Pharma executives he once denounced appearing at his summit.  </span></p>
<p><span style="font-weight: 400;">Since becoming health secretary, Kennedy has delivered some of the changes MAHA activists had long demanded, particularly on food additives and ultra-processed foods, but some of his bigger promises have stalled. His pledge to identify the root cause of autism within months went unfulfilled, he failed to win funding for a new chronic-disease agency, and his push to ban direct-to-consumer pharmaceutical advertising has gone nowhere. The biggest blow of all was Trump’s </span><a href="https://apnews.com/article/maha-glyphosate-rfk-kennedy-trump-pesticides-3d23d4771dba743a976543ca6cfa69d9" target="_blank" rel="noopener"><span style="font-weight: 400;">executive order</span></a><span style="font-weight: 400;"> to boost domestic production of the weedkiller glyphosate, forcing Kennedy to defend a chemical he’d spent years opposing.</span></p>
<p><span style="font-weight: 400;">These defeats have understandably angered many of Kennedy’s erstwhile supporters. But his success on food dyes demonstrates why it is best to work with, rather than against, industry. In the last year, Kraft Heinz, Nestle, Conagra, and other major food companies all committed to eliminating FD&amp;C colors, which have been linked to behavioral concerns in children</span><b>,</b><span style="font-weight: 400;"> from their US products. The FDA now runs a “natural-dye-pledge” website that allows the public to track whether companies actually deliver.</span></p>
<div class="ref-ar"><a href="https://stage.unherd.com/2026/01/rfk-is-right-eat-more-meat-and-cheese/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2026/01/rfk-is-right-eat-more-meat-and-cheese/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2026/01/GettyImages-2225108881.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2026/01/rfk-is-right-eat-more-meat-and-cheese/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2026/01/rfk-is-right-eat-more-meat-and-cheese/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Why you should eat the RFK diet</h5></a><p class="author"><a href="https://stage.unherd.com/2026/01/rfk-is-right-eat-more-meat-and-cheese/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Valerie Stivers</a></p></div></a></div>
<p><span style="font-weight: 400;">Perhaps his greatest success, though, is that the fight today against regulatory capture, and for cleaner food, has become a rare bipartisan cause. In California, Gov. Gavin Newsom signed legislation phasing out ultra-processed foods from school lunches, and by 2029, the state </span><a href="https://subscriber.politicopro.com/article/2026/09/newsom-adds-another-maha-feather-to-his-cap-01095624" target="_blank" rel="noopener"><span style="font-weight: 400;">could become</span></a><span style="font-weight: 400;"> the first to label them in grocery stores. Earlier this year, Sen. Cory Booker</span> <span style="font-weight: 400;">(D-NJ) </span><a href="https://www.axios.com/2026/05/24/bookers-maha-play" target="_blank" rel="noopener"><span style="font-weight: 400;">said</span></a><span style="font-weight: 400;"> that he “absolutely” supports some of Kennedy’s initiatives, including more testing of infant formula for microplastics and a push for healthier foods in schools. And progressive Democrats</span> <a href="https://stage.unherd.com/newsroom/can-democrats-claim-the-maha-movement/?edition=us" target="_blank" rel="noopener"><span style="font-weight: 400;">including</span></a><span style="font-weight: 400;"> Rep. Alexandria Ocasio-Cortez of New York and Michigan’s Abdul El-Sayed have been trying to drum up support for taking on Big Ag and Big Pharma. If Kennedy wasn’t in the picture, these topics may not have received the same kind of air time.</span></p>
<p><span style="font-weight: 400;">America’s pharma and food industries are notorious. The drug industry is routinely among the biggest spenders on federal lobbying, and it funds much of the FDA’s drug-review work through user fees, which means the regulator and the regulated are financially entangled by design. Similarly, the food industry is run by a handful of mega-corporations that control most of what fills supermarket shelves. These are fiendishly difficult opponents, and it would be unfair to judge Kennedy on failing to upend a decades-old system after just 20 months. </span></p>
<p><span style="font-weight: 400;">In the short term, he can focus on the issues popular with the public — fighting chronic disease, ultra-processed food, pharmaceutical influence, and environmental chemicals — while avoiding those </span><a href="https://www.kff.org/health-information-trust/trust-in-cdc-and-views-of-federal-childhood-vaccine-schedule-changes/" target="_blank" rel="noopener"><span style="font-weight: 400;">that aren’t</span></a><span style="font-weight: 400;"> (such as his obsession with altering childhood vaccine schedules). Such efforts may not save his party from looming defeat in the midterms, but they would at least allow Kennedy to work across the aisle.</span></p>
<p><span style="font-weight: 400;">The great midcentury historian Richard Hofstadter once argued that the problem with third parties is that once they have stung, they die. His point was that these movements are often strongest when they are outsiders; once they have acquired power and begun implementing their agenda, they lose the energy that gave them their force in the first place. The same logic might apply to MAHA. Activists upset with the slow pace of change have already started to question if Kennedy really is the chosen one, and what life will </span><a href="https://www.politico.com/news/2026/09/04/maha-unhappy-2028-candidates-01064046" target="_blank" rel="noopener"><span style="font-weight: 400;">look like</span></a><span style="font-weight: 400;"> once he’s gone.</span></p>
<p><span style="font-weight: 400;">This is no bad thing. For a movement to expand, it needs to shed some of its more eccentric adherents and broaden its appeal. That the summit’s loudest critics are also the supporters of the most unpopular policies is a telling sign that it is moving in the right direction. MAHA is growing up — and its followers should, too.</span></p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2026/10/how-maha-grew-up/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2026/10/how-maha-grew-up/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2026/10/how-maha-grew-up/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">1076836</post-id>				</item>
									<item>
					<title>Don Jr’s festival of steroids</title>
					<link>https://stage.unherd.com/2026/02/don-jrs-festival-of-steroids/?edition=us</link>
											<comments>https://stage.unherd.com/2026/02/don-jrs-festival-of-steroids/?edition=us#comments</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2026/02/image-2.jpg?w=622</unherd:featured_image>
										<unherd:main_theme>Enhanced Games</unherd:main_theme>
					<dc:creator>
						<![CDATA[Oliver Bateman]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2020/09/KevinMyers2.jpg?w=96</unherd:creator_img>
																<unherd:article_ranking>2</unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[The Age of Disruptors. Image: JG Fox, Getty]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p><strong>Oliver Bateman</strong> is a historian and journalist based in Pittsburgh.<span class="css-901oao css-16my406 r-poiln3 r-bcqeeo r-qvutc0"> He blogs, vlogs, and podcasts at his Substack, <a href="https://t.co/f9G9ruu4Uk">Oliver Bateman Does the Work</a></span></p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle>MoustacheClubUS</unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[ is a historian and journalist based in Pittsburgh.<span class="css-901oao css-16my406 r-poiln3 r-bcqeeo r-qvutc0"> He blogs, vlogs, and podcasts at his Substack, <a href="https://t.co/f9G9ruu4Uk">Oliver Bateman Does the Work</a></span>]]>
					</unherd:author_bio>
										<pubDate>Fri, 13 Feb 2026 00:02:56 +0000</pubDate>
					<updated>Fri, 13 Feb 2026 15:33:51 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[don jr]]></category>
		<category><![CDATA[steroids]]></category>
		<category><![CDATA[testosterone]]></category>
		<category><![CDATA[Transhumanism]]></category>
					<guid isPermaLink="false">https://stage.unherd.com/?p=1048467</guid>
																												<description>
								<![CDATA[Can he juice up the world?]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p>In 100 days, a man will be making the final preparations for his attempt to run faster than any human being in history. Fred Kerley, the 2022 world 100-meter champion, has publicly set a target of 9.42 seconds — a time that would obliterate Usain Bolt&#8217;s world record of 9.58 by nearly two-tenths of a second. He will do it while openly using performance-enhancing drugs. His backers include Peter Thiel, the Winklevoss twins, and Donald Trump Jr, who all believe this race could help destroy the Olympic Movement and revolutionize healthcare, all while making them billions of dollars.</p>
<p>When the Enhanced Games were first announced in 2023, the reaction was derision. Travis Tygart, CEO of the United States Anti-Doping Agency (USADA) <a href="https://www.usada.org/spirit-of-sport/need-know-enhanced-games" target="_blank" rel="noopener">called them</a> a “dangerous clown show that puts profit over principle”. The World Anti-Doping Agency (WADA) condemned the concept as “dangerous and irresponsible”. Lord Sebastian Coe, head of World Athletics, offered the bluntest verdict: “Well, it&#8217;s bollocks, isn&#8217;t it?”</p>
<p>The early coverage reinforced the freak-show narrative. Australian swimmer James Magnussen, the 2011 and 2013 100-meter freestyle world champion, promised to &#8220;juice to the gills&#8221; and break the 50-meter freestyle world record. He gained 50 pounds of muscle and became so large that it took four people 30 minutes to squeeze him into his racing suit.</p>
<p>Two years later, it doesn&#8217;t look like bollocks. Athletes are signing contracts and cashing checks — the most money many have ever earned, given the modest pay available to amateur competitors.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2025/07/the-nelk-boys-are-useful-idiots/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2025/07/the-nelk-boys-are-useful-idiots/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2025/07/0c4d29f1-9d21-4d01-864c-d41398d4a117-nelk-boys-jersey-shore-meetups.png.webp?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2025/07/the-nelk-boys-are-useful-idiots/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">More from this author</span></a><a href="https://stage.unherd.com/2025/07/the-nelk-boys-are-useful-idiots/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>The Nelk Boys are useful idiots</h5></a><p class="author"><a href="https://stage.unherd.com/2025/07/the-nelk-boys-are-useful-idiots/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Oliver Bateman</a></p></div></a></div>
<p>At an Enhanced Games-sponsored event in February 2025, Magnussen lost a $1 million prize to a leaner Greek swimmer, Kristian Gkolomeev, who had been on performance-enhancing drugs for only eight weeks and swam 20.89 seconds: 0.02 seconds faster than the existing world record. Gkolomeev&#8217;s wife had written that he earned &#8220;as little as $5,000 a year&#8221; as one of the world&#8217;s top swimmers competing by the rules. In those 20.89 seconds, Gkolomeev changed his life.</p>
<p>The Enhanced Games debut on 24 May 2026. What began as <a href="https://stage.unherd.com/newsroom/the-steroid-olympics-are-here-to-stay/" target="_blank" rel="noopener">a laughing stock</a> is becoming something harder to dismiss. The organization now has around 50 to 60 athletes on its payroll across swimming, track and field, and weightlifting — including Hafþór Björnsson, the Icelandic strongman who played The Mountain in <em>Game of Thrones</em>, who will attempt to exceed his own 510kg deadlift record while competing against longtime rival <a href="https://fitnessvolt.com/mitchell-hooper-2026-enhanced-games-deadlift-world-record/">Mitchell Hooper</a> — with 40 participating in supervised clinical trials. Athletes who choose to enhance will travel to the UAE for four months of supervised training starting in late January, with protocols managed by a global clinical trials organization for health, safety, and performance reasons. The permitted substances include testosterone replacement therapy, approved steroids, estrogen, peptides, and sleep aids. Cocaine and heroin remain prohibited.</p>
<p>It helps that there&#8217;s serious money behind the venture. Don Jr announced his backing in February 2025, declaring that the Enhanced Games represent &#8220;the future — real competition, real freedom, and real records being smashed&#8221;. He linked the venture explicitly to the administration&#8217;s broader agenda: &#8220;This is about excellence, innovation and American dominance on the world stage — something the MAGA movement is all about.&#8221;</p>
<p>The Trump family&#8217;s involvement raises uncomfortable questions. <a href="https://www.slu.edu/law/faculty/michael-duff.php" target="_blank" rel="noopener">Michael Duff</a>, a labor law professor at Saint Louis University and former trial attorney with the National Labor Relations Board, told me the arrangement &#8220;meshes all-too-well with transhumanism, which is what these games seem to represent&#8221;. He drew a comparison to other instances of presidential relatives shrewdly monetizing proximity to power: &#8220;To me there is not a whit of difference between the Hunter-Joe Biden and the two-Donalds pairings. It is a form of dynastic aristocracy that goes back a long, long way.&#8221;</p>
<p>The timing is notable. The <a href="https://www.cnn.com/2025/01/09/sport/usada-us-government-withhold-wada-payment-spt-intl" target="_blank" rel="noopener">US government has been withholding</a> $3.6 million from WADA over a Chinese doping scandal involving dozens of swimmers. Enhanced Games founder Aron D&#8217;Souza has publicly welcomed what he calls an &#8220;age of disruptors&#8221; in the White House, and has framed the event as a populist challenge to corrupt international bureaucracies. &#8220;The IOC president flies around the world in a private jet. He lives in a palace,&#8221; D&#8217;Souza <a href="https://www.businessinsider.com/enhanced-games-olympics-steroids-ped-peter-thiel-aron-dsouza-2024-3">has said.</a> &#8220;The IOC system is designed to benefit bureaucrats, not the athletes.&#8221; WADA&#8217;s Witold Bańka has called on American authorities to prevent the event from happening. The Trump administration — skeptical of international bodies and with the President&#8217;s son heavily involved financially — almost certainly will not comply. A Truth Social post from the President endorsing the Enhanced Games would be worth more than any advertising budget.</p>
<p>There is an irony here: even as Trump celebrates the United States hosting the 2026 World Cup and the 2028 Olympics and the 2034 Winter Olympics, his son is investing in a venture that seeks to undermine conventional sport&#8217;s entire legitimacy.</p>
<p>The organizers have studied another recent transformation of vice into mainstream entertainment. Christopher Jones, the Enhanced Games&#8217; Chief Communications Officer, previously worked at FanDuel, the sports betting platform now valued at approximately $31 billion. Some of the same people who helped legitimize one previously stigmatized industry are now trying to create another. &#8220;Look at the investors involved,&#8221; Jones told me. &#8220;They do not get involved with losers.&#8221;</p>
<p>And those investors want to make money. Jones described the Games as &#8220;the kickoff to a consumer products division&#8221;. The organization is <a href="https://www.enhanced.com/products" target="_blank" rel="noopener">already selling</a> testosterone therapies, peptides, and enhancement protocols on its website, using social media clips and athlete testimonials as proof points. Clinical data generated by athletes could support an FDA approval process for additional performance and recovery products aimed at the general public. The billionaire businessman Mark Cuban <a href="https://www.espn.com/dallas/nba/story/_/id/10725677/mark-cuban-dallas-mavericks-helping-fund-study-hgh-use">once funded</a> his own study into the effect of human growth hormone on injured athletes, telling me there was simply no other way to gather such data legally. The Enhanced Games hope to generate far more.</p>
<p>The organization has announced plans to go public in 2026 at an enterprise value of $1.2 billion — a valuation tied up primarily in their pharmaceutical business. To understand what&#8217;s at stake, consider the comparison: the global market for GLP-1 drugs like Ozempic and Wegovy is <a href="https://finance.yahoo.com/news/glp-1-agonists-ozempic-wegovy-092400244.html">currently worth around $70 billion</a> and is projected to exceed $200 billion by 2033. The Enhanced Games are betting that testosterone, peptides, and performance-enhancement protocols could capture a meaningful slice of that demand — pharmaceutical self-improvement marketed with the same slick simplicity as a Hims &amp; Hers subscription.</p>
<p>Shane Ryan, a 31-year-old, three-time Irish Olympian and world medalist in swimming, described the arrangement as something closer to a tech startup than a sporting body. &#8220;It&#8217;s a business,&#8221; he said. &#8220;Once you learn how much money is actually invested in it, you realize it&#8217;s not going to go away.&#8221;</p>
<p>Ryan joined the Enhanced Games after retiring from traditional competition. &#8220;I made like $20,000 or €18,000 a year,&#8221; he said of his time competing for Ireland. &#8220;You can&#8217;t live on that.&#8221; The Enhanced Games offered him a salary, comprehensive recovery support, and the chance to see how far his body could go.</p>
<p>Whether any of this truly succeeds may depend on Kerley&#8217;s race. Given that the 100-meter record is the one thing even the most casual of fans will understand, the Games will remain a curiosity until enhanced athletes run faster than clean ones. A USADA official who spoke on condition of anonymity put it plainly: &#8220;If somebody breaks that record, everything changes.&#8221;</p>
<div class="su-pullquote su-pullquote-align-left">&#8220;If somebody breaks that record, everything changes.&#8221;</div>
<p>The official identified a specific scenario the organization might be hoping for: a white sprinter breaking the record in a discipline dominated by athletes of West African descent since Jim Hines first broke 10 seconds in 1968. &#8220;If the first iconic Enhanced sprint record comes from a white guy, the marketing machine goes into overdrive,&#8221; he said. Only two white athletes have ever run under 10 seconds — France&#8217;s <a href="https://www.youtube.com/watch?v=gEBsUTltLg0" target="_blank" rel="noopener">Christophe Lemaitre</a> (9.92 in 2011) and Virginia Tech&#8217;s <a href="https://www.outkick.com/sports/virginia-tech-wr-cole-beck-the-fastest-white-guy-of-all-time-gets-smoked-in-ncaa-100m-championship" target="_blank" rel="noopener">Cole Beck</a> (a wind-aided 9.87 in 2023) — and neither is currently signed with the Enhanced Games. But the USADA official argued the commercial potential would be, in Trump&#8217;s colorful turn of phrase, &#8220;yuge&#8221;.</p>
<p>Anthony Roberts, author of <a href="https://www.amazon.com/Anabolic-Steroids-Ultimate-Research-Guide/dp/1599751003" target="_blank" rel="noopener"><em>Anabolic Steroids: Ultimate Research Guide</em></a> and a fitness journalist who has broken major steroid stories for <a href="https://www.nytimes.com/2007/09/29/sports/baseball/29doping.html" target="_blank" rel="noopener"><em>The New York Times</em></a>, offered a realistic view. &#8220;The Enhanced Games stick around as long as rich people fund it,&#8221; he told me — and in my conversations with the Enhanced Games team, it is clear they have a great deal of financial runway, carrying them through multiple iterations of the signature event. &#8220;Because it has mostly attracted retired athletes off the podium, I can&#8217;t see it becoming popular at the mainstream level. The top sprinter in the Enhanced Games isn&#8217;t currently faster than the top sprinter at the Olympics.&#8221;</p>
<p>The USADA official was similarly doubtful about the Games supplanting traditional competition. &#8220;The Olympics are baked into national identity, government funding pipelines, and a century of habit,&#8221; he said. But he acknowledged the organizers had put serious money in. His primary concern was the message the event sends to young athletes, most of whom are already experiencing money pressures in their chosen sports. &#8220;We already fight a constant battle to keep kids from thinking they need drugs to chase a scholarship or a pro contract.&#8221;</p>
<p>The organizers are not, as they explain it, trying to destroy the Olympics. They are trying to piggyback off conventional sport&#8217;s legitimacy while building a pharmaceutical empire on the side. Even so, the Games arrive at a time when moralistic conventions are under threat. Sports betting, once viewed as dangerous and confined to the shadows, is now embedded in all major broadcasts. GLP-1 drugs have made pharmaceutical weight loss mainstream, rapidly supplanting the more respectable custom of dieting. The Enhanced Games are betting that performance enhancement will follow the same trajectory, going from taboo to tolerated to normal: a future in which ordinary consumers pay for testosterone, peptides, and recovery protocols to get stronger, leaner, and younger-feeling. The long-term health consequences of mass-market hormone use remain largely unstudied, but the Enhanced Games are wagering that demand will outrun caution — as it did with sports betting, and as it is doing with GLP-1s.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2025/10/californians-are-the-elves-of-america/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2025/10/californians-are-the-elves-of-america/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2025/10/GettyImages-2242579916.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2025/10/californians-are-the-elves-of-america/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested Reading</span></a><a href="https://stage.unherd.com/2025/10/californians-are-the-elves-of-america/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Californians are the elves of America</h5></a><p class="author"><a href="https://stage.unherd.com/2025/10/californians-are-the-elves-of-america/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Cairo Smith</a></p></div></a></div>
<p>Importantly, they are also a post-national venture in a time of <a href="https://www.pewresearch.org/2025/05/08/americans-trust-in-one-another/" target="_blank" rel="noopener">declining trust in and identification with nation-states</a>. Athletes will not represent their countries; there will be no anthems, no medal counts by nation. Whether audiences will care as much about competitors without flags remains an open question, but the organizers are wagering that records and spectacle will prove sufficient.</p>
<p>For athletes like Shania Collins, a 29-year-old retired American sprinter and former US Indoor Champion, the appeal is transparency. She competed for six years as a professional, earning what she described as the bare minimum. &#8220;I had confidential sources and I&#8217;ve seen things that led me to believe that [competitors] were taking performance-enhancing drugs,&#8221; she said. &#8220;It always felt like an unfair playing field.&#8221; Her mother has taken to calling it &#8220;the honest games&#8221;.</p>
<p>Come May, amid the manufactured glitz and 24/7 gambling of Las Vegas, enhanced athletes will get to chase — and possibly exceed — times that clean competitors have never approached. If Fred Kerley breaks Bolt&#8217;s record on a global broadcast, investors such as Don Jr will have seen an early return and the Enhanced Games will have proved their thesis: that the appetite for superhuman performance outweighs any squeamishness about how it was achieved.</p>
<p>If no one does, they will at least temporarily remain what their critics have called them — a well-funded sideshow still awaiting its big moment. Either way, the answer will come down to a fraction of a second.</p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2026/02/don-jrs-festival-of-steroids/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2026/02/don-jrs-festival-of-steroids/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2026/02/don-jrs-festival-of-steroids/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">1048467</post-id>				</item>
									<item>
					<title>How ADHD medicine failed boys</title>
					<link>https://stage.unherd.com/2025/05/how-adhd-medicine-failed-boys/?edition=us</link>
											<comments>https://stage.unherd.com/2025/05/how-adhd-medicine-failed-boys/?edition=us#comments</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2025/05/GettyImages-2074140766.jpg?w=499</unherd:featured_image>
										<unherd:main_theme>Psychiatry</unherd:main_theme>
					<dc:creator>
						<![CDATA[Valerie Stivers]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2025/09/Blue-76.jpg?w=96</unherd:creator_img>
																<unherd:article_ranking>International</unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[Almost a quarter of teen boys are diagnosed with ADHD. Credit: Getty]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p>Valerie Stivers is a senior editor of <em>UnHerd</em> US.</p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle>valerie_reads</unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[Valerie Stivers is a senior editor of <em>UnHerd</em> US.]]>
					</unherd:author_bio>
										<pubDate>Thu, 15 May 2025 22:56:18 +0000</pubDate>
					<updated>Fri, 16 May 2025 10:47:20 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Adderall]]></category>
		<category><![CDATA[ADHD]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[Culture]]></category>
		<category><![CDATA[Gen Z]]></category>
		<category><![CDATA[parenting]]></category>
		<category><![CDATA[The New York Times]]></category>
		<category><![CDATA[US]]></category>
					<guid isPermaLink="false">https://stage.unherd.com/?p=676600</guid>
																												<description>
								<![CDATA[Stop blaming the kids]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p><span style="font-weight: 400;">Last month, </span><i><span style="font-weight: 400;">The New York Times Magazine</span></i><span style="font-weight: 400;"> published a comprehensive story by journalist Paul Tough, on the current state of research into Attention Deficit Hyperactivity Disorder, or ADHD. The piece reached stark and groundbreaking conclusions. To put them bluntly, there is no reliable clinical or biological basis for an ADHD diagnosis, to such an extent that the leading researchers in the field have begun to speak of viewing the suite of behaviors associated with the condition in a different light. Plus: prescription amphetamines such as Ritalin and Adderall have proved ineffective at decreasing the symptoms over the long term, do not enhance learning and may be detrimental to it, and have worrisome physical side effects. </span></p>
<p><span style="font-weight: 400;">Yet Tough, throughout the article, and in later remarks in an interview with Adam B. Kushner for his morning newsletter for </span><i><span style="font-weight: 400;">The New York Times</span></i><span style="font-weight: 400;">, is reluctant to reach his own conclusions, and presents the material in carefully couched language such as “most researchers I spoke with believe that stimulant medications are, on the whole, a positive thing for children with ADHD.” And: “most scientists I spoke to agreed that the condition is produced by some combination of biological and environmental forces.”</span></p>
<p><span style="font-weight: 400;">This kind of hedging is understandable given the sensitivity of the topic for the families involved, and it accurately reflects the medical rhetoric, though not the science. Scientists can </span><i><span style="font-weight: 400;">believe</span></i><span style="font-weight: 400;"> and </span><i><span style="font-weight: 400;">agree to</span></i><span style="font-weight: 400;"> all kinds of things that aren’t based on evidence. And they have a powerful incentives to do so — institutional inertia, the difficulty of speaking out against a popular consensus, and the financial interests of their institutions and the pharmaceutical companies, to name just a few. However, if we want to slow the flood of pills — and, most important, help American schoolchildren, especially boys — we must fight the tendency to temporize. </span></p>
<p><span style="font-weight: 400;">Tough is the author of several books on education and child development, and is a meticulous researcher and long-form feature writer of the highest professional standing. He spent a year compiling the story, which is worth reading in full, and which appears to represent the most reputable, thorough, and mainstream analysis of today’s science. In it, he documents a situation that most American families are aware of — an explosion in ADHD diagnoses, which last year spiked to 11.5% (or 7 million kids), up from about 3% (or 2 million kids) in 1993. </span></p>
<p><span style="font-weight: 400;">Of those diagnosed, a disproportionate share are boys: 21% of 14-year-old boys and 23 percent of 17-year-old boys officially have ADHD, according to 2024 figures. The actual number displaying the collection of symptoms associated with ADHD is probably much higher, given that not all families pursue a formal diagnosis. Tough does not provide hard numbers on what percentage of those diagnosed are taking prescription stimulants such as Ritalin or Adderall, but says that it’s the “preferred” treatment. </span></p>
<div class="ref-ar"><a href="https://stage.unherd.com/2026/11/test-article/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2026/11/test-article/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="" /></a><div class="content"><a href="https://stage.unherd.com/2026/11/test-article/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">More from this author</span></a><a href="https://stage.unherd.com/2026/11/test-article/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Test article</h5></a><p class="author"><a href="https://stage.unherd.com/2026/11/test-article/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Valerie Stivers</a></p></div></a></div>
<p><span style="font-weight: 400;">Most Americans aren’t aware, however, of the sketchiness of the underlying science — which has always seemed pretty obvious to dissenters, but has now been conclusively demonstrated. The field started, Tough says, with an observation, made by a Harvard-trained psychiatrist in 1937, and since very widely replicated, that giving amphetamines to children classified as having behavioral problems has the “spectacular” effect of getting them to sit down and stay cheerfully focused on a task. Skeptics have pointed out that stimulants do that to everyone, and are popular precisely with people who wish to get through boring tasks more pleasantly (long-distance truckers, Fifties housewives, every college student unprepared for an exam). </span></p>
<p><span style="font-weight: 400;">Nonetheless, the ideas that the source of the children’s noncompliant behavior might be a physical deficit, and that the drug might correct it, has been compelling. Since the Nineties, massive amounts of research has gone into proving this attractive proposition by looking for a biomarker for ADHD (such as a gene or a correlation such as “less brain electrical activity”) and scientifically demonstrating the benefits of the treatment. </span></p>
<p><span style="font-weight: 400;">Initial results were promising, Tough writes. The Multimodal Treatment of Attention Deficit Hyperactivity Disorder Study, launched in the early Nineties and funded by National Institute of Mental Health, was “one of the largest studies ever undertaken of the long-term effects of any psychiatric medication.” In 1999, the researchers announced early results that Ritalin, their stimulant of choice, produced “significantly fewer symptoms” in children with ADHD after 14 months, compared to comparison groups of ADHD kids receiving only behavioral training or no interventions at all. </span></p>
<p><span style="font-weight: 400;">In 2017, in an effort to find a biomarker, an analysis of brain scans performed by the Enigma Consortium, a global network of scientists, announced that “patients with ADHD have altered brains; therefore ADHD is a disorder of the brain.” This was the “most ambitious” project to date, per Tough. However, his more recent conversations with the scientists who participated in those projects reveal a different story. </span></p>
<p><span style="font-weight: 400;">The brain-scan differences, he says, were either nonexistent among adults or “so minor as to be almost imperceptible” among children. Martine Hoogman, a Dutch neuroscientist who led the Enigma team, wrote to Tough in an email: “‘Back then, we emphasized the differences that we found (although small), but you can also conclude that the subcortical and cortical volumes of people with ADHD and those without ADHD are almost identical.…’ In retrospect, she added, it wasn’t fitting to conclude from her findings that A.D.H.D. is a brain disorder.” </span></p>
<p><span style="font-weight: 400;">As time passed, the MTA began to turn up different results. By 36 months on stimulants, improvements in children’s behavior had disappeared — in fact, children in all three groups demonstrated “exactly the same” level of symptoms. Moreover, careful observation of the children in question revealed a diagnosis in flux. As later studies have shown, sometimes they seemed to have ADHD, sometimes they didn’t. Sometimes children in a comparison group — who didn’t have it at the study’s outset — developed it. Tough quotes Edmund Sonuga-Barke, a researcher in psychiatry and neuroscience at King’s College London, as saying that “the traditional notion that there is a natural category of ‘people with ADHD’ that clinicians can objectively measure and define ‘just doesn’t seem to be the case.’” </span></p>
<div class="su-pullquote su-pullquote-align-left">“Why is the overall consensus, as Tough represents it, still so gentle in taking on the status quo?” </div>
<p><span style="font-weight: 400;">At the same time, situational explanations for the behaviors have seemed to grow in significance. A 2016 study published by researcher Arielle Lasky and members of the MTA group, Tough writes, interviewed adults in their mid-20s who had participated in the study as children. “Subject after subject spontaneously brought up the importance of finding their ‘niche,’ or the right ‘fit,’ in school or in the workplace,” he says. When the subjects found pursuits that were more interesting to them than school had been, their symptoms disappeared. Given such results and the difficulties of finding a biological cause, Sonuga-Barke proposes that we view ADHD not as a medical problem, but one of “misalignment” between what he tactfully calls “a child’s biological makeup” — but could also easily be called a child’s personality and situation in life — and “the environment in which they are trying to function.” </span></p>
<p><span style="font-weight: 400;">More disturbing information has come out as well. The MTA study found that after 36 months, children in the group taking Ritalin were on average one inch shorter than children in the control groups, and that the height lost was not made up later — they were still shorter as adults. And last year, a study published in </span><i><span style="font-weight: 400;">The American Journal of Psychiatry</span></i><span style="font-weight: 400;"> found that even a medium-strength daily dose of Adderall more than tripled a patient’s likelihood of developing psychosis or mania. </span></p>
<p><span style="font-weight: 400;">Several studies have also debunked the appealing assumption that better classroom behavior actually translates to better learning. Children work faster and behave better, but Tough’s conclusions are mostly reflected by the words of F. Xavier Castellanos, a neuroscience researcher at New York University, whom he quotes: “There’s a real disconnect between the almost awesome effects on behavior and the minimal effects on academic achievement or attainment.” A 2023 study on adults found subjects’ strategies for problem-solving became “significantly worse under the medication.” It shouldn’t take a neuroscientist: Most people with any experience with recreational drugs in this category have noticed the same effect. </span></p>
<p><span style="font-weight: 400;">So why is the overall consensus, as Tough represents it, still so gentle in taking on the status quo? Why do the researchers still </span><i><span style="font-weight: 400;">believe</span></i><span style="font-weight: 400;"> or </span><i><span style="font-weight: 400;">agree</span></i><span style="font-weight: 400;"> that the medications are beneficial? And why does someone as smart as Tough introduce paragraphs with careful sentences such as “the failure to find a clear biomarker doesn’t mean that there is no biological basis for ADHD”? </span></p>
<p><span style="font-weight: 400;">In most human affairs, the burden of proof is on those arguing </span><i><span style="font-weight: 400;">for</span></i><span style="font-weight: 400;"> something; we aren’t required to prove a negative to move on from a bad idea. Sonuga-Barke theorizes that research priorities have been distorted by the urgency of the children’s distress and the families&#8217; needs for a solution. “In the field, we’re so frightened that people will say it doesn’t exist,” he told Tough, referring specifically to the quest for the biomarker. “We have to double down because we’re terrified of what will happen to the kids who can’t get the meds. We’ve seen the impact they can have on people’s lives.”</span></p>
<div class="ref-ar"><a href="https://stage.unherd.com/2023/04/adderall-is-not-an-identity/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2023/04/adderall-is-not-an-identity/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2023/03/GettyImages-489912964-scaled.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2023/04/adderall-is-not-an-identity/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">More from this author</span></a><a href="https://stage.unherd.com/2023/04/adderall-is-not-an-identity/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Adderall is not an identity</h5></a><p class="author"><a href="https://stage.unherd.com/2023/04/adderall-is-not-an-identity/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Oliver Bateman</a></p></div></a></div>
<p><span style="font-weight: 400;">There is, however, urgency to a change of direction. For one thing, doctors who “believe” that stimulant medications are “on the whole, a positive thing” are unlikely to arm families with the information they need to make fully informed choices about their child’s health. The obfuscating language in Tough’s story surely is being replicated throughout the medical establishment. As James Swanson, a research psychologist who worked on the initial MTA study, told Tough, “If you’re honest, you should tell kids that, look, if you’re interested in next week or next month or even the next year, this is the right treatment for you. But in the long run, you’re going to be shorter. How many kids would agree to take medication? Probably none.” </span></p>
<p><span style="font-weight: 400;">And for another, the situation looks very different when you admit that the problem is not a physical deficit of some kind, but something afflicting a large share of children and, by my guess, most teenage boys. Diagnosing and possibly medicating these kids may get them through a bad time more successfully — it’s clearly a lifeline for many struggling families — but it does nothing to prevent the problem from arising, or to help the kids learn. </span></p>
<p><span style="font-weight: 400;">In his book </span><i><span style="font-weight: 400;">The Quick Fix: Why Fad Psychology Can’t Cure Our Social Ills</span></i><span style="font-weight: 400;">, which analyzes debunked science crazes in illuminating detail, the journalist Jesse Singal discovered that “at root, when society accepts a false story, it’s often because that story tells society something it wants to hear.” He also observes that it’s a pattern for junk science to be taken up when it provides “an easy way out” of a complicated problem. </span></p>
<p><span style="font-weight: 400;">In this light, we might conclude that ADHD has been an easy way to address (or not address) the vastly complicated problem that contemporary school is unsuited to the needs of a large percentage of the child population, especially boys, and desperately needs reform. We might target our attention on the long, physically confining days; the constant usage of attention-shattering screens; the stultifying conformity; the chaos-promoting soft-discipline; and the deeper questions, exacerbated by AI, of what any of it is doing and what it’s for. </span></p>
<p><span style="font-weight: 400;">Or we might target other things. But to target anything, we have to move the blame off the kids, where it never should have been in the first place. Our children’s bodies and personalities are not deficient. We are. </span></p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2025/05/how-adhd-medicine-failed-boys/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2025/05/how-adhd-medicine-failed-boys/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2025/05/how-adhd-medicine-failed-boys/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">676600</post-id>				</item>
									<item>
					<title>RFK’s drug-ad ban is a bipartisan win</title>
					<link>https://stage.unherd.com/2025/03/rfks-drug-ad-ban-is-a-bipartisan-win/?edition=us</link>
											<comments>https://stage.unherd.com/2025/03/rfks-drug-ad-ban-is-a-bipartisan-win/?edition=us#comments</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2025/03/RFK.jpg?w=525</unherd:featured_image>
										<unherd:main_theme>Big Pharma</unherd:main_theme>
					<dc:creator>
						<![CDATA[Ross Barkan]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2025/03/blue_720.png?w=96</unherd:creator_img>
																<unherd:article_ranking>International</unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[He has a number of nutsy ideas, but also some good ones. Credit: Getty]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p>Ross Barkan writes from New York<i data-stringify-type="italic">.</i></p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle>RossBarkan</unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[Ross Barkan writes from New York<i data-stringify-type="italic">.</i>]]>
					</unherd:author_bio>
										<pubDate>Wed, 26 Mar 2025 00:00:24 +0000</pubDate>
					<updated>Wed, 26 Mar 2025 16:17:29 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Advertising]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[first amendment]]></category>
		<category><![CDATA[Free Speech]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Politics]]></category>
		<category><![CDATA[RFK Jr.]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[Trump]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[Vaccine wars]]></category>
					<guid isPermaLink="false">https://stage.unherd.com/?p=665366</guid>
																												<description>
								<![CDATA[But will Trump support him?]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p><span style="font-weight: 400">It’s still a surreal sight: Robert F. Kennedy Jr. as America’s health secretary under President Trump. The scion of a Democratic dynasty who became an anti-vaccine gadfly and seemed, in his final years, doomed to irrelevancy — a Democratic campaign for president was going nowhere, and his independent bid wasn’t faring much better — is now one of the more powerful bureaucrats in America. There is much to be alarmed about with Kennedy, from his hatred of virtually </span><i><span style="font-weight: 400">all</span></i><span style="font-weight: 400"> vaccines to his belief that bird flu should be allowed to </span><a href="https://www.nytimes.com/2025/03/18/health/kennedy-bird-flu.html"><span style="font-weight: 400">run rampant</span></a><span style="font-weight: 400"> through poultry, but many on the Left make the mistake of dismissing him outright because he’s allied himself with Trump.</span></p>
<p><span style="font-weight: 400">The United States needs a health secretary who will, at the minimum, cast a skeptical eye on the pharmaceutical industry, which turns enormous profits and helps ensure American health care will always be commodified. Before the pandemic, most Democrats had little problem railing against Big Pharma. They were the villains, deservedly so, of the opioid epidemic, and it was not an exaggeration to say several of the pharmaceutical behemoths, most notably Purdue Pharma, had blood on their hands. </span></p>
<p><span style="font-weight: 400">When Covid arrived, however, the politics shifted. Republicans resisted the vaccines once President Joe Biden was in office, even though Operation Warp Speed had been a Team Trump accomplishment. Democrats defended the Covid vaccines and their manufacturers — Pfizer and Moderna, in particular — at all costs, even though the jabs did cause injuries in relatively rare instances and couldn’t stop the spread of the novel coronavirus as originally promised. </span></p>
<div class="ref-ar"><a href="https://stage.unherd.com/2024/11/robert-kennedy-jr-america-needs-a-revolution/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2024/11/robert-kennedy-jr-america-needs-a-revolution/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2023/05/GettyImages-1187910269-e1683048561502.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2024/11/robert-kennedy-jr-america-needs-a-revolution/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2024/11/robert-kennedy-jr-america-needs-a-revolution/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Robert Kennedy Jr: America needs a revolution</h5></a><p class="author"><a href="https://stage.unherd.com/2024/11/robert-kennedy-jr-america-needs-a-revolution/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Freddie Sayers</a></p></div></a></div>
<p><span style="font-weight: 400">Naturally, RFK Jr. was a Covid-vaccine skeptic. Hence he became, in the 2020s, a public enemy for many liberals. </span></p>
<p><span style="font-weight: 400">Yet he should be listened to when it comes to one of his most cherished causes: banning pharmaceutical advertising from television. In a sane world, this would be a bipartisan cause. Few countries on Earth allow pharmaceutical companies to relentlessly market their drugs to unsuspecting consumers. Non-Americans are always shocked by what is permitted on the airwaves. Turn on the television, especially the news, for any length of time, and you will be barraged by ads for every type of malady under the Sun. Since the Nineties, drug companies </span><a href="https://www.nytimes.com/2024/12/23/health/rfk-jr-tv-drug-ads-ban.html"><span style="font-weight: 400">have spent</span></a><span style="font-weight: 400"> tens of billions on these ads.</span></p>
<p><span style="font-weight: 400">Drug advertisements began appearing with regularity in newspapers and magazines in the Eighties, but they were mostly kept off TV by a requirement that ads naming a specific illness include the long list of side effects. In the late Nineties, the Food and Drug Administration relaxed its rules, permitting advertisers to briefly summarize the drug’s risks. The TV floodgates were thrown wide open. These days, the most aggressive campaigns are for newer medications that haven’t yet gone generic; competing brands duke it out in a packed field of similar drugs to reach patients with widespread conditions like arthritis and diabetes.</span></p>
<div class="ref-ar"><a href="https://stage.unherd.com/2025/01/how-maga-got-hooked-on-supplements/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2025/01/how-maga-got-hooked-on-supplements/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2025/01/RFK-Jr.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2025/01/how-maga-got-hooked-on-supplements/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2025/01/how-maga-got-hooked-on-supplements/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>How MAGA got hooked on supplements</h5></a><p class="author"><a href="https://stage.unherd.com/2025/01/how-maga-got-hooked-on-supplements/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Frederick Kaufman</a></p></div></a></div>
<p><span style="font-weight: 400">The average American drug ad is easily parodied but plainly effective. Typically, some older adults are shown in a cheery setting with friends and family. The color palette is bright. A narrator with a warm voice speaks about health challenges that might arise. The older adults are never shown to be in pain or distress; they might be taking a jog, playing with their dog, or firing up the grill. They’re bright-eyed, maybe laughing. Towards the end of the ad, the narrator will briefly summarize the drug’s side effects. Anyone with a morbid sense of humor can enjoy the contrast, just a bit: the scene remains focused on life’s joys as the narrator informs you the drug might cause rashes, bleeding, blackouts, or </span>suicidal thoughts (in “rare cases”, rest assured).</p>
<p><span style="font-weight: 400">But we know the big business of Big Pharma is no laughing matter. The drug companies are prepared to furiously fight any sort of ban that Kennedy might attempt. They will call up their expensive lobbyists on retainer in Washington to bend rank-and-file Republicans and Democrats to their will. They will probably get to Trump, who doesn’t feel passionately about the issue. </span></p>
<p><span style="font-weight: 400">The courts have snagged reforms in the past. Efforts to minimally restrict drug ads have repeatedly been defeated, often on First Amendment grounds. The first Trump administration tried to require that commercials mention the drug’s price, but a judge blocked the policy, saying that it lacked authority from Congress.</span></p>
<div class="ref-ar"><a href="https://stage.unherd.com/2024/09/why-rfk-jr-is-so-seductive/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2024/09/why-rfk-jr-is-so-seductive/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2024/09/image-2.png?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2024/09/why-rfk-jr-is-so-seductive/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2024/09/why-rfk-jr-is-so-seductive/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Why RFK Jr is so seductive</h5></a><p class="author"><a href="https://stage.unherd.com/2024/09/why-rfk-jr-is-so-seductive/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Lee Seigel</a></p></div></a></div>
<p><span style="font-weight: 400">Will Congress act? In theory, if Trump prioritized the ban, lawmakers could push it forward. The current Republican Party will obey Trump’s commands. The narrow majority the GOP holds in the House could be bolstered by a slew of progressive and populist Democrats who might view a fight with Big Pharma as a winning issue. Several centrist Democrats in swing districts, including Marie Gluesenkamp Perez in Washington state, campaigned on a platform that was critical of pharmaceutical companies.</span></p>
<p><span style="font-weight: 400">There’s a coalition to be built if the Trump administration takes the issue seriously. If a critical mass of Senate Republicans back legislation, it’s not hard to imagine the most Left-wing members of the Democratic conference, including Bernie Sanders and Elizabeth Warren, supporting a ban on TV ads. Chris Murphy, a Democratic senator from Connecticut who may run for president and has swerved in a more populist direction, could be a convert, too.</span></p>
<p><span style="font-weight: 400">But that’s the rub: Trump has never demonstrated that he is all that interested in the granular work of getting policy priorities through Congress. In the first term, he was content to let Mitch McConnell and Paul Ryan hash out a corporate tax cut and attempt — unsuccessfully — to repeal ObamaCare.</span></p>
<div class="su-pullquote su-pullquote-align-left">“What conservatives don’t quite understand is that the truest owning of the libs will come through triangulation.”</div>
<p><span style="font-weight: 400"> For now, Congress is focused on classic GOP priorities like tax cuts for the wealthy and gutting Medicaid, the health-care program that covers more than 70 million Americans. In addition to being cruel to the poor, a budget reconciliation package with tax and health-care cuts is likely to prove inflationary, especially when paired with tariffs. Beyond the tariffs, there’s no grander project here. The populism Trump promised isn’t being delivered — DOGE, and its wanton budget cuts, certainly aren’t it.</span></p>
<p><span style="font-weight: 400">What conservatives don’t quite understand is that the truest owning of the libs will come through triangulation. Trump can begin to subdue Democrats by pursuing policies like a ban on TV pharmaceutical ads, forcing the Left to stand with him for something popular or oppose him and appear extremely out of touch. Trump doesn’t seem to have that kind of savvy. He’s fine to let his party scheme over Medicaid cuts.</span></p>
<p><span style="font-weight: 400">That will not end well for the GOP. Democrats know how to campaign on health care, and taking it away from working-class people will make the 2026 midterms rather easy for the party out of power. Those political ads write themselves. They’ll be sandwiched between the 30-second spots for heart disease pills that may cause internal bleeding and murderous thoughts. In rare cases.</span></p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2025/03/rfks-drug-ad-ban-is-a-bipartisan-win/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2025/03/rfks-drug-ad-ban-is-a-bipartisan-win/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2025/03/rfks-drug-ad-ban-is-a-bipartisan-win/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">665366</post-id>				</item>
									<item>
					<title>Is liberal society making us ill?</title>
					<link>https://stage.unherd.com/2023/06/is-liberal-society-making-us-ill/?edition=us</link>
											<comments>https://stage.unherd.com/2023/06/is-liberal-society-making-us-ill/?edition=us#comments</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2023/06/GettyImages-1233063778-1-e1687880089499.jpg?w=509</unherd:featured_image>
										<unherd:main_theme></unherd:main_theme>
					<dc:creator>
						<![CDATA[Gurwinder Bhogal]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2023/06/blued-2.jpg?w=96</unherd:creator_img>
																<unherd:article_ranking></unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[Why are girls so overrepresented in the disorders de jour? (Kevin Frayer/Getty Images)]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p><strong>Gurwinder Bhogal</strong> is a blogger who writes about technology and psychology. His blog can be found at <a href="http://gurwinder.blog/" target="_blank" rel="noopener">gurwinder.blog</a>.</p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle>G_S_Bhogal</unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[ is a blogger who writes about technology and psychology. His blog can be found at <a href="http://gurwinder.blog/" target="_blank" rel="noopener">gurwinder.blog</a>.]]>
					</unherd:author_bio>
										<pubDate>Mon, 03 Jul 2023 00:00:00 +0000</pubDate>
					<updated>Mon, 17 Jul 2023 10:54:50 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[CBT]]></category>
		<category><![CDATA[Conservatism]]></category>
		<category><![CDATA[Don't miss]]></category>
		<category><![CDATA[Gender ideology]]></category>
		<category><![CDATA[GIDS]]></category>
		<category><![CDATA[Liberalism]]></category>
		<category><![CDATA[Long Covid]]></category>
		<category><![CDATA[Mental health]]></category>
		<category><![CDATA[mental illness]]></category>
		<category><![CDATA[NHS]]></category>
		<category><![CDATA[Psychiatry]]></category>
		<category><![CDATA[Psychology]]></category>
		<category><![CDATA[Social contagion]]></category>
		<category><![CDATA[Stoicism]]></category>
		<category><![CDATA[Tavistock Clinic]]></category>
					<guid isPermaLink="false">https://old.unherd.com/?p=477700</guid>
																												<description>
								<![CDATA[Social contagions plague a vulnerable demographic]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p>As rates of Covid-19 infection started to dwindle, there came signs of a much stranger pandemic: long Covid and its host of long-term complications. You might think that, since <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271824/" target="_blank" rel="noopener">men</a> and <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288963/" target="_blank" rel="noopener">older people</a> suffer the most complications from the virus, most of those with long Covid would be older men. But this is not so. According to a US Census Bureau <a href="https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm" target="_blank" rel="noopener">survey</a>, women are almost twice as likely as men to report having it, while transgender people are significantly more likely to do so than all other groups. A German <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495281/" target="_blank" rel="noopener">study</a>, meanwhile, concluded “there is accumulating evidence that adolescent girls are at particular risk of prolonged symptoms”.</p>
<p>Given that Covid tends to affect men more than women, why would long Covid affect women more than men? And given that Covid complications are <a href="https://www.ucl.ac.uk/news/2021/jul/covid-19-risks-severe-illness-children-shown-be-very-low#:~:text=The risk of severe illness,led by researchers at UCL." target="_blank" rel="noopener">extremely rare in the young</a>, why would teenage girls be disproportionately affected by long Covid? Finally, given that we can’t accuse a virus of transphobia, why would long Covid affect transgender people most?</p>
<p>The answer lies in the fact that long Covid is not a strictly physical phenomenon. A <a href="https://www.nature.com/articles/s41591-022-01909-w.pdf" target="_blank" rel="noopener">study</a> of nearly two million people published in <em>Nature </em>found that people who reported three or more symptoms of long Covid included: 4.9% of people confirmed to have had Covid, and 4% of people with no evidence of having had Covid. So, reporting the symptoms of long Covid is only moderately associated with a prior Covid infection. In fact, long Covid correlates about as much with mood disorders as with Covid itself. One <a href="https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2796097" target="_blank" rel="noopener">study</a> found that people prone to anxiety and depression before Covid infection were 45% more likely to develop long Covid after infection, and the <em>Nature</em> study found that having anxiety and depression before getting Covid almost doubled the chances of reporting long Covid.</p>
<p>This would help explain why women and trans people are disproportionately reporting long Covid: these two demographics have particularly high rates of anxiety and depression.</p>
<p>But why exactly would mood disorders increase the likelihood of long Covid? <a href="https://www1.racgp.org.au/newsgp/clinical/how-stress-can-increase-the-chances-of-long-covid" target="_blank" rel="noopener">Some experts</a> have speculated that stress may affect the immune system’s response to Covid and lead to more serious infections. However, a Turkish study found <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256149/#:~:text=In our study%2C no relationship,a diagnosis of COVID-19" target="_blank" rel="noopener">no evidence</a> that anxiety or depression alters the body’s immune response to the virus. A much likelier explanation could be that, since symptoms of mood disorders overlap with those of long Covid, people are mistaking psychological distress for the side-effects of viral infection.</p>
<p>This is part of a broader phenomenon. Young people are reporting despair and distress at an unprecedented rate, and this mental health crisis is a symptom of a malfunctioning society — a society that is making people sick, by teaching them to feel sick. The tendency for people to misdiagnose their despair as a medical disorder can be observed far beyond reports of long Covid. Consider the surge in cases of gender dysphoria. Between 2012 and 2022, the number of adolescents referred to the NHS’s Gender Identity Development Service (GIDS) increased by <a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/gender-dysphoria-clinical-programme/implementing-advice-from-the-cass-review/" target="_blank" rel="noopener">over 2000%</a>. If the increase were simply due to decreasing stigma around being trans, it wouldn’t be mostly restricted to a single sex and age range, but it has been driven almost exclusively by <a href="https://williamsinstitute.law.ucla.edu/publications/trans-adults-united-states/" target="_blank" rel="noopener">young people</a> and <a href="https://pubmed.ncbi.nlm.nih.gov/25612159/" target="_blank" rel="noopener">natal females</a>.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2022/04/mental-illness-doesnt-make-you-special/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2022/04/mental-illness-doesnt-make-you-special/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2022/04/21273022-e1651160775670.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2022/04/mental-illness-doesnt-make-you-special/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2022/04/mental-illness-doesnt-make-you-special/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Mental illness doesn&#039;t make you special</h5></a><p class="author"><a href="https://stage.unherd.com/2022/04/mental-illness-doesnt-make-you-special/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Freddie deBoer</a></p></div></a></div>
<p>The group that’s disproportionately reporting gender dysphoria — adolescent girls — appears to be the same demographic as the group deemed in the German study to be disproportionately at risk of long Covid. This is also the group, besides trans people, deemed <a href="https://www.cdc.gov/healthyyouth/data/yrbs/pdf/YRBS_Data-Summary-Trends_Report2023_508.pdf" target="_blank" rel="noopener">most at risk</a> of mood disorders. So, again, it seems many young people, particularly girls, are confusing general distress for another illness.</p>
<p>And it’s not just reports of gender dysphoria that have multiplied among young people. Increases have occurred for <a href="https://www.sciencedirect.com/science/article/pii/S2666560321000438" target="_blank" rel="noopener">major depressive disorder</a>, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616454/" target="_blank" rel="noopener">attention-deficit disorder</a>, <a href="https://www.psychologytoday.com/gb/blog/college-wellness/202304/is-ocd-increasing-in-college-students-since-covid-19" target="_blank" rel="noopener">obsessive-compulsive disorder</a>, <a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239133" target="_blank" rel="noopener">social anxiety disorder</a>, <a href="https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/trends-in-generalised-anxiety-disorders-and-symptoms-in-primary-care-uk-populationbased-cohort-study/5A04D331090B1CFB889ECDA8B8250D51" target="_blank" rel="noopener">generalised anxiety disorder</a>, <a href="https://acamh.onlinelibrary.wiley.com/doi/10.1111/jcpp.13505" target="_blank" rel="noopener">autism spectrum disorder</a>, and various <a href="https://www.rcpsych.ac.uk/news-and-features/latest-news/detail/2022/05/18/hospital-admissions-for-eating-disorders-increased-by-84-in-the-last-five-years" target="_blank" rel="noopener">eating disorders</a>. It seems that young people, and their doctors, are viewing personal issues as medical disorders: we are living through a pathologisation pandemic.</p>
<p>Why are so many people confusing sadness for sickness? It’s human nature to look for single causes to complex problems. The physician’s habit of ascribing all a patient’s symptoms to just one diagnosis led to the formulation of Hickam’s dictum, which states: “A man can have as many diseases as he damn well pleases.” Likewise, it’s tempting to look for a neat and simple reason for people blaming their troubles on a single disorder, but to do this would be to make the same mistake as them. Pathologisation can have as many causes as it damn well pleases.</p>
<p>One may be cyberchondria, the phenomenon whereby people anxiously google symptoms, and, due to confirmation bias, ignore those that don’t apply to them while focusing on those that do, until they become convinced they have the disorder they’re reading about. Another cause may be social contagion, whereby panic spreads through the power of suggestion. According to a UK <a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4192732" target="_blank" rel="noopener">study</a>, adolescents who reported parents suffering from long Covid were almost twice as likely to report experiencing long Covid symptoms themselves, regardless of whether they’d actually had Covid.</p>
<p>It’s <a href="https://journals.sagepub.com/doi/pdf/10.1177/03000605211039812" target="_blank" rel="noopener">known</a> that social contagions tend to affect girls more than boys, a disparity that could be exacerbated by girls <a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-018-5220-4" target="_blank" rel="noopener">tending</a> to use social media more than boys. But the problem with social contagion as an explanation is that it’s a how, not a why; it offers a means without a motive.</p>
<p>Some have attempted to discern a motive. One is that girls are trying to escape unattainable ideals of femininity. As the arms race of plastic surgery and beauty filters ramps up, natural bodies seem ugly by comparison. This “selfie dysmorphia” may lead to anxiety and depression, as well as symptoms of gender dysphoria, as pubescent girls become desperate to defy the metamorphosis of their bodies into sexual objects. But this explanation doesn’t shed much light on the rise of conditions like long Covid, autism, and obsessive-compulsive disorder. However, a deeper dive into the data does.</p>
<div class="ad-insert-events"></div>
<p>When we include politics in the mental health data, it becomes clear that this isn’t simply about gender. A 2020 Pew <a href="https://www.pewresearch.org/social-trends/dataset/covid-19-late-march-2020/" target="_blank" rel="noopener">survey</a> of over 10,000 people found that self-described liberals aged 18-29 were more likely than self-described conservatives of the same age to report suffering psychological problems over the last week. They were also more than twice as likely to say they’d ever been diagnosed with a mental health disorder. Furthermore, those who were “very liberal” were more likely than those who were just “liberal” to report poor mental health. The group most likely to report poor mental health was white liberal females, an alarming 56% of whom reported having received a mental illness diagnosis.</p>
<p>Crucially, controlling for worldview narrowed the gender gap considerably: liberal men were more likely to report poor mental health than conservative women. It would seem, then, that the mental health epidemic among girls and young women is associated with their tendency to have a <a href="https://theconversation.com/young-women-are-more-left-wing-than-men-study-reveals-95624" target="_blank" rel="noopener">more Left-liberal mindset</a> than boys and young men — a difference that’s becoming <a href="https://thehill.com/homenews/campaign/3675477-young-women-are-trending-liberal-young-men-are-not/" target="_blank" rel="noopener">more pronounced</a> over time.</p>
<p>But why would Leftism be associated with poorer mental health? An <a href="https://www.sciencedirect.com/science/article/pii/S2666560321000438" target="_blank" rel="noopener">analysis</a> of data from 86,138 adolescents found, in line with the Pew survey, that between 2005 and 2018 the self-reported mental health of liberals had deteriorated more than conservatives’, and that this deterioration was worst for girls. The researchers blamed this on “alienation within a growing conservative political climate”. However, the <em>New York Times</em>’ Michelle Goldberg <a href="https://www.nytimes.com/2023/02/24/opinion/social-media-and-teen-depression.html" target="_blank" rel="noopener">debunked</a> this explanation by pointing out that liberals’ mental health woes began while Obama was in power and as the Supreme Court voted to extend gay marriage rights — hardly a conservative political climate.</p>
<p>The real reasons may be deeper. One idea, more than any other, underpins the difference in outlook between liberals and conservatives. Central to Leftism is equality, backed by the idea that people’s fortunes and misfortunes are not their own doing, and therefore undeserved. As such, Leftism de-emphasises the role of human agency in social outcomes, while overemphasising the role of environmental circumstances. As the West has shifted culturally Leftward — due to most writers and artists leaning Left — the depiction of people as hapless puppets has become dominant.</p>
<p>Today’s Left-liberal culture teaches young people that their problems are not their own fault, but rather the product of various systems beyond their control. These systems may be sociological — late capitalism, systemic racism, the patriarchy — but increasingly, they are medical. A common example is “trauma”, a psychiatric term that has become a knee-jerk justification for everything from street crime to silencing opposing views on campus. It’s a word so overused that even clinicians <a href="https://www.vox.com/the-highlight/22876522/trauma-covid-word-origin-mental-health" target="_blank" rel="noopener">fear</a> it has lost its meaning. Most people, however, are happy to have their personal failings blamed on medical issues, because it absolves them of responsibility. It’s not your fault you violently lashed out, you have trauma. It’s not your fault you lack energy, you have long Covid. It’s not your fault you hate the way you look, you have gender dysphoria.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2023/02/the-tragedy-of-becoming-a-woman/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2023/02/the-tragedy-of-becoming-a-woman/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2023/02/GettyImages-1224709686-2-scaled-e1676311578620.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2023/02/the-tragedy-of-becoming-a-woman/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2023/02/the-tragedy-of-becoming-a-woman/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>The tragedy of becoming a woman</h5></a><p class="author"><a href="https://stage.unherd.com/2023/02/the-tragedy-of-becoming-a-woman/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Sarah Ditum</a></p></div></a></div>
<p>Pathologisation is also an effective way to manufacture sympathy. The co-founder of Black Lives Matter, Patrisse Cullors, <a href="https://www.latimes.com/california/story/2022-01-13/patrisse-cullors-black-lives-matter" target="_blank" rel="noopener">responded</a> to accusations she’d used donation money to enrich friends and family by claiming that the accusations had given her post-traumatic stress disorder, a diagnosis once reserved for rape survivors and war veterans.</p>
<p>Claims like Cullors’s are instinctively met with sympathy and even awe on the Left, where overeager attempts to destigmatise mental illness can end up glamorising it. On social media, young liberals now engage in “sadfishing”, a kind of digital Munchausen’s Syndrome, where people fabricate ailments for pity and clout; some, such as the TikToker “<a href="https://www.youtube.com/watch?v=DIKuxiRAh8g" target="_blank" rel="noopener">TicsAndRoses</a>”, fake Tourette’s, while <a href="https://www.rollingstone.com/culture/culture-features/wonderland-system-tiktok-dissociative-identity-disorder-1283571/" target="_blank" rel="noopener">others</a> fake multiple personalities. The power of mental health disorders to attract attention online has turned them into fashion accessories, cute quirks to help kids stand out from the crowd, or <a href="https://inews.co.uk/inews-lifestyle/tourettes-part-dating-appeal-2408897" target="_blank" rel="noopener">“part of my dating appeal”</a>.</p>
<p>Unfortunately, these designer disorders are not just harmless labels; intentional pathologisation by influencers is causing unintentional pathologisation among viewers. <a href="https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mdc3.13316" target="_blank" rel="noopener">Reports</a> tell of adolescent girls suddenly developing “TikTok tics” after viewing videos of alleged Tourette’s sufferers. <a href="https://www.psychologytoday.com/gb/blog/abcs-child-psychiatry/202203/the-tiktok-inspired-surge-dissociative-identity-disorder" target="_blank" rel="noopener">Others</a> tell of adolescents presenting with multiple personalities after watching videos of people claiming to have dissociative identity disorder. As atomisation makes people more desperate for sympathy, and competition makes them more desperate for attention, it’s likely that sadfishing and its consequences will only worsen.</p>
<p>But as disturbing as all this is, victimhood culture is not the only force behind the pathologisation pandemic. It’s been abetted by a medical industry that has its own incentives for exaggerating the prevalence of mental disorders.</p>
<p>Medicalisation — the tendency for clinicians to recategorise ever more things as medical issues — occurs because clinicians are just as human as their patients, and are therefore just as influenced by culture and their own personal biases. The 1973 <a href="https://www.newscientist.com/definition/the-rosenhan-experiment/" target="_blank" rel="noopener">Rosenhan experiment</a> showed that psychiatrists who have been told that a healthy person is insane will begin to reinterpret that person&#8217;s ordinary behaviours, such as note-taking, as manifestations of their mental disorder. We saw this in the Tavistock scandal, where the staff of the infamous Gids clinic, conditioned by ideologues to look for gender dysphoria, became increasingly hasty to diagnose it.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2023/04/the-media-is-spreading-bad-trans-science/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2023/04/the-media-is-spreading-bad-trans-science/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2023/04/GettyImages-1245528886-1-e1681805956225.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2023/04/the-media-is-spreading-bad-trans-science/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2023/04/the-media-is-spreading-bad-trans-science/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>The media is spreading bad trans science</h5></a><p class="author"><a href="https://stage.unherd.com/2023/04/the-media-is-spreading-bad-trans-science/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Jesse Singal</a></p></div></a></div>
<p>The ability of clinicians to see precisely the symptoms they’re looking for is facilitated by <a href="https://psycnet.apa.org/record/2016-08154-001" target="_blank" rel="noopener">concept creep</a>, the tendency for the definitions of disorders to gradually expand to encompass more people. The rise in autism diagnoses, for instance, can be <a href="https://jamanetwork.com/journals/jamapediatrics/fullarticle/1919642" target="_blank" rel="noopener">largely attributed</a> to a diagnostic widening of the autism spectrum. Concept creep occurs largely due to the Shirky principle, which states: “Institutions will try to preserve the problems to which they are the solution.” The motive is often financial; the number of pregnancies deemed to require caesarean sections has increased because this method of delivering babies is <a href="https://blogs.lse.ac.uk/businessreview/2021/09/24/financial-incentives-to-doctors-and-the-high-rates-of-caesarean-births/" target="_blank" rel="noopener">more profitable</a>. Likewise, if you’re simply sad then medical companies can’t monetise you, but if your distress is reclassified as, say, gender dysphoria, those companies can sell you puberty blockers or surgical procedures. By 2021, GIDS accounted for a <a href="https://www.youtube.com/watch?v=kdBfHwzDYLg" target="_blank" rel="noopener">quarter</a> of the Tavistock trust’s income. In the States, the sex reassignment surgery market was <a href="https://www.grandviewresearch.com/industry-analysis/us-sex-reassignment-surgery-market" target="_blank" rel="noopener">valued</a> at $1.9 billion and is projected to have a lucrative annual growth rate of 11.23%.</p>
<p>So, we have a medical industry that is both financially and ideologically motivated to overstate the prevalence of illness, and we have a victimhood culture that encourages people to view themselves as oppressed by things they can’t control. In the middle of this we have ordinary people tempted to blame their problems on medical issues for the sake of easy answers.</p>
<p>These three entities together form a mutually reinforcing system. The late philosopher Ian Hacking, in his book <em>Rewriting the Soul</em>, details how in the 20th century, the press, the public, and the medical industry operated in tandem to create new forms of madness out of mere gossip. Prior to 1970, there were almost no cases of multiple personality disorder (now known as dissociative identity disorder), but after one case was well-publicised by the media, people began using the concept of multiple personalities to make sense of their own problems. In so doing, they began to conform, wittingly or otherwise, to the official symptoms of the disorder. When clinicians speculated that people may invent multiple personalities to deal with childhood sexual abuse, people began to do just that. Some even suddenly &#8220;remembered&#8221; being sexually abused, even though the concept of repressed memories has no basis in fact. Initially, patients reported having two or three personalities. Within a decade, the average number was <a href="https://www.lrb.co.uk/the-paper/v28/n16/ian-hacking/making-up-people" target="_blank" rel="noopener">17</a>.</p>
<p>Thus, patient reports influenced clinicians’ diagnoses, but clinicians’ diagnoses also influenced patient reports. Diagnostic criteria became prescriptive as well as descriptive; they told patients how they were supposed to feel and act. Hacking called this cycle of mutual reinforcement a “looping effect”, and it proved so powerful that it turned a couple of isolated cases into an epidemic. A similar looping effect, facilitated by a hyperconnected world, seems to be driving the rise in reports of mental illness today.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2022/11/who-decides-if-youre-mentally-ill/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2022/11/who-decides-if-youre-mentally-ill/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2022/11/GettyImages-1236992135-copy-scaled-e1667319525149.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2022/11/who-decides-if-youre-mentally-ill/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2022/11/who-decides-if-youre-mentally-ill/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Who decides if you&#039;re mentally ill?</h5></a><p class="author"><a href="https://stage.unherd.com/2022/11/who-decides-if-youre-mentally-ill/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Hannah Baer</a></p></div></a></div>
<p>This is a problem because imagined sickness can cause real sickness. This occurs in two ways. The first is direct: in rural India, folklore tells that being bitten by a pregnant dog can make one pregnant with the dog’s puppies, and this urban myth has created a new illness: puppy pregnancy syndrome. Victims become so convinced they’re pregnant with puppies that they suffer panic attacks and even manifest symptoms of pregnancy, from persistent nausea to the sensation of puppies crawling in their bellies.</p>
<p>But the second way fake sickness becomes real is far more common and insidious.</p>
<p>Remember how Leftism de-emphasises human agency in the name of equality? <a href="https://journals.sagepub.com/doi/abs/10.1177/0002764213506215" target="_blank" rel="noopener">Research</a> shows conservatives tend to have an internal locus of control, which means they believe that their decisions, as opposed to external forces, control their destiny. Liberals, meanwhile, tend to have an external locus, which means they believe their lives are determined by forces beyond their control.</p>
<p>The American psychologists Jonathan Haidt and Jean Twenge used national <a href="https://nida.nih.gov/research-topics/trends-statistics/monitoring-future" target="_blank" rel="noopener">survey</a> data of adolescents to map their locus of control. Their findings were based on the proportion of respondents who agreed with statements such as: “People like me don’t have a chance at a successful life” and “Whenever I try to get ahead, something stops me”. They concluded that, since the Nineties, the locus of control for all teenagers has <a href="https://jonathanhaidt.substack.com/p/mental-health-liberal-girls" target="_blank" rel="noopener">become more external</a>, but the shift has been greater for liberals, and greatest for liberal girls. Further, when the self-worth of teenagers was mapped, using responses to statements such as “I feel my life is not very useful”, the data showed a universal decline in self-worth since 2012. Again, the decline was stronger for liberals, and strongest for liberal girls.</p>
<p>People with an internal locus of control, believing they control their destiny, tend to be <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9432765/" target="_blank" rel="noopener">happier</a> and have <a href="https://pubmed.ncbi.nlm.nih.gov/11762867/" target="_blank" rel="noopener">healthier habits</a>, like good diets and frequent exercise, while people with an external locus of control, believing they’re at the mercy of fate, have <a href="https://www.sciencedirect.com/science/article/abs/pii/S0165032718325916" target="_blank" rel="noopener">higher rates</a> of anxiety and depression and are <a href="https://royalsocietypublishing.org/doi/10.1098/rsos.181133" target="_blank" rel="noopener">more likely</a> to abuse drugs and neglect their health. When you believe you have no control, you don’t.</p>
<p>And thus, as society has liberalised, and medicalised, young people have lost both self-belief and resilience. Many have subsequently become trapped in a cycle where they feel distress, and pathologise it, causing more distress, leading to more pathologisation and more distress, which eventually becomes textbook anxiety and depression. The rise in diagnoses is therefore not simply an illusion caused by medicalisation; society is teaching kids to develop real dysfunctions.</p>
<p>This is the greatest danger of the pathologisation pandemic: belief in one’s sickness is self-fulfilling. It’s a disease not of any bodily organ but of hope itself, and it harms its victim by crippling their immunity to everything else.</p>
<p>If there’s a vaccine for the pathologisation pandemic, then the best candidate is Cognitive Behavioural Therapy (CBT). This is a form of talk-based treatment based on the Ancient Greek philosophy of Stoicism. Contrary to modernity, it teaches that our feelings are not always valid, but often deluded and self-destructive. The aim is to reframe harmful thoughts into alternatives that are more accurate, agentic, and soluble. So, instead of “The world sucks”, one could think “I feel like the world sucks right now”. Where pathologisation places problems outside your control, CBT places them within your control. Where pathologisation bundles many small issues into one giant insurmountable problem, CBT breaks down giant problems into small manageable pieces.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2022/08/can-depression-be-cured/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2022/08/can-depression-be-cured/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2022/08/GettyImages-459964106-scaled.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2022/08/can-depression-be-cured/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2022/08/can-depression-be-cured/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Can depression be cured?</h5></a><p class="author"><a href="https://stage.unherd.com/2022/08/can-depression-be-cured/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Ann Manov</a></p></div></a></div>
<p>No form of psychotherapy has been as rigorously tested as CBT, and its effectiveness in restoring agency and reigniting hope is <a href="https://www.cambridge.org/core/journals/psychological-medicine/article/evidence-for-cognitive-behavioural-therapy-in-any-condition-population-or-context-a-metareview-of-systematic-reviews-and-panoramic-metaanalysis/3BE55E078F21F06CFF90FFAD1ACEA5E0" target="_blank" rel="noopener">documented</a> <a href="https://www.sciencedirect.com/science/article/abs/pii/S0272735805001005?via%3Dihub" target="_blank" rel="noopener">by</a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797481/" target="_blank" rel="noopener">decades</a> <a href="https://onlinelibrary.wiley.com/doi/10.1002/wps.21069" target="_blank" rel="noopener">of</a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584580/" target="_blank" rel="noopener">research</a>. Some <a href="https://uit.no/Content/418448/The%20effect%20of%20CBT%20is%20falling.pdf" target="_blank" rel="noopener">studies</a> suggest CBT is gradually losing effectiveness, but this is mostly because CBT, like everything else in the social sciences, has been corrupted by amateurisation and the desire to be “inclusive” and inoffensive. The newest forms of CBT, such as “Transgender-Affirmative CBT”, are the opposite of classic CBT because they seek not to cultivate strength but to validate feelings.</p>
<p>More than ever, a return is needed to the original, Stoicism-based form of CBT, which has helped everyone from the philosopher-emperor Marcus Aurelius, who governed Rome during a time of war and plague, to Vietnam POW James Stockdale, who used it to withstand torture at the notorious “Hanoi Hilton”. The ultimate cure to rampant pathologisation is to prepare the young to do battle against their greatest foe — their own minds — and to teach them a time-tested truth, bequeathed to us by history’s survivors: you are more than the things that happen to you. And you have as much control over your life as you believe you do.</p>
<p>Many of the misfortunes that befall you will not be your fault, but if you seek explanations for your suffering in things beyond your control, you risk falling prey to a culture and industry that are motivated to keep you feeling ill. Look within for the causes and, most times, you’ll find the cures. Modern society will tell you otherwise, of course, but it’s within your power to defy it, for you are not a helpless leaf in the wind but a mind that holds a world, which, depending on how you think, could be a Hell in Heaven, or a Heaven in Hell.</p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2023/06/is-liberal-society-making-us-ill/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2023/06/is-liberal-society-making-us-ill/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2023/06/is-liberal-society-making-us-ill/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">477700</post-id>				</item>
									<item>
					<title>The grubby truth about mental health memoirs</title>
					<link>https://stage.unherd.com/2022/10/the-grubby-truth-about-mental-health-memoirs/?edition=us</link>
											<comments>https://stage.unherd.com/2022/10/the-grubby-truth-about-mental-health-memoirs/?edition=us#comments</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2022/10/AAAABbmTgERjoN0ivDB04lqvJ-2C0iMeP3fJ33vS9qICY5WNeDRWeef1vTNXAZDtsyGBM9fBoninJjyyA_9VEUftu6Oxow88axCeCMQV.jpeg?w=622</unherd:featured_image>
										<unherd:main_theme></unherd:main_theme>
					<dc:creator>
						<![CDATA[Freddie deBoer]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2022/04/guy-7.jpg?w=96</unherd:creator_img>
																<unherd:article_ranking></unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[The temptation to sensationalise stories of mental health is strong. Credit: Girl, Interrupted via IMDB]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p><strong>Freddie deBoer</strong> is a writer and academic. His newsletter can be found at <a href="https://freddiedeboer.substack.com/" target="_blank" rel="noopener">freddiedeboer.substack.com</a>.</p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle></unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[ is a writer and academic. His newsletter can be found at <a href="https://freddiedeboer.substack.com/" target="_blank" rel="noopener">freddiedeboer.substack.com</a>.]]>
					</unherd:author_bio>
										<pubDate>Fri, 21 Oct 2022 23:15:00 +0000</pubDate>
					<updated>Sat, 22 Oct 2022 14:57:04 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[Bipolar]]></category>
		<category><![CDATA[Depression]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Memoir]]></category>
		<category><![CDATA[Mental health]]></category>
		<category><![CDATA[mental illness]]></category>
		<category><![CDATA[Neurology]]></category>
		<category><![CDATA[Psychiatry]]></category>
		<category><![CDATA[Psychology]]></category>
					<guid isPermaLink="false">https://old.unherd.com/?p=448463</guid>
																												<description>
								<![CDATA[I envy people who remember their illness]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p>I don’t quite know what to do with mental illness memoirs. I’m naturally interested in their subject, as I suffer from bipolar disorder myself. And they fulfil an important social function: despite the rise of innumerable online voices yelling about mental health and ableism, the reality of psychiatric illness remains unknown to most people. Personal narratives tell us things that medical literature doesn’t. The more stories we tell, the more we might expand our moral imagination for the sick.</p>
<p>And yet I worry, too. I worry because selling a book, especially for any kind of decent advance, is a tricky business, and the temptation to be prurient and sensationalist must be considerable. I am a <a href="https://stage.unherd.com/2022/04/mental-illness-doesnt-make-you-special/" target="_blank" rel="noopener">committed enemy of romanticising mental illness</a>, which contributes to the impression that the mentally ill are somehow living deeper, more “intense” lives, rather than more painful ones. I want mental health memoirists to understand their profound responsibility to tell the grubby, sad truth about this life.</p>
<div class="ad-insert"></div>
<p>But mostly, I envy people who write mental illness memoirs. I envy their memories. They can recall the details of their psychiatric histories; I often can’t. Years have passed, faster and faster, since the major incidents in the history of my condition. For important portions of that history, I was brutally depressed, or grindingly manic, or actively psychotic, conditions not conducive to the formation of lasting memories. I have spent 15 years on and off (though mostly off) memory-destroying medications, and have now been on them for five years straight. And for most of that time I was actively in denial, about all of it, to the point of believing at points that it wasn’t real. I did not tell my siblings, those I was always closest to, for more than a decade after my first diagnosis. Sometimes I’d assert that I was finally on the straight and narrow, finally cured — an assertion that always, always preceded the next ruinous crash.</p>
<p>Some things I remember like they were yesterday. Some I don’t remember at all. When I write about my own mental health history, I write in ellipses and at a Dutch angle — for aesthetics, yes, to satisfy my own standards as a writer, but also because to tell it otherwise would make me feel like a liar. I just don’t trust my memory of some details.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2022/04/mental-illness-doesnt-make-you-special/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2022/04/mental-illness-doesnt-make-you-special/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2022/04/21273022-e1651160775670.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2022/04/mental-illness-doesnt-make-you-special/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">More from this author</span></a><a href="https://stage.unherd.com/2022/04/mental-illness-doesnt-make-you-special/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Mental illness doesn&#039;t make you special</h5></a><p class="author"><a href="https://stage.unherd.com/2022/04/mental-illness-doesnt-make-you-special/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Freddie deBoer</a></p></div></a></div>
<p>I have spotted a similar instinct in other mental health memoirs. <em>Girl, Interrupted</em> is imagistic and ruminative, much less a recounting of the day-by-day events of Susanna Kaysen’s commitment to McLean Hospital, and much more a series of pleasantly meandering meditations on the concept of sanity and the self. Kaysen also includes original forms and files from her hospital stay; George Scialabba&#8217;s brilliant and haunting <em>How to be Depressed </em>consists of little else.</p>
<p>And then there’s <em>Strangers to Ourselves</em>. It’s not a straightforward memoir but rather a collection of brief vignettes, or case studies, about mental illness, written by Rachel Aviv. Her own story opens the volume. She became anorexic as a six-year-old, barely literate, and mostly unable to define what was happening to her. Aviv leaves unsettled the question of whether she was “really” anorexic — her age and stated motives for not eating complicate the question — and instead contrasts her own condition with those of the older patients around her. By reproducing her own experience of mental illness, Aviv brings a little skin to the game in a text that’s mostly about telling other people’s stories for them.</p>
<p>More important, her personal history segues into Aviv setting the boundaries of her project. The book is about people whose “lives unfold in different eras and cultures, but they also share a setting: the psychic hinterlands, the outer edges of human experience, where language tends to fail”. She explains her holistic approach:</p>
<p style="padding-left: 40px;">&#8220;the book draws not only from conversations with them but from their diaries, letters, unpublished memoirs, poems, and prayers… It’s impossible to go back in time and uncover what baseline feelings existed before a story was told — when a person’s angst and loneliness and disorientation had yet to be given a name and a vessel — but I find myself searching for the gap between people’s experiences and the stories that organise their suffering, sometimes defining the course of their lives.&#8221;</p>
<p>This is what I needed, from this book, up front: both information about how these individual stories were compiled and an acknowledgment that we all, as patients, construct truths with the raw material of memories that so often refuse to cohere, and therefore use the textual record to confirm and supplement our stories. In the opening section, she quotes her younger self as writing: “I had some thing that was a siknis its cald anexorea.” I was initially sceptical: it sounds like an adult writing the way they think a child would write. But Aviv later explains that she had dug out her childhood diary. I didn’t need her to do so to make her recollection of her illness more real; it just helps to know that the exact wording came from the page and not her memory.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2022/10/dont-punish-kanye-west/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2022/10/dont-punish-kanye-west/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2022/10/GettyImages-612082132-1.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2022/10/dont-punish-kanye-west/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2022/10/dont-punish-kanye-west/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Don&#039;t punish Kanye West</h5></a><p class="author"><a href="https://stage.unherd.com/2022/10/dont-punish-kanye-west/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Hadley Freeman</a></p></div></a></div>
<p>Sometimes, texts are all there is to go on. Aviv can’t speak to some of her subjects, such as Ray, a depressive who has been dead for years. Instead, she pulls significantly from his unpublished memoir, which follows his decision to sue a psychiatric facility where he was committed. Ray struggled through psychoanalysis at Chestnut Lodge, where he lived in for long months, only to come later to feel that he had been fooled by a broken paradigm that forbade the use of antidepressants. As Aviv tells it, Ray’s psychiatrist seemed to think of such drugs as a shortcut rather than a cure, and therefore avoided their use.</p>
<p>Aviv tells Ray’s story both for its own sake and to consider the fundamental conflict in late 20th-century psychiatry. The Freudian assumption that all psychiatric conditions could be traced to discrete events in childhood, and cured through excavating these memories in psychoanalysis, dominated American psychiatry for decades. It led a lot of patients to endlessly recite early traumas, without much therapeutic gain. That approach was overtaken by an ascendant hope that new drugs could fix chemical imbalances in the brain and turn psychiatry into a medical field like any other. Now, we appear to have swung back the other way: decades of disappointments in psychopharmacology have inspired many to declare that “there’s no such thing as a chemical imbalance”, which has become an inescapable social media bromide.</p>
<p>What frustrates me is that people seem unable to accept that the interaction between the brain and the mind is extremely complex. That the simplistic not-enough-serotonin theory of depression appears to be wrong does not imply that <em>all</em> neurological explanations are off-limits. We don’t have to yaw constantly between “all brain” and “all mind” explanations. Aviv, thankfully, settles on no pat answers to these questions, instead, simply meditating on them via Ray’s strange story.</p>
<p>Likewise, she uses every case study to examine the nuances of some broader social or economic or political issue. There’s Bapu, a Brahmin-class Indian woman whose religious adherence straddles the line between faith and madness; her story considers the conflict between Western medicine and spiritualism. There’s Naomi, a young black mother whose deepening paranoia compels her to attempt to drown herself and her two young children; her story illustrates how entrenched racism complicates psychiatric care for people of colour. There’s Laura, an affluent young woman who starts taking a cocktail of medications at a young age and finds it very hard to stop; her narrative helps explore the thorny questions of how long patients should stay on drugs. It’s never advisable to draw too deeply from individual stories in analysing societal trends, but the connections Aviv draws to such trends give the book teeth, making it more than merely poignant.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2022/08/can-depression-be-cured/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2022/08/can-depression-be-cured/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2022/08/GettyImages-459964106-scaled.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2022/08/can-depression-be-cured/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2022/08/can-depression-be-cured/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Can depression be cured?</h5></a><p class="author"><a href="https://stage.unherd.com/2022/08/can-depression-be-cured/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Ann Manov</a></p></div></a></div>
<p>The final section enables us to consider Aviv’s responsibility to her subjects and the difficulties of telling their stories. It focuses on Hava, an anorexic who Aviv encountered at a young age and whose life she sees as something of a road untraveled, given her own early struggles. Hava appeared to be making clear progress in her life, finding a steady boyfriend and planning for her future; sadly, years of making herself sick had damaged her body’s ability to regulate the reflex, and one night she choked on her own vomit in her sleep. She is one the three people profiled who were dead prior to the completion of the book, but Aviv’s deference to their own words makes their stories seem like memoirs all the same.</p>
<p>Perhaps it’s a sign of solipsism that this book often provoked me to wonder what Aviv would make of my story. I crave the simplicity of having my life printed out in black and white text; I also dread the inevitably reductive nature of such an exercise, and I’m scared of what someone else’s eyes might see in my narrative. For me personally, mysteries abound. I couldn’t possibly tell you the name of the doctor who diagnosed me as bipolar. At the time, I was not conscious in a conventional sense and everything that happened seemed to happen somewhere outside of me, people puttering around and talking in strange language I didn’t understand. There was an ER, there was a shot of haloperidol, and there was a stretch in a grey and muted psychiatric facility. Someone must have written my diagnosis down on a chart. Who that was is known only to God and, I imagine, to some mouldering file somewhere that I have absolutely no interest in digging up.</p>
<p>There are a lot of things I don’t understand about my own history. Worse, I can’t remember if the weight of years, mental illness and medication has simply obscured that knowledge, or if I never knew. In general, my time in the mental health system has been marked by constant confusion; I would feel like a liar if I said, “and then this month, in 2011, this happened”.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2022/08/the-curse-of-miserable-older-white-women/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2022/08/the-curse-of-miserable-older-white-women/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2022/08/GettyImages-84959843-scaled.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2022/08/the-curse-of-miserable-older-white-women/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2022/08/the-curse-of-miserable-older-white-women/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>The curse of Miserable Older White Women</h5></a><p class="author"><a href="https://stage.unherd.com/2022/08/the-curse-of-miserable-older-white-women/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Phoebe Maltz Bovy</a></p></div></a></div>
<p>Do the subjects in <em>Strangers to Ourselves </em>struggle the same way? What must it feel like, for those who are still living, to read this book? Aviv tends to avoid the overly literal, rescuing the book from questions of simple authenticity and making it, usefully, a record of how foggy our recollections can be. But I can also imagine readers who might be frustrated by the lack of clear lines between certain truth and imperfect memory. All of us long for order in the stories we read. I think that’s why people gravitate towards mental illness narratives, to clarify something that has been obscured by instability. But how do you faithfully translate what is by its nature not translatable?</p>
<p>I honestly don’t think writers tell lies in mental illness memoirs. I wouldn’t even say they bend the truth. I would suggest, perhaps, that they take the fragments of what they know happened, and through them assert a kind of truth, as part of a therapeutic process. That asserted truth might not look exactly like that of a dispassionate observer — say, one of the many doctors who wander into our lives, speak to us condescendingly, make marks on a chart, and shuffle out of our story. But I can’t see much harm done, when patients tell it themselves. The conceit of a memoir is that other people will be entertained by our misfortune; so long as we tell our stories with integrity, those who suffer through the instability and boredom and deprivation of dignity common to serious mental illness are entitled to our own frames. I only hope that both writers and readers know that the attempt to organise the experience is quixotic and we are narrativising the un-narrativisable. I understand the feeling that we must try anyway.</p>
<p>Aviv, like me, is wary of the way that definition can trap and limit us. In our online culture of mental illness, diagnoses are celebrated: young people wield them like talismans for a sense of validation. And I am not entirely a stranger to the seductive power of becoming one’s diagnosis, letting it become the load-bearing element of your personality. But I am also no stranger to the way that, further down the road, that self-definition becomes cramped and uncomfortable, even horrifying, as you start to want to be something else. (To the newly-diagnosed, I urge you, do not become your illness.) For years I resisted writing anything about my mental illness; now I worry constantly that when I do so, I pigeonhole and limit myself.</p>
<p>“People can feel freed by these stories,” Aviv writes, “but they can also get stuck in them… a role that at first seemed freeing, but it began to destroy them.” This is the most recurrent theme in <em>Strangers to Ourselves</em>: the double-edged sword of the stories we tell to make our disorders comprehensible. Aviv’s is the kind of mental illness narrative I trust and value the most: suspicious of narrative itself. It’s perhaps a kind I could even write myself. The bigger kind, the longer kind, the “and then this happened on this date” kind, is both beyond my abilities and against my best interest. As Aviv writes, “there are stories that save us, and stories that trap us, and in the midst of an illness it can be very hard to know which is which”.</p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2022/10/the-grubby-truth-about-mental-health-memoirs/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2022/10/the-grubby-truth-about-mental-health-memoirs/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2022/10/the-grubby-truth-about-mental-health-memoirs/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">448463</post-id>				</item>
									<item>
					<title>Covid has created a capitalist nightmare</title>
					<link>https://stage.unherd.com/2022/02/covid-has-created-a-capitalist-nightmare/?edition=us</link>
											<comments>https://stage.unherd.com/2022/02/covid-has-created-a-capitalist-nightmare/?edition=us#comments</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2022/02/2GettyImages-74356685-scaled-e1645554686260.jpg?w=757</unherd:featured_image>
										<unherd:main_theme></unherd:main_theme>
					<dc:creator>
						<![CDATA[Thomas Fazi]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2021/04/Toby-Green.jpg?w=96</unherd:creator_img>
																<unherd:article_ranking></unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[We have lost. (China Photos/Getty Images)]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p><strong>Thomas Fazi</strong> is an <em>UnHerd</em> columnist and translator. His latest book is <a href="https://www.hurstpublishers.com/book/the-covid-consensus/" target="_blank" rel="noopener">The Covid Consensus</a>, co-authored with Toby Green.</p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle>battleforeurope</unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[ is a professor of history and associate of the Global Health Institute at King's College, London. His<span style="font-weight: 400;"> new book about Crispina Peres, <em>The Heretic of Cacheu</em>, is published by Allen, Lane</span><span style="font-weight: 400;">.</span>]]>
					</unherd:author_bio>
										<pubDate>Wed, 23 Feb 2022 00:01:39 +0000</pubDate>
					<updated>Wed, 23 Feb 2022 00:01:39 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Amazon]]></category>
		<category><![CDATA[Apple]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[Big tech]]></category>
		<category><![CDATA[Blackrock]]></category>
		<category><![CDATA[Capitalism]]></category>
		<category><![CDATA[Covid]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Facebook]]></category>
		<category><![CDATA[Feudalism]]></category>
		<category><![CDATA[Google]]></category>
		<category><![CDATA[lockdown]]></category>
		<category><![CDATA[Pandemic]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Wealth]]></category>
					<guid isPermaLink="false">https://old.unherd.com/?p=362926</guid>
																												<description>
								<![CDATA[Big Tech and Big Pharma are more powerful than ever ]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p>Over the past two years, as the pandemic claimed the lives of millions of people and upturned the lives of everyone else, a silent revolution was taking place. Western capitalism suddenly found itself usurped; replaced by an even more oligarchic and authoritarian capitalist mode of power — what we might call neo-feudalism. Even as restrictions are lifted in the UK and other countries, the consequences of these changes will be felt for a long time to come.</p>
<p>On the one hand, hundreds of thousands of small and medium businesses were forced to shut down, triggering <a href="https://www.oecd.org/employment/covid-19.htm" target="_blank" rel="noopener">one of the worst jobs crises since the Great Depression.</a> In 2020 alone, <a href="https://www.ilo.org/global/about-the-ilo/newsroom/news/WCMS_766949/lang--en/index.htm" target="_blank" rel="noopener">workers</a> around the world cumulatively lost $3.7 trillion in earnings — an 8.3% decline.</p>
<p>On the other, a handful of mega-corporations, particularly in the Big Tech and Big Pharma sectors, have made a killing, <a href="https://policy-practice.oxfam.org/resources/power-profits-and-the-pandemic-from-corporate-extraction-for-the-few-to-an-econ-621044/" target="_blank" rel="noopener">raking in hundreds of billions more in “pandemic super-profits”</a> than over the previous four-year average. Topping the list are behemoths such as Amazon, Apple, Microsoft, Alphabet (Google), Facebook, Pfizer, Johnson &amp; Johnson, AstraZeneca and Merck.</p>
<div class="ad-insert"></div>
<p>The success of the Tech giants — Amazon, Apple, Microsoft, Alphabet, Facebook — is easily explained. As people found themselves confined to their homes, they turned to the internet for pretty much everything: shopping, dining, working, schooling, entertainment, socialising, even sex. In other words, what represented a curse for countless small and medium traditional businesses, represented a blessing for a handful of corporate behemoths.</p>
<p>The golden egg for the pharmaceutical companies, however, came later with the vaccines: the <a href="https://www.oxfam.org/en/press-releases/pfizer-biontech-and-moderna-making-1000-profit-every-second-while-worlds-poorest" target="_blank" rel="noopener">companies</a> behind two of the most successful Covid-19 vaccines — Pfizer, BioNTech and Moderna — made combined profits of $34 billion in 2021. And if the “new normal” ends up including permanent booster shots, such super-profits will become the norm. Crucially, these profits are then distributed to shareholders who predominantly belong to the richest 1% of society. It’s hardly surprising then that billionaires around the world <a href="https://www.oxfam.org/en/research/inequality-virus" target="_blank" rel="noopener">saw their wealth increase by $3.9 trillion</a> just in 2020. As Oxfam starkly put it <a href="https://oxfamilibrary.openrepository.com/bitstream/handle/10546/621341/bp-inequality-kills-170122-en.pdf" target="_blank" rel="noopener">in a recent report</a>: “The wealth of the 10 richest men has doubled, while the incomes of 99% of humanity are worse off”.</p>
<p>To see what this means in practice, one need only turn to Latin America, whose billionaires increased their wealth by <a href="https://forbes.co/2022/01/17/economia-y-finanzas/pandemia-aumento-52-la-riqueza-de-millonarios-latinos-pero-ahondo-la-pobreza-oxfam/" target="_blank" rel="noopener">52% during the pandemic</a>. In Mexico, meanwhile, multimillionaires saw their wealth increase <a href="https://es.sports.yahoo.com/noticias/multimillonarios-m%C3%A9xico-31-ricos-cierre-000038571.html?guccounter=1&amp;guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvLnVrLw&amp;guce_referrer_sig=AQAAABpm1IutWFbP5cbzNEZkRHif-KlbR5EtITDLmu_U_DYF1fe26wJdbMfKhfIxOsYEKKsSDIjtjrF8uINiVIu12exMZS6s4RteY3h-foj9ixxzroDBicMXcOfieWVWyuRMtkqXO4QGMiDl0e2Aa9E66lPvwQqqJxXOyZ20UBxsKW81">by 31.4%</a> in 2021 alone. On the other hand, over the last two years, <a href="https://www.telesurtv.net/opinion/200-millones-de-personas-en-pobreza-dejo-la-pandemia-en-America-Latina-20211211-0007.html" target="_blank" rel="noopener">78 million people</a> in the region were plunged into extreme poverty, while 13% of children abandoned education altogether.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2021/11/the-lefts-covid-failure/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2021/11/the-lefts-covid-failure/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2021/11/GettyImages-1236694526-scaled-copy.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2021/11/the-lefts-covid-failure/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">More from these authors</span></a><a href="https://stage.unherd.com/2021/11/the-lefts-covid-failure/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>The Left&#039;s Covid failure</h5></a><p class="author"><a href="https://stage.unherd.com/2021/11/the-lefts-covid-failure/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Thomas Fazi and Toby Green</a></p></div></a></div>
<p>In Africa, where low-income countries predominate, the picture is equally stark. A <a href="https://reliefweb.int/report/world/economic-recovery-covid-19-prospects-sub-saharan-africa" target="_blank" rel="noopener">report</a> this month noted that not only had GDP fallen by as much as 7.8% in some cases, but that remittances from abroad had fallen by 25%. In a context where remittances from rich countries accounted for <a href="https://unctad.org/press-material/edar-facts-and-figures-unctad-economic-development-africa-report-2018" target="_blank" rel="noopener">over half of private capital flows</a> to Africa shortly prior to the pandemic, this has had a devastating effect on the daily economy, with <a href="https://reliefweb.int/report/world/economic-recovery-covid-19-prospects-sub-saharan-africa" target="_blank" rel="noopener">over 40 million additional people</a> in extreme poverty.</p>
<p>Couple this with a <a href="https://stage.unherd.com/thepost/the-worlds-poorest-countries-are-facing-an-unprecedented-debt-crisis/" target="_blank" rel="noopener">debt crisis</a>, and it is not surprising that the impact on daily lives has been devastating: in Angola, a <a href="https://www.youtube.com/watch?v=9oamsSMBFFI&amp;t=950s" target="_blank" rel="noopener">recent report</a> described how youth unemployment doubled to nearly 60% in the past two years. Meanwhile, the continent’s billionaires have seen an uptick in their fortunes, as elsewhere; a <a href="https://www.premiumtimesng.com/news/top-news/507655-despite-pandemic-africas-billionaires-15-richer-in-2021.html" target="_blank" rel="noopener">January report from Nigeria</a> found that Africa’s 18 billionaires had seen their wealth increase by 15% in 2021 alone.</p>
<p>Yet in many ways this is a global phenomenon; on every continent, there has been a hyper-concentration of wealth, and poorer communities have suffered. Wealth has been further racialised, with minority communities suffering the most in rich countries, and poorer continents the worst affected.</p>
<p>Why, then, have Left-leaning commentators supported the policies that have led to these terrible outcomes?</p>
<p>The usual explanation is that these impacts were an inevitable impact of the pandemic. And yet the evidence for this is weak, not least because most of those affected by the virus have been elderly people often beyond an age of active employment. In <a href="https://africanarguments.org/2021/12/medical-colonialism-pandemic-impacts-and-vaccine-delivery/" target="_blank" rel="noopener">Africa</a>, a 1% increase in mortality from Covid in a country like Nigeria cannot explain the 20% collapse in formal employment. In fact, Tanzania — one of the very few countries that did not impose Covid restrictions in 2020 — was also almost the only country in Africa <a href="https://www.prospectmagazine.co.uk/world/for-poor-countries-lockdowns-cost-more-lives-than-they-save" target="_blank" rel="noopener">to see its GDP increase</a>, by as much as 5% according to some reports. Meanwhile in Sweden, where restrictions were much milder than in the rest of Europe, the country returned to pre-pandemic levels of production <a href="https://www.theguardian.com/business/2022/jan/02/a-wounded-pm-and-ailing-economy-forces-england-to-go-swedish-on-covid" target="_blank" rel="noopener">by the middle of 2021</a>, in contrast to many other European countries (while registering lower per capita mortality rates than many other countries).</p>
<p>And so it seems that the staggering increase in inequality, and in the concentration of capital, must be the consequence of the Covid response measures, not of Covid-19. What, then, are some of the likely consequences of this massive accumulation of capital by a tiny number of people, expropriated from SME owners and the global working class?</p>
<p>A dystopian future seems to be emerging from the ashes of the pandemic — one in which not only is wealth more concentrated than ever in the hands of a small elite, but in which practically every sector of the economy is dominated by a handful of all-powerful mega-corporations. Perhaps it&#8217;s unsurprising, then, that those who have most profited from the pandemic response, such as Bill Gates and Mark Zuckerberg, also supported that response and removed information from their portals which criticised it.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2022/02/the-covid-regime-has-fooled-us-all/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2022/02/the-covid-regime-has-fooled-us-all/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2022/02/GettyImages-1231940432-1.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2022/02/the-covid-regime-has-fooled-us-all/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2022/02/the-covid-regime-has-fooled-us-all/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>The Covid regime has fooled us all</h5></a><p class="author"><a href="https://stage.unherd.com/2022/02/the-covid-regime-has-fooled-us-all/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Jacob Siegel</a></p></div></a></div>
<p>However, there’s a further element that makes this scenario even more disturbing, if possible, and that is the growing consolidation not only within, but also between, sectors. This becomes evident when we look at the investment funds that actually “own” these corporations. BlackRock and Vanguard are the two largest asset management firms in the world, respectively managing <a href="https://www.ft.com/content/7603e676-779b-4c13-8f46-a964594e3c2f" target="_blank" rel="noopener">$10</a> and $8 trillion. That’s 3.7 and 3 times more than the UK’s annual GDP. These two funds are the top “owners” of all the major Big Pharma (Pfizer, Johnson &amp; Johnson, Merck), Big Tech (Facebook, Twitter) and Big Media (New York Times, Time Warner, Comcast, Disney, News Corp) corporations. Even more worrying is the fact that despite having shareholdings of “only” 5-7% in these companies, there is <a href="https://bse.eu/sites/default/files/working_paper_pdfs/1216.pdf" target="_blank" rel="noopener">growing evidence</a> that institutional investors such as BlackRock and Vanguard try to influence company management and boards on strategy.</p>
<p>It would appear that these funds also coordinate among themselves. When analysing the voting behaviour in board meetings of the two funds, <a href="https://doi.org/10.1017/bap.2017.6" target="_blank" rel="noopener">researchers found</a> that they coordinate it through centralised corporate governance departments. This is hardly surprising if we consider that BlackRock and Vanguard are also <a href="https://money.cnn.com/quote/shareholders/shareholders.html?symb=BLK&amp;subView=institutional" target="_blank" rel="noopener">each other’s main institutional investors</a>: in other words, they partially “own” each other through cross-shareholding. So, we are effectively in the presence of a single super-entity that “owns” and controls a huge chunk of the Western economy. While this <a href="https://www.cambridge.org/core/journals/business-and-politics/article/hidden-power-of-the-big-three-passive-index-funds-reconcentration-of-corporate-ownership-and-new-financial-risk/30AD689509AAD62F5B677E916C28C4B6">was already the case before the pandemic</a>, the latter has accelerated this trend. More importantly, it has brought to the surface the way in which these funds, through their cross-sector corporate control, can “harmonise” these companies’ behaviour to further their interests.</p>
<p>We can see this in the case of debate around pandemic strategies on social media, and the censorship exercised today by social media platforms against any critical voice, no matter how qualified. A good example might be the <a href="https://www.youtube.com/watch?v=dSF1T3pnvYY" target="_blank" rel="noopener">removal from YouTube</a> of a video of a senior editor of the <em>British Medical Journal</em>, Peter Doshi, discussing the Pfizer Covid vaccine trial <a href="https://mark-skidmore.com/2021/11/06/dr-peter-doshis-remarkable-speech-everybody-knows/" target="_blank" rel="noopener">in a US Senate hearing</a> — in which among other things Doshi had questioned the accuracy of the reporting of the Pfizer vaccine effectiveness.</p>
<p>This is worrying in itself. But it becomes even more worrying when we consider that the companies selling the vaccine, the media outlets shaping the mainstream vaccine narrative and the social media platforms enforcing that narrative are, to a large degree, “owned” and controlled by the same two funds: BlackRock and Vanguard, which, incidentally, <a href="https://www.cityam.com/blackrock-and-vanguard-rake-in-billions-omicron-variant-made-moderna-and-pfizer-shareholders-10bn-in-a-week/" target="_blank" rel="noopener">are raking in billions</a> from the vaccines. This harmonisation among sectors (and between the latter and governments) points to the rise of a new ultra-powerful complex — the techno-media-pharma (TMP) complex. This is evident in increased “synergies” between these sectors: take Google’s growing investments in the health, pharmaceutical and pandemic-prevention sectors, for example, <a href="https://aws.amazon.com/government-education/nonprofits/" target="_blank" rel="noopener">or Amazon’s investment in Covid-19 research.</a></p>
<p>Of course, none of this would be possible without <a href="https://www.businessinsider.com/case-against-covid-industrial-complex-pandemic-pharma-politicians-tech-profiting-2021-3?r=US&amp;IR=T" target="_blank" rel="noopener">the active support of governments</a>, which create an enabling environment that rewards participants in the TMP complex. This is evident, for example, in the secrecy, overpricing, cronyism, and inefficiency that has characterised Covid procurement deals: Covid tests, PPE, vaccines, and now vaccine passport technologies have all been parcelled out to transnational corporations without proper tendering processes or legislative oversight. In other words, this is not a scenario in which governments disappear, but rather one that relies on increasingly powerful and authoritarian state apparatuses furthering the interests of big capital.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2022/02/new-zealands-lockdown-fairytale-is-over/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2022/02/new-zealands-lockdown-fairytale-is-over/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2022/02/GettyImages-1369677038-2.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2022/02/new-zealands-lockdown-fairytale-is-over/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2022/02/new-zealands-lockdown-fairytale-is-over/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>New Zealand&#039;s lockdown fairytale is over</h5></a><p class="author"><a href="https://stage.unherd.com/2022/02/new-zealands-lockdown-fairytale-is-over/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Tom Chodor</a></p></div></a></div>
<p>This is hardly surprising when we consider the extent to which these corporate giants have meshed with our political systems. The US is a good case in point. <a href="https://www.techtransparencyproject.org/articles/eric-schmidt-obamas-chief-corporate-ally" target="_blank" rel="noopener">Obama was very close to Eric Schmidt, CEO of Google,</a> who later became a close collaborator of the Pentagon in developing military <a href="https://www.washingtonpost.com/politics/2021/11/22/former-google-ceo-speaks-out-working-with-pentagon/" target="_blank" rel="noopener">applications of AI</a>. Today, Biden’s economic policies are heavily influenced by the director of the National Economic Council, <a href="https://en.wikipedia.org/wiki/Brian_Deese" target="_blank" rel="noopener">Brian Deese, a former BlackRock executive</a>. This ultra-elite is now in a position to shape every aspect of our lives — and it’s frankly terrifying.</p>
<p>If the Left is to recover from <a href="https://stage.unherd.com/2021/11/the-lefts-covid-failure/" target="_blank" rel="noopener">the catastrophic policies that it has supported during the pandemic</a>, it must begin by recognising that it is lazy and misplaced to denounce those who point out these inconvenient truths: that wealth is hyper-concentrated as never before, that this is as a result of the policy choices during the pandemic, that these choices were unprecedented, and have been supported by those who enriched themselves enormously along the way, and censored any alternative point of view.</p>
<p>If we don’t want a world dominated by a very few ultra-wealthy people, and their vision for retaining that wealth, an unprecedented collective effort will be needed to fight for a different future. The huge TMP conglomerates will have to be broken up and their profits used for the benefit of all humanity, and not just their shareholders. This will be the struggle against the post-pandemic capitalist nightmare — and we are already losing.</p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2022/02/covid-has-created-a-capitalist-nightmare/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2022/02/covid-has-created-a-capitalist-nightmare/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2022/02/covid-has-created-a-capitalist-nightmare/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">362926</post-id>				</item>
									<item>
					<title>How science has been corrupted</title>
					<link>https://stage.unherd.com/2021/12/how-science-has-been-corrupted-2/?edition=us</link>
											<comments>https://stage.unherd.com/2021/12/how-science-has-been-corrupted-2/?edition=us#comments</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2021/05/gettyimages-1211656392-594x594-1.jpg?w=541</unherd:featured_image>
										<unherd:main_theme></unherd:main_theme>
					<dc:creator>
						<![CDATA[Matthew Crawford]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2020/05/mattcrawford.png?w=96</unherd:creator_img>
																<unherd:article_ranking></unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[Increasingly, science is pressed into duty as authority. Kevin Frayer/Getty]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p><strong>Matthew B Crawford</strong> is a Future of Freedom Research Fellow at the Independent Institute, as well as a senior fellow at the Institute for Advanced Studies in Culture. He writes the Substack <a href="https://mcrawford.substack.com/" target="_blank" rel="noopener">Archedelia</a>.</p>
<p>&nbsp;</p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle></unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[ is a Future of Freedom Research Fellow at the Independent Institute, as well as a senior fellow at the Institute for Advanced Studies in Culture. He writes the Substack <a href="https://mcrawford.substack.com/" target="_blank" rel="noopener">Archedelia</a>.

&nbsp;]]>
					</unherd:author_bio>
										<pubDate>Tue, 21 Dec 2021 00:00:39 +0000</pubDate>
					<updated>Tue, 21 Dec 2021 00:00:39 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Best of 2021]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[CCP]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Covid]]></category>
		<category><![CDATA[Science]]></category>
					<guid isPermaLink="false">https://old.unherd.com/?p=299341</guid>
																												<description>
								<![CDATA[The pandemic has revealed a darkly authoritarian side to expertise]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p>When I was small, my father would conduct experiments around the house. When you blow across the top of a wine bottle, how many modes of vibration are there? How do you get the higher notes?</p>
<p>Another time, the matter under investigation might be the “angle of repose” of a pile of sand, as in an hour-glass. Does it depend on the particle size? On their shape? Do these factors determine the rate at which an hour-glass empties?</p>
<p>My favorite was the question of what technique will empty a jug of water fastest. Should you simply turn it upside down and let the air rush in (as it must, to replace the water) in that halting, glug-glug-glug fashion, or hold it at a gentler angle so the pour is unbroken? Answer: turn the jug upside down and swirl it vigorously to set up a whirlpool effect. This creates a hollow space at the centre of the flow, where air is free to enter. The jug will empty very quickly.</p>
<p>My father became famous for these “kitchen physics” experiments after he included assignments based on them in a textbook he wrote, published in 1968 and beloved by generations of physics students: <em><a href="https://www.abebooks.co.uk/Waves-Berkeley-Physics-Course-Vol-3/10291625501/bd" target="_blank" rel="noopener">Waves (Berkeley Physics Course, Vol. 3)</a>.</em> My sister and I, aged two and five, are thanked in the acknowledgments for having surrendered our Slinkies to the cause.</p>
<div><div style="left: 0; width: 100%; height: 0; position: relative; padding-bottom: 56.25%;"><iframe src="//cdn.iframe.ly/api/iframe?url=https%3A%2F%2Fyoutu.be%2F2oro0ttU2_A&amp;key=357d953055da7177194e1a84a2d8a5a3&amp;playerjs=1" style="border: 0; top: 0; left: 0; width: 100%; height: 100%; position: absolute;" allowfullscreen scrolling="no" allow="encrypted-media; accelerometer; gyroscope; picture-in-picture; autoplay"></iframe></div></div>
&nbsp;
<p>He pursued such investigations, not simply as a pedagogical exercise, but to satisfy his own curiosity. And he made time for this even while working at the frontier of particle physics, in the lab of Louis Alvarez at Lawrence Berkeley Laboratory. This was fairly early on in the transition of the practice of science into “big science”.</p>
<p>Alvarez won the Nobel Prize in 1968 for his invention and use of the bubble chamber, an instrument for detecting particle decays. It was a device that would comfortably fit on a table top. Today you can build one yourself, if you like. But over the next few decades particle accelerators became enormous installations (CERN, SLAC) requiring the kind of real estate only governments and major institutions, indeed consortiums of institutions, can secure. Scientific papers came to have, not a handful of authors, but hundreds. Scientists became scientist-bureaucrats: savvy institutional players adept at getting government grants, managing sprawling workforces, and building research empires.</p>
<p>Inevitably, such an environment selected for certain human types, the kind who would find such a life appealing. A healthy dose of careerism and political talent was required. Such qualities are orthogonal, let us say, to the underlying truth-motive of science.</p>
<p>You can well imagine the appeal of getting back to basics for someone who was drawn to a scientific career when the prospect had a more intimate scale to it. Kitchen physics is about the pure intellectual refreshment of wondering about something that you observe in the world with your own unaided powers, and then investigating it. This is the basic image we have of what science is, immortalised in the anecdote of Galileo going up into the leaning tower of Pisa and dropping various objects to see how fast they fall.</p>
<p><strong>Science as authority</strong></p>
<p>In 1633, Galileo was brought before the Inquisition for his demonstration that the earth is not fixed but revolves around the sun. This was a problem, obviously, because the ecclesiastical authorities believed their legitimacy rested on a claim to have an adequate grasp of reality, as indeed it did. Galileo had no interest in being a martyr, and recanted to save his skin. But in the lore of Enlightenment, he is said to have muttered under his breath, “but it does move!”</p>
<p>This anecdote has a prominent place in the story we tell about what it means to be modern. On one side, science with its devotion to truth. On the other side, authority, whether ecclesiastical or political. In this tale, “science” stands for a freedom of the mind that is inherently at odds with the idea of authority.</p>
<p>The pandemic has brought into relief a dissonance between our idealised image of science, on the one hand, and the work “science” is called upon to do in our society, on the other. I think the dissonance can be traced to this mismatch between science as an activity of the solitary mind, and the institutional reality of it. Big science is fundamentally social in its practice, and with this comes certain entailments.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2021/08/how-china-could-win-the-lab-leak-debate/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2021/08/how-china-could-win-the-lab-leak-debate/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2021/08/GettyImages-1219964516-e1628784655702-1.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2021/08/how-china-could-win-the-lab-leak-debate/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2021/08/how-china-could-win-the-lab-leak-debate/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Science journals have been corrupted by China</h5></a><p class="author"><a href="https://stage.unherd.com/2021/08/how-china-could-win-the-lab-leak-debate/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Ian Birrell</a></p></div></a></div>
<p>As a practical matter, “politicised science” is the only kind there is (or rather, the only kind you are likely to hear about). But it is precisely the apolitical image of science, as disinterested arbiter of reality, that makes it such a powerful instrument of politics. This contradiction is now out in the open. The “anti-science” tendencies of populism are in significant measure a response to the gap that has opened up between the practice of science and the ideal that underwrites its authority. As a way of generating knowledge, it is the pride of science to be falsifiable (unlike religion).</p>
<p>Yet what sort of authority would it be that insists its own grasp of reality is merely provisional? Presumably, the whole point of authority is to explain reality and provide certainty in an uncertain world, for the sake of social coordination, even at the price of simplification. To serve the role assigned it, science must become something more like religion.</p>
<p>The chorus of complaints about a declining “faith in science” states the problem almost too frankly. The most reprobate among us are climate sceptics, unless those be the Covid deniers, who are charged with not obeying the science. If all this has a medieval sound, it ought to give us pause.</p>
<p>We live in a mixed regime, an unstable hybrid of democratic and technocratic forms of authority. Science and popular opinion must be made to speak with one voice as far as possible, or there is conflict. According to the official story, we try to harmonise scientific knowledge and opinion through education. But in reality, science is hard, and there is a lot of it. We have to take it mostly on faith. That goes for most journalists and professors, as well as plumbers. The work of reconciling science and public opinion is carried out, not through education, but through a kind of distributed demagogy, or Scientism. We are learning that this is not a stable solution to the perennial problem of authority that every society must solve.</p>
<p>The phrase “follow the science” has a false ring to it. That is because science doesn’t <em>lead</em> anywhere. It can illuminate various courses of action, by quantifying the risks and specifying the tradeoffs. But it can’t make the necessary choices for us. By pretending otherwise, decision-makers can avoid taking responsibility for the choices they make on our behalf.</p>
<p>Increasingly, science is pressed into duty as authority. It is invoked to legitimise the transfer of sovereignty from democratic to technocratic bodies, and as a device for insulating such moves from the realm of political contest.</p>
<p>Over the past year, a fearful public has acquiesced to an extraordinary extension of expert jurisdiction over every domain of life. A pattern of “government by emergency” has become prominent, in which resistance to such incursions are characterised as “anti-science”.</p>
<p>But the question of political legitimacy hanging over rule by experts is not likely to go away. If anything, it will be more fiercely fought in coming years as leaders of governing bodies invoke a climate emergency that is said to require a wholesale transformation of society. We need to know how we arrived here.</p>
<p>In <a href="https://www.abebooks.co.uk/9781732265141/Revolt-Public-Crisis-Authority-New-1732265143/plp"><em>The Revolt of the Public</em></a>, former intelligence analyst Martin Gurri traces the roots of a “politics of negation” that has engulfed Western societies, tied to a wholesale collapse of authority across all domains ­— politics, journalism, finance, religion, science. He blames it on the internet. Authority has always been located in hierarchical structures of expertise, guarded by accreditation and long apprenticeship, whose members develop a “reflexive loathing of the amateur trespasser”.</p>
<p>For authority to be really authoritative, it must claim an epistemic monopoly of some kind, whether of priestly or scientific knowledge. In the 20th century, especially after the spectacular successes of the Manhattan Project and the Apollo moon landing, there developed a spiral wherein the public came to expect miracles of technical expertise (flying cars and moon colonies were thought to be imminent). Reciprocally, stoking expectations of social utility is normalised in the processes of grant-seeking and institutional competition that are now inseparable from scientific practice.</p>
<p>The system was sustainable, if uneasily so, as long as inevitable failures could be kept offstage. This required robust gatekeeping, such that the assessment of institutional performance was an intra-elite affair (the blue-ribbon commission; peer review), allowing for the development of “informal pacts of mutual protection”, as Gurri puts it. The internet, and the social media which disseminate instances of failure with relish, have made such gatekeeping impossible. That is the core of the very parsimonious and illuminating argument by which Gurri accounts for the revolt of the public.</p>
<p>In recent years, <a href="https://www.firstthings.com/article/2016/05/scientific-regress" target="_blank" rel="noopener">a replication crisis</a> in science has swept aside a disturbing number of the findings once thought robust in many fields. This has included findings that lie at the foundation of whole research programs and scientific empires, now crumbled. The reasons for these failures are fascinating, and provide a glimpse into the human element of scientific practice.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/07/why-we-stopped-trusting-experts/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/07/why-we-stopped-trusting-experts/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/07/GettyImages-671580868-e1594809567505.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/07/why-we-stopped-trusting-experts/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2020/07/why-we-stopped-trusting-experts/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Why we stopped trusting &#039;experts&#039;</h5></a><p class="author"><a href="https://stage.unherd.com/2020/07/why-we-stopped-trusting-experts/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Oliver Traldi</a></p></div></a></div>
<p>Henry H. Bauer, chemistry professor and former dean of arts and sciences at Virginia Tech, <a href="https://www.ivorcatt.co.uk/x2av.htm" target="_blank" rel="noopener">published a paper in 2004</a> in which he undertook to describe how science is actually conducted in the 21st century: it is, he says, fundamentally corporate (in the sense of being collective). “It remains to be appreciated that 21st-century science is a different kind of thing than the ‘modern science’ of the 17th through 20th centuries….”</p>
<p>Now, science is primarily organised around “knowledge monopolies” that exclude dissident views. They do so not as a matter of piecemeal failures of open-mindedness by individuals jealous of their turf, but systemically.</p>
<p>The all-important process of peer review depends on disinterestedness, as well as competence. “Since about the middle of the 20th century, however, the costs of research and the need for teams of cooperating specialists have made it increasingly difficult to find reviewers who are both directly knowledgeable and also disinterested; truly informed people are effectively either colleagues or competitors.”</p>
<p>Bauer writes that “journeymen peer-reviewers tend to stifle rather than encourage creativity and genuine innovation. Centralized funding and centralized decision-making make science more bureaucratic and less an activity of independent, self-motivated truth-seekers.” In universities, “the measure of scientific achievement becomes the amount of ‘research support’ brought in, not the production of useful knowledge”. (University administrations skim a standard 50% off the top of any grant to cover the “indirect costs” of supporting the research.)</p>
<p>Given the resources required to conduct big science, it needs to serve some institutional master, whether that be commercial or governmental. In the last 12 months we have seen the pharmaceutical industry and its underlying capacity for scientific accomplishment at its best. The development of mRNA vaccines represents a breakthrough of real consequence. This has occurred in commercial laboratories that were temporarily relieved of the need to impress financial markets or stoke consumer demand by large infusions of government support. This ought to give pause to the political reflex to demonise pharmaceutical companies that is prevalent on both the Left and the Right.</p>
<p>But it cannot be assumed that “the bottom line” exerts a disciplining function on scientific research that automatically aligns it with the truth motive. Notoriously, pharmaceutical companies have, on a significant scale, paid physicians to praise, recommend and prescribe their products, and recruited researchers to put their names to articles ghost-written by the firms which are then placed in scientific and professional journals. Worse, the clinical trials whose results are relied upon by federal agencies in deciding whether to approve drugs as safe and effective are generally conducted or commissioned by the pharmaceutical companies themselves.</p>
<p>The bigness of big science — both the corporate form of the activity, and its need for large resources generated otherwise than by science itself — places science squarely in the world of extra-scientific concerns, then. Including those concerns taken up by political lobbies. If the concern has a high profile, any dissent from the official consensus may be hazardous to an investigator’s career.</p>
<p>Public opinion polls generally indicate that what “everybody knows” about some scientific matter, and its bearing on public interests, will be identical to the well-institutionalized view. This is unsurprising, given the role the media plays in creating consensus. Journalists, rarely competent to assess scientific statements critically, cooperate in propagating the pronouncements of self-protecting “research cartels” as science.</p>
<p>Bauer’s concept of a research cartel came into public awareness in an episode that occurred five years after his article appeared. In 2009, someone hacked the emails of the Climate Research Unit at the University of East Anglia in Britain and released them, prompting the “climategate” scandal in which the scientists who sat atop the climate bureaucracy were revealed to be stonewalling against requests for their data from outsiders. This was at a time when many fields, in response to their own replication crises, were adopting data sharing as a norm in their research communities, as well as other practices such as reporting null findings and the pre-registration of hypotheses in shared forums.</p>
<p>The climate research cartel staked its authority on the peer review process of journals deemed legitimate, which meddling challengers had not undergone. But, as Gurri notes in his treatment of climategate, “since the group largely controlled peer review for their field, and a consuming subject of the emails was how to keep dissenting voices out of the journals and the media, the claim rested on a circular logic”.</p>
<p>One can be fully convinced of the reality and dire consequences of climate change while also permitting oneself some curiosity about the political pressures that bear on the science, I hope. Try to imagine the larger setting when the IPPC convenes. Powerful organisations are staffed up, with resolutions prepared, communications strategies in place, corporate “global partners” secured, interagency task forces standing by and diplomatic channels open, waiting to receive the good word from an empaneled group of scientists working in committee.</p>
<p>This is not a setting conducive to reservations, qualifications, or second thoughts. The function of the body is to produce a product: political legitimacy.</p>
<p><strong>The third leg: moralism</strong></p>
<p>The climategate scandal delivered a blow to the IPPC, and therefore to the networked centres of power for which it serves as science-settler. This perhaps led to a heightened receptivity in those centres for the arrival of a figure such as Greta Thunberg who escalates the moral urgency of the cause (“How dare you!), giving it an impressive human face that can galvanise mass energy. She is notable both for being knowledgeable and for being a child, even younger and more fragile-looking than her age, and therefore an ideal victim-sage.</p>
<p>There appears to be a pattern, not limited to climate science-politics, in which the mass energy galvanised by celebrities (who always speak with certainty) strengthens the hand of activists to organise campaigns in which any research institution that fails to discipline a dissident investigator is said to be serving as a channel of “disinformation”. The institution is placed under a kind of moral receivership, to be lifted when <span lang="EN-US">the heads of the institution denounce the offending investigator and distance themselves from his or her findings. They then seek to repair the damage by affirming the ends of the activists in terms that out-do the affirmations of rival institutions. </span></p>
<p>As this iterates across different areas of establishment thinking, especially those that touch on ideological taboos, it follows a logic of escalation that restricts the types of inquiry that are acceptable for research supported by institutions, and shifts them in the direction dictated by political lobbies.</p>
<p>Needless to say, all this takes place far from the field of scientific argument, but the drama is presented as one of restoring scientific integrity. In the internet era of relatively open information flows, a cartel of expertise can be maintained only if it is part of a larger body of organised opinion and interests that, together, are able to run a sort of moral-epistemic protection racket. Reciprocally, political lobbies depend on scientific bodies that are willing to play their part.</p>
<p>This could be viewed as part of a larger shift within institutions from a culture of persuasion to one in which coercive moral decrees emanate from somewhere above, hard to locate precisely, but conveyed in the ethical style of HR. Weakened by the uncontrolled dissemination of information and attendant fracturing of authority, the institutions that ratify particular pictures of what is going on in the world must not merely assert a monopoly of knowledge, but place a moratorium on the asking of questions and noticing of patterns.</p>
<p>Research cartels mobilise the denunciatory energies of political activists to run interference and, reciprocally, the priorities of activist NGOs and foundations meter the flow of funding and political support to research bodies, in a circle of mutual support.</p>
<p>One of the most striking features of the present, for anyone alert to politics, is that we are increasingly governed through the device of panics that give every appearance of being contrived to generate acquiescence in a public that has grown skeptical of institutions built on claims of expertise. And this is happening across many domains. Policy challenges from outsiders presented through fact and argument, offering some picture of what is going on in the world that is rival to the prevailing one, are not answered in kind, but are met rather with denunciation. In this way, epistemic threats to institutional authority are resolved into moral conflicts between good people and bad people.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/12/how-race-politics-liberated-the-elites/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/12/how-race-politics-liberated-the-elites/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/12/GettyImages-1228697748.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/12/how-race-politics-liberated-the-elites/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Further reading</span></a><a href="https://stage.unherd.com/2020/12/how-race-politics-liberated-the-elites/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>How race politics liberated the elites</h5></a><p class="author"><a href="https://stage.unherd.com/2020/12/how-race-politics-liberated-the-elites/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Matthew Crawford</a></p></div></a></div>
<p>The ramped-up moral content of pronouncements that are ostensibly expert-technical needs to be explained. I suggested there are two rival sources of political legitimacy, science and popular opinion, that are imperfectly reconciled through a kind of distributed demagogy, which we may call scientism. This demagogy is distributed in the sense that interlocked centers of power rely on it to mutually prop one another up.</p>
<p>But as this arrangement has begun to totter, with popular opinion coming untethered from expert authority and newly assertive against it, a third leg has been added to the structure in an effort to stabilise it: the moral splendor of the Victim. To stand with the Victim, as every major institution now appears to do, is to arrest criticism. Such is the hope, at any rate.</p>
<p>In the unforgettable Summer of 2020, the moral energy of anti-racism was harnessed to the scientific authority of public health, and vice versa. Thus “white supremacy” was a public health emergency — one urgent enough to dictate the suspension of social distancing mandates for the sake of protests. So how did the description of America as white supremacist get converted into a scientific-sounding claim?</p>
<p><a href="https://www.tabletmag.com/sections/news/articles/the-covid-class-war-heats-up-michael-lind">Michael Lind</a> has argued that covid laid bare a class war, not between labor and capital, but between two groups that could both be called “elites”: on one side, small business owners who opposed lockdowns and, on the other, professionals who enjoyed greater job security, were able to work from home, and typically took a maximalist position on hygiene politics. We can add that, being in the “knowledge economy,” professionals naturally show more deference to experts, since the basic currency of the knowledge economy is epistemic prestige.</p>
<p>This divide got mapped onto the pre-existing schism that had organised itself around President Trump, with the population sorted into good people and bad people. For professionals, not just the status of one’s soul, but one’s standing and viability in the institutional economy, depended on getting conspicuously on the right side of that divide. According to the Manichaean binary established in 2016, the fundamental question mark over one’s head is that of the strength and sincerity of one’s anti-racism. For white people who worked in technical bodies connected to public health, the confluence of the George Floyd protests and the pandemic seemed to have presented an opportunity to convert their moral precarity on the issue of race into its opposite: moral authority.</p>
<p>Over 1,200 health experts, speaking as health experts, signed an open letter encouraging mass protests as necessary to address the “pervasive lethal force of white supremacy”. This pervasive force is something they are specially qualified to detect by their scientific knowledge. Editorials in journals such as <em>The Lancet</em>, <em>The New England Journal of Medicine</em>, <em>Scientific American</em> and even <em>Nature</em> now speak the language of Critical Race Theory, invoking the invisible miasma of “whiteness” as explanatory device, controlling variable and justification for whatever pandemic policy prescription it seems good to align themselves with.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2021/04/how-critical-race-theory-captured-the-church/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2021/04/how-critical-race-theory-captured-the-church/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2021/04/GettyImages-142369634.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2021/04/how-critical-race-theory-captured-the-church/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2021/04/how-critical-race-theory-captured-the-church/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>How Critical Race Theory captured the Church</h5></a><p class="author"><a href="https://stage.unherd.com/2021/04/how-critical-race-theory-captured-the-church/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Giles Udy</a></p></div></a></div>
<p>The science is remarkably clear. It has also been bent to expansive purposes. In February 2021, the medical journal <em>The Lancet</em> convened a Commission on Public Policy and Health in the Trump Era to deplore the president’s politicisation of science – while urging “science-led proposals” that would address public health through reparations for descendants of slaves and other victims of historical oppression, the enhancement of affirmative action, and the adoption of the Green New Deal, among other measures. One can certainly make a case for such policies sincerely, freely, and with due consideration. Many people have. But perhaps it is also the case that the moral sorting and resulting insecurity among technocratic professionals has made them quick to defer to activists and sign on to grander visions of a transformed society.</p>
<p>The spectacular success of “public health” in generating fearful acquiescence in the population during the pandemic has created a rush to take every technocratic-progressive project that would have poor chances if pursued democratically, and cast it as a response to some existential threat. In the first week of the Biden administration, the Senate majority leader urged the president to declare a “climate emergency” and assume powers that would authorise him to sidestep Congress and rule by executive fiat. Ominously, we are being prepared for “climate lockdowns”<span lang="EN-US">.</span></p>
<p><strong>The wisdom of the East</strong></p>
<p>Western nations have long had contingency plans for dealing with pandemics, in which quarantine measures were delimited by liberal principles – respecting individual autonomy and avoiding coercion as much as possible. Thus, it was the already-infected and the especially vulnerable who should be isolated, as opposed to locking healthy people in their homes. China, on the other hand, is an authoritarian regime that solves collective problems through rigorous control of its population and pervasive surveillance. Accordingly, when the COVID pandemic began in earnest, China locked down all activities in Wuhan and other affected areas. In the West, it was simply assumed that such a course of action was not an available option.</p>
<p>As UK epidemiologist Neil Ferguson said to <a href="https://www.thetimes.co.uk/article/people-don-t-agree-with-lockdown-and-try-to-undermine-the-scientists-gnms7mp98" target="_blank" rel="noopener">the <em>Times</em></a> last December: “It’s a communist one-party state, we said. We couldn’t get away with [lockdowns] in Europe, we thought… and then Italy did it. And we realised we could.” He added that “These days, lockdown feels inevitable.”</p>
<p>Thus, what had seemed impossible due to the bedrock principles of Western society now feels not merely possible but inevitable. And this complete inversion happened over the course of a few months.</p>
<p>Acceptance of such a bargain would seem to depend entirely on the gravity of the threat. There is surely some point of hazard beyond which liberal principles become an unaffordable luxury. Covid is indeed a very serious illness, with an infection fatality rate about ten times higher than that of the flu: roughly one percent of all those who are infected die. Also, however, unlike the flu this mortality rate is so skewed by age and other risk factors, varying by more than a thousand-fold from the very young to the very old, that the aggregate figure of one percent can be misleading. As of November 2020, the average age of those killed by Covid in Britain was <a href="https://www.ft.com/content/879f2a2b-e366-47ac-b67a-8d1326d40b5e" target="_blank" rel="noopener">82.4 years old</a>.</p>
<p>In July of 2020, <a href="https://www.ft.com/content/879f2a2b-e366-47ac-b67a-8d1326d40b5e" target="_blank" rel="noopener">29 % of British citizens believed that “6-10 percent or higher” of the population had already been killed by Covid</a>. About 50% of those polled had a more realistic estimate of 1%. The actual figure was about one tenth of one percent. So the public’s perception of the risk of dying of Covid was inflated by one to two orders of magnitude. This is highly significant.</p>
<p>Public opinion matters in the West far more than in China. Only if people are sufficiently scared will they give up basic liberties for the sake of security – this is the basic formula of Hobbes’s Leviathan. Stoking fear has long been an essential element of the business model of mass media, and this appears to be on a trajectory of integration with state functions in the West, in a tightening symbiosis. While the Chinese government resorts to external coercion, in the West coercion must come from inside; from a mental state in the individual. The state is nominally in the hands of people elected to serve as representatives of the people, so it cannot be an object of fear. Something else must be the source of fear, so the state may play the role of saving us. But playing this role requires that state power be directed by experts.</p>
<p>Early in 2020, public opinion accepted the necessity of a short-term suspension of basic liberties on the supposition that, once the emergency had passed, we could go back to being not-China. But this is to assume a robustness of liberal political culture that may not be warranted. Lord Sumption, a jurist and retired member of the UK’s Supreme Court, makes a case for regarding lockdowns in the West as the crossing of a line that is not likely to get uncrossed. In an interview with Freddie Sayers at <a href="https://stage.unherd.com/2021/03/lord-sumption-civil-disobedience-has-begun/"><em>UnHerd</em></a>, he points out that, by law, the government has broad powers to act under emergency. “There are many things governments can do, which it is generally accepted they should not do. And one of them, until last March, was to lock up healthy people in their homes.”</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2021/03/lord-sumption-civil-disobedience-has-begun/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2021/03/lord-sumption-civil-disobedience-has-begun/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2021/03/sumption4.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2021/03/lord-sumption-civil-disobedience-has-begun/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2021/03/lord-sumption-civil-disobedience-has-begun/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Lord Sumption: civil disobedience has begun</h5></a><p class="author"><a href="https://stage.unherd.com/2021/03/lord-sumption-civil-disobedience-has-begun/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Jonathan Sumption</a></p></div></a></div>
<p>He makes the Burkean observation that our status as a free society rests, not on laws, but on convention, a “collective instinct” about what we ought to do, rooted in habits of thinking and feeling that develop slowly over decades and centuries. These are fragile. It is far easier to destroy a convention than to establish one. This suggests going back to being not-China may be quite difficult.</p>
<p>As Lord Sumption says, “When you depend for your basic freedoms on convention, rather than law, once the convention is broken, the spell is broken. Once you get to a position where it is unthinkable to lock people up, nationally, except when somebody thinks it’s a good idea, then frankly there is no longer any barrier at all. We have crossed that threshold. And governments do not forget these things. I think this is a model that will come to be accepted, if we are not very careful, as a way of dealing with all manner of collective problems.” In the US as in the UK, the government has immense powers. “The only thing that protects us from the despotic use of that power is a convention that we have decided to discard.”</p>
<p>Clearly, an admiration for Chinese-style governance has been blossoming in what we call centrist opinion, in large part as a response to the populist upsets of the Trump and Brexit era. It is also clear that “Science” (as opposed to actual science) is playing an important role in this. Like other forms of demagogy, scientism presents stylised facts and a curated picture of reality. In doing so, it may generate fears strong enough to render democratic principles moot.</p>
<p>The pandemic is now in retreat and the vaccines are available to all who want them in most parts of the United States. But many people refuse to give up their masks, as though they had joined some new religious order. The wide deployment of fear as an instrument of state propaganda has had a disorienting effect, such that our perception of risk has come detached from reality.</p>
<p>We accept all manner of risks in the course of life, without thinking about it. To pick one out and make it an object of intense focus is to adopt a distorted outlook that has real costs, paid somewhere beyond the rim of one’s tunnel vision. To see our away out of this — to place risks in their proper context — requires an affirmation of life, refocusing on all those worthwhile activities that elevate existence beyond the merely vegetative.</p>
<p><strong>Losing face</strong></p>
<p>Perhaps the pandemic has merely accelerated, and given official warrant to, our long slide toward atomisation. By the nakedness of our faces we encounter one another as individuals, and in doing so we experience fleeting moments of grace and trust. To hide our faces behind masks is to withdraw this invitation. This has to be politically significant.</p>
<p>Perhaps it is through such microscopic moments that we become aware of ourselves as a people, bound up in a shared fate. That’s what solidarity is. Solidarity, in turn, is the best bulwark against despotism, as Hannah Arendt noted in <em>On The Origins of Totalitarianism</em>. Withdrawal from such encounter now has the stamp of good citizenship, i.e., good hygiene. But what sort of regime are we to be citizens of?</p>
<p>“Following the science” to minimise certain risks while ignoring others absolves us of exercising our own judgment, anchored in some sense of what makes life worthwhile. It also relieves us of the existential challenge of throwing ourselves into an uncertain world with hope and confidence. A society incapable of affirming life and accepting death will be populated by the walking dead, adherents of a cult of the demi-life who clamour for ever more guidance from experts.</p>
<p>It has been said, a people gets the government it deserves.</p>
<p>&nbsp;</p>
<p><em>This article was first published in May.</em></p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2021/12/how-science-has-been-corrupted-2/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2021/12/how-science-has-been-corrupted-2/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2021/12/how-science-has-been-corrupted-2/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">299341</post-id>				</item>
									<item>
					<title>Should Big Pharma be destroyed?</title>
					<link>https://stage.unherd.com/2021/12/should-big-pharma-be-destroyed/?edition=us</link>
											<comments>https://stage.unherd.com/2021/12/should-big-pharma-be-destroyed/?edition=us#comments</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2021/12/GettyImages-1231653643-1.jpg?w=623</unherd:featured_image>
										<unherd:main_theme></unherd:main_theme>
					<dc:creator>
						<![CDATA[Tom Chivers]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2019/09/chivers.jpg?w=96</unherd:creator_img>
																<unherd:article_ranking></unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[Pharma bad behaviour is not new. Credit: Erik McGregor/LightRocket via Getty]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p><strong>Tom Chivers</strong> is a science writer. His second book, <em>How to Read Numbers</em>, is out now.</p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle>TomChivers</unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[ is a science writer. His second book, <em>How to Read Numbers</em>, is out now.]]>
					</unherd:author_bio>
										<pubDate>Mon, 06 Dec 2021 00:00:00 +0000</pubDate>
					<updated>Mon, 06 Dec 2021 00:00:00 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[Covid]]></category>
		<category><![CDATA[Don't miss]]></category>
		<category><![CDATA[drug resarch]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[R&D]]></category>
					<guid isPermaLink="false">https://old.unherd.com/?p=284486</guid>
																												<description>
								<![CDATA[There are few alternatives to the cut-throat capitalist system]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p>The pandemic has not been bad for everyone. Vaccine manufacturers – <a href="https://www.reuters.com/breakingviews/modernas-40-bln-shot-gain-2021-11-29/?utm_campaign=trueAnthem%3A%20Trending%20Content&amp;utm_medium=trueAnthem&amp;utm_source=facebook&amp;fbclid=IwAR0e1LRcd0Aea4BP3lwsOxGSKZ43q4JXTUBladbYlfzvOviQLrzBOi1ztzA" target="_blank" rel="noopener">notably Moderna and Pfizer</a> – have gained billions of dollars in value from making and selling the jabs. The rise of the Omicron variant means they get to do it again; the CEO of Pfizer <a href="https://www.bbc.co.uk/news/health-59488848" target="_blank" rel="noopener">thinks</a> we’ll be needing boosters every year for years, and it seems unlikely that he’ll be too disappointed about that. The vaccines have ended up in rich arms rather than poor ones, leading to accusations of <a href="https://jacobinmag.com/2021/11/covid-19-pfizer-moderna-jj-mrna-profits-poor-countries" target="_blank" rel="noopener">vaccine “apartheid”</a>.</p>
<p>But pharma bad behaviour is not new. For example: there’s a thing in patent law called “evergreening”. It’s most famously used by big pharma companies who don’t want their expensive drugs to reach the end of their 20-year patent and become available as a generic, so they develop a very slightly different version of the same drug and get a new patent on that.</p>
<p>Venlafaxine is an antidepressant, marketed as Effexor. As it neared the end of its patent, the manufacturer developed a new version – desvenlafaxine, marketed as Pristiq. Desvenlafaxine is what the body <a href="https://theconversation.com/explainer-evergreening-and-how-big-pharma-keeps-drug-prices-high-33623" target="_blank" rel="noopener">naturally breaks venlafaxine down into</a>; your liver takes the venlafaxine and metabolises it into desvenlafaxine. It is also either <a href="https://www.ema.europa.eu/en/documents/withdrawal-report/withdrawal-assessment-report-ellefore_en.pdf" target="_blank" rel="noopener">less effective</a> or <a href="https://www.cambridge.org/core/journals/cns-spectrums/article/an-indirect-comparison-of-the-efficacy-and-safety-of-desvenlafaxine-and-venlafaxine-using-placebo-as-the-common-comparator/5F67FF73B0CDD8CDB6DC77B5F5FE3582" target="_blank" rel="noopener">no more effective</a> than the original.</p>
<div class="ad-insert"></div>
<p>The patent for Effexor expired in December 2008; Pristiq entered the market in early 2009. By 2014, Pristiq was <a href="https://mentalhealthdaily.com/2014/08/30/most-popular-antidepressants-in-2014-cymbalta-pristiq-viibryd/" target="_blank" rel="noopener">the second most prescribed antidepressant</a> in the US, <a href="https://slatestarcodex.com/2016/09/07/reverse-voxsplaining-brand-name-drugs/" target="_blank" rel="noopener">despite being</a> “a slightly worse version of an older antidepressant with no proven advantages that also costs fifteen times as much”. (A month’s supply of Effexor at the time cost $20; a month’s supply of Pristiq cost $300.)</p>
<p>And it’s not the only bad thing they do. When a drug reaches the end of its patent, other companies can make generic versions. To encourage that, the <a href="https://www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/small-business-assistance-180-day-generic-drug-exclusivity">US FDA says</a> that the first company to do so gets 180 days of exclusivity, so it can establish itself in the market. “Until recently,” says Dr Vishal Gulati, a venture capitalist specialising in healthcare, “it was legal for the original company to pay off the company to not launch the product. Companies would get a license to make the generic, and then be paid to not launch it.” They were literally paying to prevent patients from getting cheaper healthcare.</p>
<p>What’s going wrong here? There’s a very tempting explanation, which is that big pharma is evil. But I never find that satisfying as an explanation. Instead, I’d rather think about incentive structures.</p>
<p>There’s an inherent tension at the heart of any knowledge-based business — anything which develops new technology or information and sells it. You want it to do two things: to create that knowledge, to advance our understanding; and to spread it around, so that the world can benefit from it. Information is a “non-rival good”: if I benefit from it, that doesn’t stop you from benefiting from it too. An example is <a href="https://www.owen.org/musings/ip/" target="_blank" rel="noopener">a lighthouse</a>. If I see the beam, and avoid the rocks, it doesn’t stop you from doing the same. By contrast, a hamburger is a “rival good”: if I eat it, you can’t.</p>
<p>People can make money selling hamburgers. But it’s much harder to do so by operating a lighthouse.</p>
<p>The trouble with knowledge-based businesses is that they are more like lighthouses than like burgers. If you create a new piece of software, or a new technology — or a piece of investigative journalism — then there’s nothing stopping me from simply copying it. And then you won’t make any money off it. That makes it less likely that you’ll spend the time and effort to create any more new things.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2018/11/big-pharma-kills-off-competition/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2018/11/big-pharma-kills-off-competition/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2018/11/GettyImages-879167778.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2018/11/big-pharma-kills-off-competition/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2018/11/big-pharma-kills-off-competition/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>How Big Pharma kills off competition</h5></a><p class="author"><a href="https://stage.unherd.com/2018/11/big-pharma-kills-off-competition/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Jonathan Tepper</a></p></div></a></div>
<p>So we created intellectual property laws in order to stop that. Creators of a thing can get a patent or a copyright, and are granted exclusive rights to produce that thing for some number of years — 20 years, in the case of pharmaceuticals.</p>
<p>Problem solved, right? Well, obviously not. Because we don’t <em>just</em> want a world in which new things are created. We also want a world in which everyone can gain access to those things. Intellectual property rights prevent us from making extremely cheap copies of things that we already know how to make. If a foreign correspondent reports human rights abuses in Yemen, it’s best for society if as many people as possible to read that report, so that we can act on it. But intellectual property rights (and their downstream effect, paywalls in journalism) stop that from happening.</p>
<p>This is a direct trade-off. “My mental image of all this is we’re basically squeezing a balloon,” says Owen Barder, a development economist. You can squeeze the top, and move the problem to the bottom. Or you can squeeze the bottom, and move the problem to the top. But the balloon is still there.</p>
<p>And this isn’t the whole problem. We want pharma companies to develop drugs and vaccines for the developing world. But people in the developing world can’t pay as much money as people in the rich world, obviously.</p>
<p>Pharma R&amp;D is expensive: sometimes billions of dollars to research one drug. And for every drug that is successful, there might be 20 that aren’t, and the research into those needs to be paid for as well. That money needs to come from somewhere. At the moment, it comes from patients in rich countries paying sometimes hundreds of dollars for pills that might, individually, cost a few cents to make. The “marginal cost” of each dose is tiny — <a href="https://jacobinmag.com/2021/11/covid-19-pfizer-moderna-jj-mrna-profits-poor-countries"><em>Jacobin</em></a> and <a href="https://www.oxfam.ca/news/vaccine-monopolies-make-cost-of-vaccinating-the-world-against-covid-at-least-5-times-more-expensive-than-it-could-be/">Oxfam</a> fume that the Covid vaccines, for instance, are priced at many times the manufacturing cost — but that cost needs to cover the “fixed cost” of all the R&amp;D (and marketing, staff costs, etc) you’ve put in.</p>
<p>The ideal solution to this would be selling the drug to everyone at the maximum cost they’re willing to pay. Charge hundreds of dollars in the US, a bit less in the UK and EU, much less in Bulgaria, and almost nothing in Malawi. “If you could perfectly price-discriminate, you’d be charging above the marginal cost in lots of countries, and at the marginal cost for the ones who couldn’t afford more than that,” says Barder.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2018/11/big-pharma-kills-off-competition/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2018/11/big-pharma-kills-off-competition/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2018/11/GettyImages-879167778.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2018/11/big-pharma-kills-off-competition/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2018/11/big-pharma-kills-off-competition/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>How Big Pharma kills off competition</h5></a><p class="author"><a href="https://stage.unherd.com/2018/11/big-pharma-kills-off-competition/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Matthew Crawford</a></p></div></a></div>
<p>But that’s not possible. For one thing, if they tried it, people would buy the pills in Malawi for a few cents and fly to the US and sell them at a profit. But more important, Congress or Parliament (and the press) would kick off – why are our citizens paying hundreds of times over the odds? It would be politically impossible to do. So, instead, they make the drug at a single price, which only rich countries can pay, until the sales in those countries have paid off the R&amp;D costs. “Drug companies are just responding to the incentives we’ve set,” says Barder. “They’re doing the thing we asked them to do.”</p>
<p>The temptation, when faced with problems like these, is to argue that big pharma should be destroyed, and all drug research run by publicly funded university laboratories. And maybe that would work – but it’s a huge gamble. Pharma companies do some bad things, but they objectively do make drugs that are hugely valuable to society. And it’s not that publicly funded bodies are free of bad incentives. Academica has huge problems of its own — academics are rewarded for <a href="https://stage.unherd.com/2020/01/why-the-drugs-dont-work/">publishing lots of papers</a>, rather than for necessarily finding out true things. Government’s incentives are to remain popular, rather than to fund the most effective things: it would be easy to imagine lots of money going to fund treatments for picturesque children with cancer, rather than for, say, diabetes, even if it were a much less effective way of saving lives.</p>
<p>Still, it might work. At the moment, as Barder says, there’s a tendency to “socialise the losses and privatise the gains”: private companies get rich off research that is often begun in university departments. A starting point might be to pump lots of money into university research, let them bring drugs to market, and see if they can outperform big pharma. What would be crazy, though, is to destroy big pharma first, and then hope that our new nationalised version can keep new drugs coming through.</p>
<p>A more low-key version, says Gulati, might be for academic institutions to become better at demanding equity in pharmaceutical products that are based on their early research. He also suggests that countries such as the UK could negotiate cheaper drugs by offering the NHS as a source of clinical trial subjects — as has happened with Novartis’s new cholesterol drug <a href="https://www.novartis.com/news/media-releases/world-first-agreement-between-novartis-and-nhs-enables-broad-and-rapid-access-first-class-cholesterol-lowering-medicine-leqvio-vinclisiran">inclisiran, aka Leqvio</a>. That’s hugely valuable to pharma companies, and it’s something the NHS can do easily and safely, with its huge, centralised, well-protected data systems.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2021/11/the-humiliation-of-america/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2021/11/the-humiliation-of-america/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2021/11/2GettyImages-1229770167-scaled-e1634928963293.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2021/11/the-humiliation-of-america/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2021/11/the-humiliation-of-america/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>How Covid despots humiliated America</h5></a><p class="author"><a href="https://stage.unherd.com/2021/11/the-humiliation-of-america/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Jacob Howland</a></p></div></a></div>
<p>Those ideas might help make drugs cheaper in the UK and other rich countries: getting them to poorer countries is a different problem, with different solutions. Governments could buy out patents — if a firm thinks it can make $10 billion over the next 10 years for its product, we could say that we’ll give them the $10 billion now (or a bit less) in exchange for the rights to make the drug available at cost.</p>
<p>Barder likes one idea, put forward by the late economist <a href="https://en.wikipedia.org/wiki/Jean_Olson_Lanjouw">Jean Olson Lanjouw</a>. “Her suggestion was,” says Barder, “that if I’m AstraZeneca and I show up at the UK patent office asking for IP protection for a new drug, the patent office should say ‘Well done. Can you tell me what you expect the market value for this drug to be in all 200 countries in the world?’”</p>
<p>Then AstraZeneca or whoever would say “I expect most of my revenue to come from the US, UK, EU and Japan, and relatively little from sub-Saharan Africa and Bangladesh.” And the patent office would grant them a patent, on the condition that they license it for free use in those countries that make up the bottom 2% of their revenue. “It’s like a tax of 2%,” says Barder, “but those countries might well make up 80% of the disease burden.” It hasn’t been tried, as far as I know, but it’s worth thinking about, and it would avoid the problems of Congress or Parliament demanding that the drug be made cheap here — although it would only work for global diseases that affect the rich world as well as the poor — diseases like cancer, or heart disease, or hypertension. It wouldn&#8217;t help incentivise research into diseases like malaria or dengue, which have no impact on the rich world. The “advanced market commitment”, which I discussed <a href="https://stage.unherd.com/2020/11/should-big-pharma-profit-from-covid/">here</a>, and involves Western governments promising to give pharma companies a bonus for every dose bought by developing nations, might be more effective for that.</p>
<p>Andrey Zarur, the CEO of the biotech firm GreenLight[1.  I have done several pieces of paid writing for GreenLight over the last two years], who are <a href="https://twitter.com/andreyzarur/status/1466768100553117696">producing their own mRNA vaccine for Covid at the moment</a>, comes at the whole thing from a different angle“Pfizer was not designed to make low-cost therapeutics available to every corner of the world,” he says: it’s a 150-year-old company with settled investors and a particular way of working.</p>
<p>He compares it to Apple. “You have a $1,000 iPhone 13,” he says. “Who’s that designed for? My children. Idiot teenagers with rich parents.” Poorer countries need smartphones too, but the solution is not to force Apple to sell smartphones to Ethiopia at a discount. “What you need is an innovative company with different processes.” Instead of demanding changes from 150-year-old companies that are very good at the specific things they do, create smaller, newer companies which do the thing you want. “There’s six billion people in the developing world,” says Zarur. “You should be able to figure out a way to turn a reasonable profit with reasonably priced drugs.”</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2021/07/the-truth-about-woke-coke/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2021/07/the-truth-about-woke-coke/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2021/07/GettyImages-1295955502.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2021/07/the-truth-about-woke-coke/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2021/07/the-truth-about-woke-coke/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>The truth about &#039;Woke Coke&#039;</h5></a><p class="author"><a href="https://stage.unherd.com/2021/07/the-truth-about-woke-coke/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Jacob Howland</a></p></div></a></div>
<p>It’s obviously true that pharma companies have done bad things. It’s also obviously true that they’ve done marvellous things — I have relatives who are alive today who wouldn’t be without the pharmaceutical industry’s products.</p>
<p>Perhaps there are other systems which could have produced those drugs, other than the undeniably cutthroat capitalist system we have today. But any system would have bad incentives and obvious, easy-to-publicise disasters.</p>
<p>The job of government in this situation should be to find the bad incentives, the market failures, and to patch them; to make it work, to decide which end of the balloon to squeeze. The Indian government, for example, decided a few years ago that it would not accept evergreening any more — it passed a law saying that it would only offer new patents on drugs that were sufficiently different from existing ones.</p>
<p>In 2013, the government <a href="https://globalizationandhealth.biomedcentral.com/articles/10.1186/1744-8603-10-3">won a court case</a> against Novartis, which had tried to get a new patent on a cancer drug, imatinib mesylate — a crystalline version of an existing cancer drug, imatinib. The government said that the new version was no better than the existing one and was simply an attempt to squeeze more money out of the healthcare system.</p>
<p>It worked. You could argue (as Novartis did) that it will reduce innovation; but the point is you can change the system, change the incentives, encourage the behaviour you want, without smashing the system entirely.</p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2021/12/should-big-pharma-be-destroyed/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2021/12/should-big-pharma-be-destroyed/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2021/12/should-big-pharma-be-destroyed/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">284486</post-id>				</item>
									<item>
					<title>Macron&#8217;s vaccine passport gamble</title>
					<link>https://stage.unherd.com/2021/08/macrons-vaccine-passport-gamble/?edition=us</link>
											<comments>https://stage.unherd.com/2021/08/macrons-vaccine-passport-gamble/?edition=us#comments</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2021/08/GettyImages-1234027892-1.jpg?w=622</unherd:featured_image>
										<unherd:main_theme></unherd:main_theme>
					<dc:creator>
						<![CDATA[John Lichfield]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2019/10/John.jpg?w=96</unherd:creator_img>
																<unherd:article_ranking></unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[Macron: literally Hitler. Credit: CLEMENT MAHOUDEAU/ AFP via Getty]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p><strong>John Lichfield</strong> was Paris correspondent of <em>The Independent</em> for 20 years. Half-English and half-Belgian, he was born in Stoke-on-Trent and lives in Normandy.</p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle>john_lichfield</unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[ was Paris correspondent of <em>The Independent</em> for 20 years. Half-English and half-Belgian, he was born in Stoke-on-Trent and lives in Normandy.]]>
					</unherd:author_bio>
										<pubDate>Thu, 05 Aug 2021 23:00:43 +0000</pubDate>
					<updated>Thu, 05 Aug 2021 23:00:43 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[anti-vax]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Emmanuel Macron]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[Marine Le Pen]]></category>
					<guid isPermaLink="false">https://old.unherd.com/?p=182461</guid>
																												<description>
								<![CDATA[Mandatory passes could provoke a new Gilets Jaunes movement]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p><em>Le virus c’est l’état</em> (&#8220;The virus is the state&#8221;) — so reads a freshly-painted slogan on a motorway bridge on the Norman-Breton border.</p>
<p>This may be the work of the anarchist far-left. It may be the work of the libertarian Right. It may — though less plausibly — have been painted by ordinary apolitical people infuriated by President Emmanuel Macron’s decision to ban all fun and long-distance travel for unvaccinated citizens from Monday.</p>
<p>All three of these groups, along with many other angry citizens, <a href="https://www.france24.com/en/france/20210731-france-sees-third-weekend-of-protests-against-obligatory-health-pass" target="_blank" rel="noopener">were represented in the protests against the <em>“passe sanitaire”</em> (health pass) on Saturday,</a> which attracted over 200,000 people to 150 demonstrations in French towns and cities last Saturday.</p>
<div class="ad-insert"></div>
<p>Politics goes to the street more rapidly in France than other democracies — but protests during the late July-August holiday season are very unusual. And the numbers have doubled since they kicked off three weeks ago. Further protests are expected this weekend.</p>
<p>The political and social geology of the gatherings is equally bizarre. There are anarchists. There are fundamentalist Catholics. There are dotty conspiracy theorists. There are priggish anti-vaccine fanatics, some of whom attacked and destroyed a stall in front of a pharmacy offering free Covid tests on Saturday’s march in Montpellier. There is the anti-capitalist hard-Left, which believes the pandemic was invented by “Big pharma” to sell vaccines. There is anti-Semitic ultra-right — some of them holding banners which read simply <em>“qui?”</em> or “who?”.<a href="https://www.liberation.fr/politique/qui-le-nouveau-slogan-antisemite-de-lextreme-droite-20210731_UKAKGHD2NVAMDCZIA3E4MK6E6E/" target="_blank" rel="noopener"> The intended message is that “you-know-who”</a> (ie the Jews) are somehow responsible for the pandemic.</p>
<p>There is the rump of the anti-Macron Gilets Jaunes movement of 2018-9, which has little support and no clear aims but is keen to latch on to any protest against the President. And there are also many hundreds of moderate-seeming, apolitical people. Many are young. Many come in family groups. Some are anti-vaccine. Others detest the idea of health passes restricting personal freedoms or creating separate categories of French people: the government-approved “fully-jabbed” and the unvaccinated and “unclean”.</p>
<p>In Caen, Mélanie, a primary school teacher in her thirties, said: “I’m vaccinated. I’ve never protested before. I’m not interested in politics. But I can’t accept a segregated society. This is supposed to be the country which invented human rights.”</p>
<p>In Paris there were four separate marches to accommodate the different points of view. In other towns and cities, habitual enemies walked together in condemnation of Macron and the French parliament which approved the health pass last week.</p>
<p>Some amendments were accepted during the emergency debate but the broad thrust of Macron’s policy passed both houses of parliament. To travel long distances or to visit a café, restaurant, cinema or museum from next Monday you must be able to show a code proving one of three things: you are fully vaccinated; you have recovered from Covid; or you recently tested negative. <a href="https://www.gouvernement.fr/info-coronavirus/pass-sanitaire" target="_blank" rel="noopener">All health and care workers must be vaccinated by 15 September or risk suspension or dismissal.</a></p>
<p>Similar, though more limited, “vaccine passports” have been introduced in other EU countries, as well as in New York City. But the French pass is the most comprehensive in Europe. Macron argues that it rewards those who put aside individual or selfish concerns to protect themselves and others – a classic example of <em>“fraternité”,</em> one of the three principles proclaimed by the French Republic.</p>
<p>Opponents say that the pass contravenes the principle of <em>“liberté” </em>or freedom of individual choice; or that it offends against the principle of “<em>égalité” </em>because it divides the French into first and second-class citizens.</p>
<p>These allegations – and the suggestion that Macron is somehow turning France into a dictatorship &#8211; – fell flat on their face yesterday. The <em>Conseil Constitutionnel</em>, which fulfils some of duties of the US Supreme court, approved the pass with a couple of relatively minor tweaks.</p>
<p>All in all, the health pass has exposed the contradictory and — somewhat teenaged — French attitudes to “the state”.</p>
<p>The French <em>Etat</em> (the “virus” on the Norman-Breton motorway bridge) is expected to be all-protecting. It is also constantly criticised for being intrusive and suffocating. Mummy, or <em>Maman</em>, state is expected to do the laundry; she is also criticised if she interferes in her children’s/citizen’s lives.</p>
<p>Another less of the health-pass protests — but not an entirely new one — is that part of the French ultra or alternative Left is now as “anti-state” as the American hard Right. In the United States, and up to a point in the UK, the politics of Covid scepticism has been a largely a Right-wing affair. In France it is more diffuse.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2021/05/macrons-cunning-plan/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2021/05/macrons-cunning-plan/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2021/05/GettyImages-669932952.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2021/05/macrons-cunning-plan/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">More from this author</span></a><a href="https://stage.unherd.com/2021/05/macrons-cunning-plan/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Macron, the failed Machiavelli</h5></a><p class="author"><a href="https://stage.unherd.com/2021/05/macrons-cunning-plan/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> John Lichfield</a></p></div></a></div>
<p>I visited friends in a picturesque Breton village this week which is divided between two hostile tribes: ultra- conservative Catholic locals and green, alternative-artistic incomers. “They now agree on one thing,” my friend said. “They don’t really believe Covid exists.”</p>
<p>And yet and yet…</p>
<p>It is important to point out — as some foreign media commentary on the protests fails to point out — that the Macron health pass has already been an immense success.</p>
<p>Its intention is to revive the French vaccine programme, which was famously slow in January and February. It was quietly excellent from March to mid-June, but faded again as it ran into layers of the vax-shy, vax-lazy, vax-sceptical and vax-resistant.</p>
<p>France has long been the most anti-vaccine country in the developed world. One opinion poll last year suggested that fewer than one in two adults would seek vaccination against Covid-19. <a href="https://stage.unherd.com/2020/11/why-is-france-full-of-anti-vaxxers/" target="_blank" rel="noopener">The real numbers of the willing proved much higher</a> but they slumped in late June — as they also have in Britain.</p>
<p>Confronted with a Delta surge threatening a fourth Covid wave, Macron reneged on his promise not to coerce or force the French to be vaccinated. The impact was immediate, with one million people booking jabs online in the 24 hours after his announcement. Since when, well over 7 million French people have received their first vaccine, taking the total to over 44 million or 80% of the adult population. The rate of vaccination has almost doubled and shows no sign of slowing in the habitually inactive month of August.</p>
<p>Roland Lescure, spokesman for Macron’s party, La République en Marche (LRM) and member of parliament for French expats in North America, said: “There were 200,000 demonstrators with all kinds of motives (last Saturday). On the same day 500,000 people were vaccinated – which means 8.5m first vaccinations in the month of July. The result is not even close.”</p>
<p>Arguably, Macron’s decision to impose the pass — and it was largely his decision — will save hundreds of French lives.</p>
<p>Some of the old vaccine critics, such as the hard-left leader Jean-Luc Mélenchon and the far-right leader Marine Le Pen, now criticise the health-pass without fully supporting the protests. Centre-right and centre-left opposition parties voted in favour – but say little in pubic to support Macron’s approach. There is, after all, a presidential election next spring.</p>
<p>Opinion polls suggest that the health pass is broadly popular with French people. Between 60 and 70% of samples questioned by pollsters say that they approve. Only 40% (at most) say they support the protesters although 50% say they “understand them”. <a href="https://www.francebleu.fr/infos/sante-sciences/covid-19-plus-de-six-francais-sur-dix-pour-le-pass-sanitaire-et-la-vaccination-obligatoire-selon-un-1626460495" target="_blank" rel="noopener">The Gilets Jaunes movement</a> – with which the pass protests have been compared – attracted over 70% support in its early months.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2021/03/why-we-love-to-hate-the-english/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2021/03/why-we-love-to-hate-the-english/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2021/03/GettyImages-542918126-scaled.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2021/03/why-we-love-to-hate-the-english/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2021/03/why-we-love-to-hate-the-english/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Why we French love to hate the English</h5></a><p class="author"><a href="https://stage.unherd.com/2021/03/why-we-love-to-hate-the-english/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Anne-Elisabeth Moutet</a></p></div></a></div>
<p>On the other hand, while support for the GJ’s gradually declined, support for the anti-passers — both in the polls and on the street — seems to be increasing.</p>
<p>They may, in part, represent a surge of anger against the on-off social restrictions of the last 18 months. No attempt to organise protests against mask-wearing or curfews has been successful in France. The anti-health pass protests have channelled months of frustration.</p>
<p>When Jean-Paul Sartre died in 1980 his funeral attracted a huge crowd, one man saying that he had “come to demonstrate against Sartre’s death”. Many of the non-political participants on Saturday’s marches were demonstrating — consciously or not – against Covid-19.</p>
<p><a href="https://www.francetvinfo.fr/sante/maladie/coronavirus/pass-sanitaire/manifestations-contre-le-pass-sanitaire-un-mouvement-qui-peut-etre-explosif-et-dont-les-limites-sont-difficiles-a-cerner-analyse-inquiet-le-sociologue-jean-viard_4723175.html" target="_blank" rel="noopener">The sociologist Jean Viard says</a> that a leaderless coalition of the ordinary and the politically-motivated should worry the government. “This movement is a cocktail which could prove explosive and whose boundaries are difficult to draw,” he said.</p>
<p>In particular, he predicted, the protests could be the harbinger of a more widespread social unrest (and not just in France) if the Covid pandemic – fuelled by new variants – drags into 2022 or beyond.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2021/03/why-is-france-such-a-sweet-enemy/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2021/03/why-is-france-such-a-sweet-enemy/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2021/03/GettyImages-1220896314.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2021/03/why-is-france-such-a-sweet-enemy/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2021/03/why-is-france-such-a-sweet-enemy/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Why we love to hate the French</h5></a><p class="author"><a href="https://stage.unherd.com/2021/03/why-is-france-such-a-sweet-enemy/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Ed West</a></p></div></a></div>
<p>Government ministers admit that they are surprised that the protests have not faded away and this Saturday will be an important test. Another big turnout on the first full weekend of August, even if somewhat lower than last week, will suggest that the movement is here to stay. It could grow larger in September and, potentially, damage Macron’s campaign for re-election in April.</p>
<p>On the other hand, Macron’s gamble could pay off. France is well on the way to reaching its target of first-vaccinating 50 million people over the age of 12 by the end of this month. On present trends, France should overtake the UK total of first vaccinations (covering people 18 and over) within the next two to three weeks.</p>
<p>The Delta wave, which hit France late, is already showing signs of fading. The health pass was always meant to be temporary. Once France reaches 52 million or so first jabs – around over 90% of over 12’s – Macron could declare it to have been hugely successful and no longer necessary. He could even hope — cautiously — to reap a Covid bonus in the elections in April.</p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2021/08/macrons-vaccine-passport-gamble/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2021/08/macrons-vaccine-passport-gamble/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2021/08/macrons-vaccine-passport-gamble/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">182461</post-id>				</item>
									<item>
					<title>How science has been corrupted</title>
					<link>https://stage.unherd.com/2021/05/how-science-has-been-corrupted/?edition=us</link>
											<comments>https://stage.unherd.com/2021/05/how-science-has-been-corrupted/?edition=us#comments</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2021/05/gettyimages-1211656392-594x594-1.jpg?w=541</unherd:featured_image>
										<unherd:main_theme></unherd:main_theme>
					<dc:creator>
						<![CDATA[Matthew Crawford]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2020/05/mattcrawford.png?w=96</unherd:creator_img>
																<unherd:article_ranking></unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[Increasingly, science is pressed into duty as authority. Kevin Frayer/Getty]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p><strong>Matthew B Crawford</strong> is a Future of Freedom Research Fellow at the Independent Institute, as well as a senior fellow at the Institute for Advanced Studies in Culture. He writes the Substack <a href="https://mcrawford.substack.com/" target="_blank" rel="noopener">Archedelia</a>.</p>
<p>&nbsp;</p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle></unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[ is a Future of Freedom Research Fellow at the Independent Institute, as well as a senior fellow at the Institute for Advanced Studies in Culture. He writes the Substack <a href="https://mcrawford.substack.com/" target="_blank" rel="noopener">Archedelia</a>.

&nbsp;]]>
					</unherd:author_bio>
										<pubDate>Mon, 10 May 2021 00:00:00 +0000</pubDate>
					<updated>Mon, 10 May 2021 00:00:00 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[Covid]]></category>
		<category><![CDATA[Don't miss]]></category>
		<category><![CDATA[lockdown]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[scientism]]></category>
					<guid isPermaLink="false">https://old.unherd.com/?p=115584</guid>
																												<description>
								<![CDATA[The pandemic has revealed a darkly authoritarian side to expertise]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p>When I was small, my father would conduct experiments around the house. When you blow across the top of a wine bottle, how many modes of vibration are there? How do you get the higher notes?</p>
<p>Another time, the matter under investigation might be the “angle of repose” of a pile of sand, as in an hour-glass. Does it depend on the particle size? On their shape? Do these factors determine the rate at which an hour-glass empties?</p>
<p>My favorite was the question of what technique will empty a jug of water fastest. Should you simply turn it upside down and let the air rush in (as it must, to replace the water) in that halting, glug-glug-glug fashion, or hold it at a gentler angle so the pour is unbroken? Answer: turn the jug upside down and swirl it vigorously to set up a whirlpool effect. This creates a hollow space at the centre of the flow, where air is free to enter. The jug will empty very quickly.</p>
<p>My father became famous for these “kitchen physics” experiments after he included assignments based on them in a textbook he wrote, published in 1968 and beloved by generations of physics students: <em><a href="https://www.abebooks.co.uk/Waves-Berkeley-Physics-Course-Vol-3/10291625501/bd" target="_blank" rel="noopener">Waves (Berkeley Physics Course, Vol. 3)</a>.</em> My sister and I, aged two and five, are thanked in the acknowledgments for having surrendered our Slinkies to the cause.</p>
<div><div style="left: 0; width: 100%; height: 0; position: relative; padding-bottom: 56.25%;"><iframe src="//cdn.iframe.ly/api/iframe?url=https%3A%2F%2Fyoutu.be%2F2oro0ttU2_A&amp;key=357d953055da7177194e1a84a2d8a5a3&amp;playerjs=1" style="border: 0; top: 0; left: 0; width: 100%; height: 100%; position: absolute;" allowfullscreen scrolling="no" allow="encrypted-media; accelerometer; gyroscope; picture-in-picture; autoplay"></iframe></div></div>
&nbsp;
<p>He pursued such investigations, not simply as a pedagogical exercise, but to satisfy his own curiosity. And he made time for this even while working at the frontier of particle physics, in the lab of Louis Alvarez at Lawrence Berkeley Laboratory. This was fairly early on in the transition of the practice of science into “big science”.</p>
<p>Alvarez won the Nobel Prize in 1968 for his invention and use of the bubble chamber, an instrument for detecting particle decays. It was a device that would comfortably fit on a table top. Today you can build one yourself, if you like. But over the next few decades particle accelerators became enormous installations (CERN, SLAC) requiring the kind of real estate only governments and major institutions, indeed consortiums of institutions, can secure. Scientific papers came to have, not a handful of authors, but hundreds. Scientists became scientist-bureaucrats: savvy institutional players adept at getting government grants, managing sprawling workforces, and building research empires.</p>
<p>Inevitably, such an environment selected for certain human types, the kind who would find such a life appealing. A healthy dose of careerism and political talent was required. Such qualities are orthogonal, let us say, to the underlying truth-motive of science.</p>
<p>You can well imagine the appeal of getting back to basics for someone who was drawn to a scientific career when the prospect had a more intimate scale to it. Kitchen physics is about the pure intellectual refreshment of wondering about something that you observe in the world with your own unaided powers, and then investigating it. This is the basic image we have of what science is, immortalised in the anecdote of Galileo going up into the leaning tower of Pisa and dropping various objects to see how fast they fall.</p>
<p><strong>Science as authority</strong></p>
<p>In 1633, Galileo was brought before the Inquisition for his demonstration that the earth is not fixed but revolves around the sun. This was a problem, obviously, because the ecclesiastical authorities believed their legitimacy rested on a claim to have an adequate grasp of reality, as indeed it did. Galileo had no interest in being a martyr, and recanted to save his skin. But in the lore of Enlightenment, he is said to have muttered under his breath, “but it does move!”</p>
<p>This anecdote has a prominent place in the story we tell about what it means to be modern. On one side, science with its devotion to truth. On the other side, authority, whether ecclesiastical or political. In this tale, “science” stands for a freedom of the mind that is inherently at odds with the idea of authority.</p>
<p>The pandemic has brought into relief a dissonance between our idealised image of science, on the one hand, and the work “science” is called upon to do in our society, on the other. I think the dissonance can be traced to this mismatch between science as an activity of the solitary mind, and the institutional reality of it. Big science is fundamentally social in its practice, and with this comes certain entailments.</p>
<p>As a practical matter, “politicised science” is the only kind there is (or rather, the only kind you are likely to hear about). But it is precisely the apolitical image of science, as disinterested arbiter of reality, that makes it such a powerful instrument of politics. This contradiction is now out in the open. The “anti-science” tendencies of populism are in significant measure a response to the gap that has opened up between the practice of science and the ideal that underwrites its authority. As a way of generating knowledge, it is the pride of science to be falsifiable (unlike religion).</p>
<p>Yet what sort of authority would it be that insists its own grasp of reality is merely provisional? Presumably, the whole point of authority is to explain reality and provide certainty in an uncertain world, for the sake of social coordination, even at the price of simplification. To serve the role assigned it, science must become something more like religion.</p>
<p>The chorus of complaints about a declining “faith in science” states the problem almost too frankly. The most reprobate among us are climate sceptics, unless those be the Covid deniers, who are charged with not obeying the science. If all this has a medieval sound, it ought to give us pause.</p>
<p>We live in a mixed regime, an unstable hybrid of democratic and technocratic forms of authority. Science and popular opinion must be made to speak with one voice as far as possible, or there is conflict. According to the official story, we try to harmonise scientific knowledge and opinion through education. But in reality, science is hard, and there is a lot of it. We have to take it mostly on faith. That goes for most journalists and professors, as well as plumbers. The work of reconciling science and public opinion is carried out, not through education, but through a kind of distributed demagogy, or Scientism. We are learning that this is not a stable solution to the perennial problem of authority that every society must solve.</p>
<p>The phrase “follow the science” has a false ring to it. That is because science doesn’t <em>lead</em> anywhere. It can illuminate various courses of action, by quantifying the risks and specifying the tradeoffs. But it can’t make the necessary choices for us. By pretending otherwise, decision-makers can avoid taking responsibility for the choices they make on our behalf.</p>
<p>Increasingly, science is pressed into duty as authority. It is invoked to legitimise the transfer of sovereignty from democratic to technocratic bodies, and as a device for insulating such moves from the realm of political contest.</p>
<p>Over the past year, a fearful public has acquiesced to an extraordinary extension of expert jurisdiction over every domain of life. A pattern of “government by emergency” has become prominent, in which resistance to such incursions are characterised as “anti-science”.</p>
<p>But the question of political legitimacy hanging over rule by experts is not likely to go away. If anything, it will be more fiercely fought in coming years as leaders of governing bodies invoke a climate emergency that is said to require a wholesale transformation of society. We need to know how we arrived here.</p>
<p>In <a href="https://www.abebooks.co.uk/9781732265141/Revolt-Public-Crisis-Authority-New-1732265143/plp"><em>The Revolt of the Public</em></a>, former intelligence analyst Martin Gurri traces the roots of a “politics of negation” that has engulfed Western societies, tied to a wholesale collapse of authority across all domains ­— politics, journalism, finance, religion, science. He blames it on the internet. Authority has always been located in hierarchical structures of expertise, guarded by accreditation and long apprenticeship, whose members develop a “reflexive loathing of the amateur trespasser”.</p>
<p>For authority to be really authoritative, it must claim an epistemic monopoly of some kind, whether of priestly or scientific knowledge. In the 20th century, especially after the spectacular successes of the Manhattan Project and the Apollo moon landing, there developed a spiral wherein the public came to expect miracles of technical expertise (flying cars and moon colonies were thought to be imminent). Reciprocally, stoking expectations of social utility is normalised in the processes of grant-seeking and institutional competition that are now inseparable from scientific practice.</p>
<p>The system was sustainable, if uneasily so, as long as inevitable failures could be kept offstage. This required robust gatekeeping, such that the assessment of institutional performance was an intra-elite affair (the blue-ribbon commission; peer review), allowing for the development of “informal pacts of mutual protection”, as Gurri puts it. The internet, and the social media which disseminate instances of failure with relish, have made such gatekeeping impossible. That is the core of the very parsimonious and illuminating argument by which Gurri accounts for the revolt of the public.</p>
<p>In recent years, <a href="https://www.firstthings.com/article/2016/05/scientific-regress" target="_blank" rel="noopener">a replication crisis</a> in science has swept aside a disturbing number of the findings once thought robust in many fields. This has included findings that lie at the foundation of whole research programs and scientific empires, now crumbled. The reasons for these failures are fascinating, and provide a glimpse into the human element of scientific practice.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/07/why-we-stopped-trusting-experts/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/07/why-we-stopped-trusting-experts/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/07/GettyImages-671580868-e1594809567505.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/07/why-we-stopped-trusting-experts/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2020/07/why-we-stopped-trusting-experts/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Why we stopped trusting &#039;experts&#039;</h5></a><p class="author"><a href="https://stage.unherd.com/2020/07/why-we-stopped-trusting-experts/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Oliver Traldi</a></p></div></a></div>
<p>Henry H. Bauer, chemistry professor and former dean of arts and sciences at Virginia Tech, <a href="https://www.ivorcatt.co.uk/x2av.htm" target="_blank" rel="noopener">published a paper in 2004</a> in which he undertook to describe how science is actually conducted in the 21st century: it is, he says, fundamentally corporate (in the sense of being collective). “It remains to be appreciated that 21st-century science is a different kind of thing than the ‘modern science’ of the 17th through 20th centuries….”</p>
<p>Now, science is primarily organised around “knowledge monopolies” that exclude dissident views. They do so not as a matter of piecemeal failures of open-mindedness by individuals jealous of their turf, but systemically.</p>
<p>The all-important process of peer review depends on disinterestedness, as well as competence. “Since about the middle of the 20th century, however, the costs of research and the need for teams of cooperating specialists have made it increasingly difficult to find reviewers who are both directly knowledgeable and also disinterested; truly informed people are effectively either colleagues or competitors.”</p>
<p>Bauer writes that “journeymen peer-reviewers tend to stifle rather than encourage creativity and genuine innovation. Centralized funding and centralized decision-making make science more bureaucratic and less an activity of independent, self-motivated truth-seekers.” In universities, “the measure of scientific achievement becomes the amount of ‘research support’ brought in, not the production of useful knowledge”. (University administrations skim a standard 50% off the top of any grant to cover the “indirect costs” of supporting the research.)</p>
<p>Given the resources required to conduct big science, it needs to serve some institutional master, whether that be commercial or governmental. In the last 12 months we have seen the pharmaceutical industry and its underlying capacity for scientific accomplishment at its best. The development of mRNA vaccines represents a breakthrough of real consequence. This has occurred in commercial laboratories that were temporarily relieved of the need to impress financial markets or stoke consumer demand by large infusions of government support. This ought to give pause to the political reflex to demonise pharmaceutical companies that is prevalent on both the Left and the Right.</p>
<p>But it cannot be assumed that “the bottom line” exerts a disciplining function on scientific research that automatically aligns it with the truth motive. Notoriously, pharmaceutical companies have, on a significant scale, paid physicians to praise, recommend and prescribe their products, and recruited researchers to put their names to articles ghost-written by the firms which are then placed in scientific and professional journals. Worse, the clinical trials whose results are relied upon by federal agencies in deciding whether to approve drugs as safe and effective are generally conducted or commissioned by the pharmaceutical companies themselves.</p>
<p>The bigness of big science — both the corporate form of the activity, and its need for large resources generated otherwise than by science itself — places science squarely in the world of extra-scientific concerns, then. Including those concerns taken up by political lobbies. If the concern has a high profile, any dissent from the official consensus may be hazardous to an investigator’s career.</p>
<p>Public opinion polls generally indicate that what “everybody knows” about some scientific matter, and its bearing on public interests, will be identical to the well-institutionalized view. This is unsurprising, given the role the media plays in creating consensus. Journalists, rarely competent to assess scientific statements critically, cooperate in propagating the pronouncements of self-protecting “research cartels” as science.</p>
<p>Bauer’s concept of a research cartel came into public awareness in an episode that occurred five years after his article appeared. In 2009, someone hacked the emails of the Climate Research Unit at the University of East Anglia in Britain and released them, prompting the “climategate” scandal in which the scientists who sat atop the climate bureaucracy were revealed to be stonewalling against requests for their data from outsiders. This was at a time when many fields, in response to their own replication crises, were adopting data sharing as a norm in their research communities, as well as other practices such as reporting null findings and the pre-registration of hypotheses in shared forums.</p>
<p>The climate research cartel staked its authority on the peer review process of journals deemed legitimate, which meddling challengers had not undergone. But, as Gurri notes in his treatment of climategate, “since the group largely controlled peer review for their field, and a consuming subject of the emails was how to keep dissenting voices out of the journals and the media, the claim rested on a circular logic”.</p>
<p>One can be fully convinced of the reality and dire consequences of climate change while also permitting oneself some curiosity about the political pressures that bear on the science, I hope. Try to imagine the larger setting when the IPPC convenes. Powerful organisations are staffed up, with resolutions prepared, communications strategies in place, corporate “global partners” secured, interagency task forces standing by and diplomatic channels open, waiting to receive the good word from an empaneled group of scientists working in committee.</p>
<p>This is not a setting conducive to reservations, qualifications, or second thoughts. The function of the body is to produce a product: political legitimacy.</p>
<p><strong>The third leg: moralism</strong></p>
<p>The climategate scandal delivered a blow to the IPPC, and therefore to the networked centres of power for which it serves as science-settler. This perhaps led to a heightened receptivity in those centres for the arrival of a figure such as Greta Thunberg who escalates the moral urgency of the cause (“How dare you!), giving it an impressive human face that can galvanise mass energy. She is notable both for being knowledgeable and for being a child, even younger and more fragile-looking than her age, and therefore an ideal victim-sage.</p>
<p>There appears to be a pattern, not limited to climate science-politics, in which the mass energy galvanised by celebrities (who always speak with certainty) strengthens the hand of activists to organise campaigns in which any research institution that fails to discipline a dissident investigator is said to be serving as a channel of “disinformation”. The institution is placed under a kind of moral receivership, to be lifted when <span lang="EN-US">the heads of the institution denounce the offending investigator and distance themselves from his or her findings. They then seek to repair the damage by affirming the ends of the activists in terms that out-do the affirmations of rival institutions. </span></p>
<p>As this iterates across different areas of establishment thinking, especially those that touch on ideological taboos, it follows a logic of escalation that restricts the types of inquiry that are acceptable for research supported by institutions, and shifts them in the direction dictated by political lobbies.</p>
<p>Needless to say, all this takes place far from the field of scientific argument, but the drama is presented as one of restoring scientific integrity. In the internet era of relatively open information flows, a cartel of expertise can be maintained only if it is part of a larger body of organised opinion and interests that, together, are able to run a sort of moral-epistemic protection racket. Reciprocally, political lobbies depend on scientific bodies that are willing to play their part.</p>
<p>This could be viewed as part of a larger shift within institutions from a culture of persuasion to one in which coercive moral decrees emanate from somewhere above, hard to locate precisely, but conveyed in the ethical style of HR. Weakened by the uncontrolled dissemination of information and attendant fracturing of authority, the institutions that ratify particular pictures of what is going on in the world must not merely assert a monopoly of knowledge, but place a moratorium on the asking of questions and noticing of patterns.</p>
<p>Research cartels mobilise the denunciatory energies of political activists to run interference and, reciprocally, the priorities of activist NGOs and foundations meter the flow of funding and political support to research bodies, in a circle of mutual support.</p>
<p>One of the most striking features of the present, for anyone alert to politics, is that we are increasingly governed through the device of panics that give every appearance of being contrived to generate acquiescence in a public that has grown skeptical of institutions built on claims of expertise. And this is happening across many domains. Policy challenges from outsiders presented through fact and argument, offering some picture of what is going on in the world that is rival to the prevailing one, are not answered in kind, but are met rather with denunciation. In this way, epistemic threats to institutional authority are resolved into moral conflicts between good people and bad people.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/12/how-race-politics-liberated-the-elites/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/12/how-race-politics-liberated-the-elites/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/12/GettyImages-1228697748.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/12/how-race-politics-liberated-the-elites/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Further reading</span></a><a href="https://stage.unherd.com/2020/12/how-race-politics-liberated-the-elites/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>How race politics liberated the elites</h5></a><p class="author"><a href="https://stage.unherd.com/2020/12/how-race-politics-liberated-the-elites/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Matthew Crawford</a></p></div></a></div>
<p>The ramped-up moral content of pronouncements that are ostensibly expert-technical needs to be explained. I suggested there are two rival sources of political legitimacy, science and popular opinion, that are imperfectly reconciled through a kind of distributed demagogy, which we may call scientism. This demagogy is distributed in the sense that interlocked centers of power rely on it to mutually prop one another up.</p>
<p>But as this arrangement has begun to totter, with popular opinion coming untethered from expert authority and newly assertive against it, a third leg has been added to the structure in an effort to stabilise it: the moral splendor of the Victim. To stand with the Victim, as every major institution now appears to do, is to arrest criticism. Such is the hope, at any rate.</p>
<p>In the unforgettable Summer of 2020, the moral energy of anti-racism was harnessed to the scientific authority of public health, and vice versa. Thus “white supremacy” was a public health emergency — one urgent enough to dictate the suspension of social distancing mandates for the sake of protests. So how did the description of America as white supremacist get converted into a scientific-sounding claim?</p>
<p><a href="https://www.tabletmag.com/sections/news/articles/the-covid-class-war-heats-up-michael-lind">Michael Lind</a> has argued that covid laid bare a class war, not between labor and capital, but between two groups that could both be called “elites”: on one side, small business owners who opposed lockdowns and, on the other, professionals who enjoyed greater job security, were able to work from home, and typically took a maximalist position on hygiene politics. We can add that, being in the “knowledge economy,” professionals naturally show more deference to experts, since the basic currency of the knowledge economy is epistemic prestige.</p>
<p>This divide got mapped onto the pre-existing schism that had organised itself around President Trump, with the population sorted into good people and bad people. For professionals, not just the status of one’s soul, but one’s standing and viability in the institutional economy, depended on getting conspicuously on the right side of that divide. According to the Manichaean binary established in 2016, the fundamental question mark over one’s head is that of the strength and sincerity of one’s anti-racism. For white people who worked in technical bodies connected to public health, the confluence of the George Floyd protests and the pandemic seemed to have presented an opportunity to convert their moral precarity on the issue of race into its opposite: moral authority.</p>
<p>Over 1,200 health experts, speaking as health experts, signed an open letter encouraging mass protests as necessary to address the “pervasive lethal force of white supremacy”. This pervasive force is something they are specially qualified to detect by their scientific knowledge. Editorials in journals such as <em>The Lancet</em>, <em>The New England Journal of Medicine</em>, <em>Scientific American</em> and even <em>Nature</em> now speak the language of Critical Race Theory, invoking the invisible miasma of “whiteness” as explanatory device, controlling variable and justification for whatever pandemic policy prescription it seems good to align themselves with.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2021/04/how-critical-race-theory-captured-the-church/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2021/04/how-critical-race-theory-captured-the-church/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2021/04/GettyImages-142369634.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2021/04/how-critical-race-theory-captured-the-church/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2021/04/how-critical-race-theory-captured-the-church/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>How Critical Race Theory captured the Church</h5></a><p class="author"><a href="https://stage.unherd.com/2021/04/how-critical-race-theory-captured-the-church/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Giles Udy</a></p></div></a></div>
<p>The science is remarkably clear. It has also been bent to expansive purposes. In February 2021, the medical journal <em>The Lancet</em> convened a Commission on Public Policy and Health in the Trump Era to deplore the president’s politicisation of science – while urging “science-led proposals” that would address public health through reparations for descendants of slaves and other victims of historical oppression, the enhancement of affirmative action, and the adoption of the Green New Deal, among other measures. One can certainly make a case for such policies sincerely, freely, and with due consideration. Many people have. But perhaps it is also the case that the moral sorting and resulting insecurity among technocratic professionals has made them quick to defer to activists and sign on to grander visions of a transformed society.</p>
<p>The spectacular success of “public health” in generating fearful acquiescence in the population during the pandemic has created a rush to take every technocratic-progressive project that would have poor chances if pursued democratically, and cast it as a response to some existential threat. In the first week of the Biden administration, the Senate majority leader urged the president to declare a “climate emergency” and assume powers that would authorise him to sidestep Congress and rule by executive fiat. Ominously, we are being prepared for “climate lockdowns”<span lang="EN-US">.</span></p>
<p><strong>The wisdom of the East</strong></p>
<p>Western nations have long had contingency plans for dealing with pandemics, in which quarantine measures were delimited by liberal principles – respecting individual autonomy and avoiding coercion as much as possible. Thus, it was the already-infected and the especially vulnerable who should be isolated, as opposed to locking healthy people in their homes. China, on the other hand, is an authoritarian regime that solves collective problems through rigorous control of its population and pervasive surveillance. Accordingly, when the COVID pandemic began in earnest, China locked down all activities in Wuhan and other affected areas. In the West, it was simply assumed that such a course of action was not an available option.</p>
<p>As UK epidemiologist Neil Ferguson said to <a href="https://www.thetimes.co.uk/article/people-don-t-agree-with-lockdown-and-try-to-undermine-the-scientists-gnms7mp98" target="_blank" rel="noopener">the <em>Times</em></a> last December: “It’s a communist one-party state, we said. We couldn’t get away with [lockdowns] in Europe, we thought… and then Italy did it. And we realised we could.” He added that “These days, lockdown feels inevitable.”</p>
<p>Thus, what had seemed impossible due to the bedrock principles of Western society now feels not merely possible but inevitable. And this complete inversion happened over the course of a few months.</p>
<p>Acceptance of such a bargain would seem to depend entirely on the gravity of the threat. There is surely some point of hazard beyond which liberal principles become an unaffordable luxury. Covid is indeed a very serious illness, with an infection fatality rate about ten times higher than that of the flu: roughly one percent of all those who are infected die. Also, however, unlike the flu this mortality rate is so skewed by age and other risk factors, varying by more than a thousand-fold from the very young to the very old, that the aggregate figure of one percent can be misleading. As of November 2020, the average age of those killed by Covid in Britain was <a href="https://www.ft.com/content/879f2a2b-e366-47ac-b67a-8d1326d40b5e" target="_blank" rel="noopener">82.4 years old</a>.</p>
<p>In July of 2020, <a href="https://www.ft.com/content/879f2a2b-e366-47ac-b67a-8d1326d40b5e" target="_blank" rel="noopener">29 % of British citizens believed that “6-10 percent or higher” of the population had already been killed by Covid</a>. About 50% of those polled had a more realistic estimate of 1%. The actual figure was about one tenth of one percent. So the public’s perception of the risk of dying of Covid was inflated by one to two orders of magnitude. This is highly significant.</p>
<p>Public opinion matters in the West far more than in China. Only if people are sufficiently scared will they give up basic liberties for the sake of security – this is the basic formula of Hobbes’s Leviathan. Stoking fear has long been an essential element of the business model of mass media, and this appears to be on a trajectory of integration with state functions in the West, in a tightening symbiosis. While the Chinese government resorts to external coercion, in the West coercion must come from inside; from a mental state in the individual. The state is nominally in the hands of people elected to serve as representatives of the people, so it cannot be an object of fear. Something else must be the source of fear, so the state may play the role of saving us. But playing this role requires that state power be directed by experts.</p>
<p>Early in 2020, public opinion accepted the necessity of a short-term suspension of basic liberties on the supposition that, once the emergency had passed, we could go back to being not-China. But this is to assume a robustness of liberal political culture that may not be warranted. Lord Sumption, a jurist and retired member of the UK’s Supreme Court, makes a case for regarding lockdowns in the West as the crossing of a line that is not likely to get uncrossed. In an interview with Freddie Sayers at <a href="https://stage.unherd.com/2021/03/lord-sumption-civil-disobedience-has-begun/"><em>UnHerd</em></a>, he points out that, by law, the government has broad powers to act under emergency. “There are many things governments can do, which it is generally accepted they should not do. And one of them, until last March, was to lock up healthy people in their homes.”</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2021/03/lord-sumption-civil-disobedience-has-begun/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2021/03/lord-sumption-civil-disobedience-has-begun/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2021/03/sumption4.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2021/03/lord-sumption-civil-disobedience-has-begun/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2021/03/lord-sumption-civil-disobedience-has-begun/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Lord Sumption: civil disobedience has begun</h5></a><p class="author"><a href="https://stage.unherd.com/2021/03/lord-sumption-civil-disobedience-has-begun/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Jonathan Sumption</a></p></div></a></div>
<p>He makes the Burkean observation that our status as a free society rests, not on laws, but on convention, a “collective instinct” about what we ought to do, rooted in habits of thinking and feeling that develop slowly over decades and centuries. These are fragile. It is far easier to destroy a convention than to establish one. This suggests going back to being not-China may be quite difficult.</p>
<p>As Lord Sumption says, “When you depend for your basic freedoms on convention, rather than law, once the convention is broken, the spell is broken. Once you get to a position where it is unthinkable to lock people up, nationally, except when somebody thinks it’s a good idea, then frankly there is no longer any barrier at all. We have crossed that threshold. And governments do not forget these things. I think this is a model that will come to be accepted, if we are not very careful, as a way of dealing with all manner of collective problems.” In the US as in the UK, the government has immense powers. “The only thing that protects us from the despotic use of that power is a convention that we have decided to discard.”</p>
<p>Clearly, an admiration for Chinese-style governance has been blossoming in what we call centrist opinion, in large part as a response to the populist upsets of the Trump and Brexit era. It is also clear that “Science” (as opposed to actual science) is playing an important role in this. Like other forms of demagogy, scientism presents stylised facts and a curated picture of reality. In doing so, it may generate fears strong enough to render democratic principles moot.</p>
<p>The pandemic is now in retreat and the vaccines are available to all who want them in most parts of the United States. But many people refuse to give up their masks, as though they had joined some new religious order. The wide deployment of fear as an instrument of state propaganda has had a disorienting effect, such that our perception of risk has come detached from reality.</p>
<p>We accept all manner of risks in the course of life, without thinking about it. To pick one out and make it an object of intense focus is to adopt a distorted outlook that has real costs, paid somewhere beyond the rim of one’s tunnel vision. To see our away out of this — to place risks in their proper context — requires an affirmation of life, refocusing on all those worthwhile activities that elevate existence beyond the merely vegetative.</p>
<p><strong>Losing face</strong></p>
<p>Perhaps the pandemic has merely accelerated, and given official warrant to, our long slide toward atomisation. By the nakedness of our faces we encounter one another as individuals, and in doing so we experience fleeting moments of grace and trust. To hide our faces behind masks is to withdraw this invitation. This has to be politically significant.</p>
<p>Perhaps it is through such microscopic moments that we become aware of ourselves as a people, bound up in a shared fate. That’s what solidarity is. Solidarity, in turn, is the best bulwark against despotism, as Hannah Arendt noted in <em>On The Origins of Totalitarianism</em>. Withdrawal from such encounter now has the stamp of good citizenship, i.e., good hygiene. But what sort of regime are we to be citizens of?</p>
<p>“Following the science” to minimise certain risks while ignoring others absolves us of exercising our own judgment, anchored in some sense of what makes life worthwhile. It also relieves us of the existential challenge of throwing ourselves into an uncertain world with hope and confidence. A society incapable of affirming life and accepting death will be populated by the walking dead, adherents of a cult of the demi-life who clamour for ever more guidance from experts.</p>
<p>It has been said, a people gets the government it deserves.</p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2021/05/how-science-has-been-corrupted/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2021/05/how-science-has-been-corrupted/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2021/05/how-science-has-been-corrupted/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">115584</post-id>				</item>
									<item>
					<title>China&#8217;s plan for medical domination</title>
					<link>https://stage.unherd.com/2021/02/chinas-plan-for-medical-domination/?edition=us</link>
											<comments>https://stage.unherd.com/2021/02/chinas-plan-for-medical-domination/?edition=us#comments</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2021/02/GettyImages-1211365730-2.jpg?w=525</unherd:featured_image>
										<unherd:main_theme></unherd:main_theme>
					<dc:creator>
						<![CDATA[Steve Boggan]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2021/02/Steve-Boggan.jpg?w=96</unherd:creator_img>
																<unherd:article_ranking></unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[Covid-19 vaccines were tested on primates (Photo by NICOLAS ASFOURI/AFP via Getty Images)]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p><strong>Steve Boggan</strong> is an investigative journalist and former Chief Reporter at <em>The Independent</em>. He is also the author of <i>Follow the Money</i> and <i>Gold Fever</i>.</p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle>tendollarguy</unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[ is an investigative journalist and former Chief Reporter at <em>The Independent</em>. He is also the author of <i>Follow the Money</i> and <i>Gold Fever</i>.]]>
					</unherd:author_bio>
										<pubDate>Mon, 08 Feb 2021 00:10:55 +0000</pubDate>
					<updated>Mon, 08 Feb 2021 11:34:35 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[China 2021]]></category>
		<category><![CDATA[Coronavirus]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Vaccine]]></category>
		<category><![CDATA[vaccines]]></category>
					<guid isPermaLink="false">https://old.unherd.com/?p=56081</guid>
																												<description>
								<![CDATA[If there's another pandemic, the West could be dependent on Beijing for vaccine development ]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p>Deborah Green[1.  Deborah Green is a pseudonym] has just made a life-or-death decision — and she isn’t happy about it. “We have two cancer drugs in development and we had to choose which one would move up to the next level,” she says. “We made our choice, but you can’t help wondering how many lives might have been saved by the other one.”</p>
<p>The choice made by Green, the head of animal testing compliance for one of the world’s biggest pharmaceutical companies, is one increasingly being made by biomedical researchers across the world — but not because of financial constraints, ethical considerations or scientific limitations.</p>
<p>It is all because of a shortage of monkeys.</p>
<p>On almost every continent, pharmaceutical research is being undermined by a dearth of primates caused by an export ban introduced by China last year to restrict the spread of Covid-19. It’s a measure that was initially welcomed in the West, but which is now being seen as an existential threat to biomedical research in the UK, Europe and the US.</p>
<p>Scientists fear that unless this shortage is addressed, the West will become dangerously reliant on China to test new treatments for heart disease, cancers and neurological disorders. More worryingly, come the next global pandemic, the ability to affect which vaccines are approved — and how quickly — could lie firmly in the hands of the Communist Party of China.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2021/01/how-china-could-turn-off-britains-lights/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2021/01/how-china-could-turn-off-britains-lights/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2021/01/GettyImages-493418000.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2021/01/how-china-could-turn-off-britains-lights/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested article</span></a><a href="https://stage.unherd.com/2021/01/how-china-could-turn-off-britains-lights/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>How China could turn off Britain&#039;s lights</h5></a><p class="author"><a href="https://stage.unherd.com/2021/01/how-china-could-turn-off-britains-lights/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Clive Hamilton</a></p></div></a></div>
<p>“It isn’t too dramatic to say that this could be the beginning of the end for biopharmaceutical research in the West,” says Green. “I believe China’s long-term aim is to become the world leader in the sector, the place you will have to go to if you want to test your products. But you have to ask yourself whether you want China to be in control of such an important part of our lives — and to have access to so much of our intellectual property.”</p>
<p>The past 12 months have well demonstrated China’s growing influence on the West. But while attention has been focused on Covid-19, Huawei’s involvement in the UK’s 5G rollout and the threat to democracy in Hong Kong, its impact on Britain’s research sector has slipped under the radar.</p>
<p>Despite protests from critics, the testing of drugs and treatments on “Non-Human Primates” (NHPs), as scientists call them, cannot be replaced by computer modelling. It remains a requirement for many new drugs — including the Oxford-AstraZeneca and Pfizer-BioNTech Covid-19 vaccines — before trials can be allowed in humans.</p>
<p>In 2019, 2,015 new NHPs were used in experiments in the UK. Only 220 of them were not imported; most being bred under licence at a government breeding facility at Porton Down in Wiltshire. Some 1,154 came from breeding centres in Africa, largely from the island of Mauritius. And 782 came from Asia — roughly 75% of which came from China.</p>
<p>So when, in January last year, China imposed a ban on the export of all animals, the flow of a sizeable number of NHPs — roughly a quarter of those needed in the UK — was suddenly switched off. But that was only the beginning. British researchers also carry out a significant portion of their research through companies in other, worse-hit countries. And as a result, they have been left scrambling around to find the animals they need to complete their research.</p>
<p>US biotech companies were especially hard-hit. The US relies on China for 60% of its monkeys — some 35,000 a year — and because most of the big pharma companies are multinational, shortages in one area have resulted in bottlenecks in others, including the UK. Desperately in demand, the average price of the animals most-often used — rhesus macaques, cynomolgus macaques and marmosets — has doubled to $10,000 in the past year.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/12/the-useful-idiots-are-back-again/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/12/the-useful-idiots-are-back-again/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/12/GettyImages-1190028286.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/12/the-useful-idiots-are-back-again/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested article</span></a><a href="https://stage.unherd.com/2020/12/the-useful-idiots-are-back-again/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>China&#039;s useful idiots</h5></a><p class="author"><a href="https://stage.unherd.com/2020/12/the-useful-idiots-are-back-again/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> James Bloodworth</a></p></div></a></div>
<p>Kirk Leech, executive director of the UK-based European Animal Research Association, which represents contract research organisations (CROs) — private labs that conduct animal research on behalf of pharmaceutical companies — has seen rare cases of desperate firms paying $30,000 a-head for monkeys.</p>
<p>“As China is the primary source of NHPs purpose-bred for scientific purposes, this ban has had a dramatic impact on both the supply and the cost of NHPs around the world and the ability of researchers to access the animals essential for the development of new vaccines and medicines,” he says.</p>
<p style="padding-left: 40px;"><em>“This export ban is a clear and present danger to human health, creating obstacles to, and additional expenses for, the development of vaccines and therapeutics, including for Covid-19. The Pfizer-BioNTech vaccine relied on preclinical data generated by BioNTech in Germany, using rhesus macaques. The Oxford-AstraZeneca vaccine and the Janssen vaccine have also relied on preclinical testing with NHPs for safety and efficacy.”</em></p>
<p>In the event of another global health crisis like the one we are experiencing, he warns, the repercussions could be severe: “Imagine a new pandemic; we would need a global response, we would need vaccine research and we would need to use NHPs. If shortages grow worse due to China’s actions, UK researchers would not be able to respond as they have to the Covid-19 pandemic. That is a real fear.”</p>
<p>Surely, then, the answer is simply to breed more monkeys outside China? In the long-term, that certainly seems to be the solution. But for at least half a decade, numbers will remain finite. More important, decisions to increase breeding could, counter-intuitively, make matters worse.</p>
<p>“The problem is we can’t simply increase the numbers of monkeys we have for sale,” one major Mauritian breeder told me, on condition of anonymity. “For every 100 breeding females, only around 60 babies are produced, and they are usually sold at two years. In order to increase the numbers, we would have to hold back females for breeding instead of selling them, and that would add to the shortage.</p>
<p>“We would have to hold them back for a further three years until they were mature enough to breed, and a female will produce only one baby every 18 to 20 months. A monkey generation [the time it takes for an animal to be born, reach adulthood and procreate] is five years, so that’s a whole generation taken out until numbers can be increased.</p>
<p>“Since the Chinese export ban, we’ve been receiving calls from researchers all round the world begging for monkeys. Some people sound desperate, but there’s nothing we can do in the short term.”</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/07/the-lefts-shameful-silence-on-china/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/07/the-lefts-shameful-silence-on-china/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/07/GettyImages-1223718778-e1594637837340.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/07/the-lefts-shameful-silence-on-china/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested article</span></a><a href="https://stage.unherd.com/2020/07/the-lefts-shameful-silence-on-china/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>The Left&#039;s shameful silence on China</h5></a><p class="author"><a href="https://stage.unherd.com/2020/07/the-lefts-shameful-silence-on-china/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Paul Embery</a></p></div></a></div>
<p>But if the situation is so potentially-damaging to the UK’s life sciences, why isn’t the research sector issuing dire warnings over its future ­— or lack of one?</p>
<p>According to senior industry insiders, there is a two-pronged reluctance to publicly debate the problem. First is the memory of violent demonstrations against the animal research sector at the turn of the century, when staff at Huntingdon Life Sciences (HLS) in Cambridgeshire were targeted by extremists. Brian Cass, managing director of HLS was beaten outside his home by three men; the company’s marketing director, Andrew Gay, was temporarily blinded in a chemical spray attack; and the homes of workers and contractors were firebombed.</p>
<p>Violent animal activism has since all but evaporated. Yet memories endure of its peak in 2006, when extremists dug up the body of Gladys Hammond, a member of the family which ran Darley Oaks in Staffordshire, a farm which bred guinea pigs for the research industry. Three people who “ransomed” the body in return for the farm halting its business were jailed for 12 years each, but the fear of attracting such levels of violence and hatred remain.</p>
<p>Second, and more significantly, there is concern among CROs that if it became public knowledge that they were being affected by primate shortages, their pharmaceutical clients might turn elsewhere — probably China.</p>
<p>Only one CRO in the UK was prepared to comment publicly, yet anonymously, saying the Chinese ban “will result in global demand exceeding supply and what initially began as a US issue will also negatively impact the European research sector. The lack of access to NHPs due to the China ban will create obstacles to the development of vaccines including for Covid-19 and therapeutics globally.”</p>
<p>Leech — who represents the CROs<strong>, </strong>as well as pharmaceutical companies, private researchers and some universities — has called upon the British government and the European Commission to demand China lifts the ban, arguing it is in breach of World Trade Organisation General Tariffs and Trade <a href="https://www.wto.org/english/res_e/publications_e/ai17_e/gatt1994_art11_oth.pdf" target="_blank" rel="noopener noreferrer">rules</a>. He says importing countries had bio-safety arrangements in place within a month and that the ban could have been lifted by then. The UK and European Commission say they are conducting internal discussions but have not yet agreed to act.</p>
<p>As for why China would deliberately starve the US and Europe of such a vital resource, I twice asked the Chinese Embassy in London to address the accusation that its actions were designed to undermine research in the West, but it failed to reply.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2018/09/wests-utter-failure-see-chinas-end-game/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2018/09/wests-utter-failure-see-chinas-end-game/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2018/09/GettyImages-871894532.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2018/09/wests-utter-failure-see-chinas-end-game/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested article</span></a><a href="https://stage.unherd.com/2018/09/wests-utter-failure-see-chinas-end-game/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>The West&#039;s utter failure to see China&#039;s end game</h5></a><p class="author"><a href="https://stage.unherd.com/2018/09/wests-utter-failure-see-chinas-end-game/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Mike Martin</a></p></div></a></div>
<p>It is worth noting, however, that such allegations about China’s quest for pharmaceutical dominance are nothing new. In 2016, David Cyranoski, writing for the <a href="https://www.researchgate.net/publication/301569169_Monkey_kingdom">journal</a> <em>Nature</em>, was granted access to the Yunnan Key Laboratory of Primate Biomedical Research near Kunming in south west China. In his article “Monkey Kingdom”, he described a research nirvana where animal rights activism doesn’t exist and bureaucracy presents no obstacles.</p>
<p>“With support from central and local governments, high-tech primate facilities have sprung up in Shenzhen, Hangzhou, Suzhou and Guangzhou over the past decade,” he wrote. “These centres can provide scientists with monkeys in large numbers, and offer high-quality animal care and cutting-edge equipment with little red tape.”</p>
<p>He described how “many [researchers] have since sought refuge for their experiments in China… Some of the Chinese centres are even advertising themselves as primate-research hubs where scientists can fly in to take advantage of the latest tools, such as gene editing and advanced imaging.”</p>
<p>Finally, and with estimable prescience, Cyranoski concluded: “With China fast becoming a global centre for primate research, some scientists fear that it could hasten the atrophy of such science in the West and lead to a near monopoly, in which researchers become over-reliant on one country for essential disease research and drug testing.”</p>
<p>Deborah Green agrees. “When you look at China’s stated intentions for their industry, there have been a number of moves that seem intended to drive research towards it,” she says. “That’s everything from their control over lab supplies, PPE, research animals and so on. You can look at what China is spending on pharmaceutical research and development. The US is the biggest investor in this sector but China is now very close, and that number has gone from a very low number to rivalling that of the US in a very short time.”</p>
<p>“This all adds up to a reason to believe that China is trying to take control of this sector,” says Green. “Between the moves to push research towards China, and the animal rights activity in Europe and the US, we are going to see a continuing diminishing of research in the western world and a shift of it towards China. There are already researchers from major academic institutions in the US, and Europe sending their primate work to China. It’s cheaper, there is less regulation and they have the capacity to do it.”</p>
<p>But if major institutions and drug companies start sending highly advanced and hugely sensitive research to be advanced in China, isn&#8217;t this a risk every bit as great as that posed by Huawei, whose role in Britain’s 5G infrastructure is now being blocked by the UK government?</p>
<p>“I think this all presents serious issues when you look at China’s attitudes to intellectual property (IP), in that it has a very poor record on respecting IP rights,” says Green. “There is a great risk in taking the products that we develop and sending them over there for testing”</p>
<p>One solution, she says, would be for Western governments to help to create the infrastructure to breed NHPs. “These animals can’t simply be bred anywhere,” she admits. “They need sub-tropical conditions because ideally from a welfare point of view, they should be raised outdoors in large spaces. But where this is possible in parts of the United States and southern Europe, a bit of government protection from animal rights activists would be welcome. In the meantime, we’re hanging on, but we’re losing by inches.”</p>
<p>And if the West does lose, it seems there will be only one winner: China.</p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2021/02/chinas-plan-for-medical-domination/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2021/02/chinas-plan-for-medical-domination/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2021/02/chinas-plan-for-medical-domination/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">56081</post-id>				</item>
									<item>
					<title>Should Big Pharma profit from Covid?</title>
					<link>https://stage.unherd.com/2020/11/should-big-pharma-profit-from-covid/?edition=us</link>
											<comments>https://stage.unherd.com/2020/11/should-big-pharma-profit-from-covid/?edition=us#comments</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2020/11/GettyImages-1229023125-e1605551442678.jpg?w=448</unherd:featured_image>
										<unherd:main_theme></unherd:main_theme>
					<dc:creator>
						<![CDATA[Tom Chivers]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2019/09/chivers.jpg?w=96</unherd:creator_img>
																<unherd:article_ranking></unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[Pfizer will stand to make a profit of £9.8 billion from their Covid-19 vaccine. Erik McGregor/LightRocket via Getty]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p><strong>Tom Chivers</strong> is a science writer. His second book, <em>How to Read Numbers</em>, is out now.</p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle>TomChivers</unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[ is a science writer. His second book, <em>How to Read Numbers</em>, is out now.]]>
					</unherd:author_bio>
										<pubDate>Tue, 17 Nov 2020 00:11:17 +0000</pubDate>
					<updated>Tue, 17 Nov 2020 12:13:42 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[Bill Gates]]></category>
		<category><![CDATA[Coronavirus]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Moderna]]></category>
		<category><![CDATA[Owen Jones]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Vaccine]]></category>
					<guid isPermaLink="false">https://old.unherd.com/?p=50311</guid>
																												<description>
								<![CDATA[Pfizer and Moderna will make billions from vaccines — luckily for us all]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p><span style="font-weight: 400;">It is said that the pharma industry spends more money on researching cures for baldness than it does for researching cures for malaria. </span><span style="font-weight: 400;">This is, I think, </span><a href="https://blogs.sciencemag.org/pipeline/archives/2013/03/14/does_baldness_get_more_funding_than_malaria" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">not true</span></a><span style="font-weight: 400;">. I say this with great sadness, because</span><a href="https://www.wired.co.uk/article/bill-gates-capitalism" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;"> Bill Gates repeated the claim</span></a><span style="font-weight: 400;">, and Bill Gates will, I hope, be remembered as one of the great heroes of the 21st century: someone who will have saved literally millions of lives, through his work on malaria and, lately, on funding Covid-19 vaccines. But even heroes can be wrong.</span></p>
<p><span style="font-weight: 400;">Still: even though Gates was wrong on the specific case, he is bang on when he suggests that there is a market failure. The pharma industry has done many wonderful things. To pick one example that is very salient to me, metastatic melanoma was </span><a href="https://www.buzzfeed.com/tomchivers/how-the-cures-for-cancer-snuck-up-on-us" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">essentially a death sentence 20 years ago</span></a><span style="font-weight: 400;">; now I have two relatives who are alive and healthy, several years after diagnosis, because immunotherapy has made it manageable, if not curable.</span></p>
<p><span style="font-weight: 400;">But there are real problems with the pharma industry. While it is amazing at developing drugs for chronic conditions for rich people in rich countries, it is less effective at producing medicines — notably, but not limited to, vaccines and antibiotics — which are not profitable in the short term but which are socially beneficial in the long term. It’s also not well set up to produce cheap drugs for poorer countries, even if those drugs are relatively easy to make and distribute. People are dying of treatable diseases because it’s not profitable to cure them.</span></p>
<p><span style="font-weight: 400;">This is the backdrop to </span><a href="https://www.theguardian.com/commentisfree/2020/nov/12/covid-vaccine-patent-pharmaceutical-industry-profits-public-sector"><span style="font-weight: 400;">an article by Owen Jones in the <em>Guardian</em></span></a><span style="font-weight: 400;"> last week, in which he pointed out that Pfizer will stand to make a profit of £9.8 billion from their Covid-19 vaccine. That is, he says, unethical. He quotes activists saying that Pfizer’s patent on its vaccine – and, I assume although he does not say, other firms’ patents on their vaccines – should be suspended, so that cheap, generic versions can be produced and rolled out to the developing world. As it is, biotech patents stand for 20 years; until then, firms essentially have monopolistic power, and can set prices how they like.</span></p>
<p><span style="font-weight: 400;">I have a lot of sympathy for Jones&#8217;s sentiment. He has identified a real problem. But his proposed solution is a bad one, and I worry that it would lead to disaster. You want pharma companies to distribute their products in as equitable a way as possible, but you also want them to </span><i><span style="font-weight: 400;">continue to make those products</span></i><span style="font-weight: 400;">. And taking away their profits when they make a good one will not encourage them to do the same next time. So what is the best course of action?</span></p>
<p><span style="font-weight: 400;">First, it’s worth noting that £9.8 billion is not in fact very much money. Obviously it’s </span><i><span style="font-weight: 400;">quite</span></i><span style="font-weight: 400;"> a lot of money, on the human scale. But in terms of the global economy it’s peanuts. A paper by the economist Larry Summers </span><a href="https://jamanetwork.com/journals/jama/fullarticle/2771764" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">estimates</span></a><span style="font-weight: 400;"> that even if we control the virus by the end of 2021, it will still cost the US economy alone about $16 trillion (£12 trillion), if you account for the deaths and misery as well as its simple economic costs. The IMF is more optimistic, putting it at </span><a href="https://blogs.imf.org/2020/04/14/the-great-lockdown-worst-economic-downturn-since-the-great-depression/" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">a mere $9 trillion</span></a><span style="font-weight: 400;"> worldwide, although that doesn’t take into account the non-financial costs.</span></p>
<p><span style="font-weight: 400;">Take the latter, lower figure. If Pfizer making a profit reduces the impact of the virus by one-tenth of one percent, then it will pay for itself, even before we start thinking about the lives lost. I think it is a safe bet that the vaccine will have a much greater effect than that; Pfizer will only see a tiny fraction of the total benefits the vaccine will bring the world.</span></p>
<p><span style="font-weight: 400;">(It’s also worth noting that AstraZeneca have said that they won’t make a profit from </span><i><span style="font-weight: 400;">their</span></i><span style="font-weight: 400;"> vaccine “during the pandemic”, although they</span><a href="https://www.ft.com/content/c474f9e1-8807-4e57-9c79-6f4af145b686"><span style="font-weight: 400;"> reserve the right</span></a><span style="font-weight: 400;"> to say when “the pandemic” is over.)</span></p>
<p><span style="font-weight: 400;">But the main point is that there is a real, and to some extent unresolvable, tension in what it is that we want pharma companies to do. On the one hand, we want them to produce new drugs that save our lives. On the other, we want them to manufacture those drugs cheaply and get them to as many people as possible.</span></p>
<p><span style="font-weight: 400;">Imagine that a drug firm produces a vaccine for some deadly disease that is affecting people in both the developed and the developing world. Roughly speaking, a new vaccine costs about a billion dollars to get to market, after putting it through animal trials, Phase I safety trials and Phase II and Phase III efficacy trials, applying for licensing, and so on. Let’s imagine it costs about a dollar a dose to make. So if you only made enough of the vaccine to dose one person, the cost of that dose would be $1,000,000,001.</span></p>
<p><span style="font-weight: 400;">But if you make </span><i><span style="font-weight: 400;">two</span></i><span style="font-weight: 400;"> doses, the average cost per dose is $500,000,001. If you make four, it’s $250,000,001. If you make a billion, it’s $2. The more doses you make and sell, the closer your </span><i><span style="font-weight: 400;">average</span></i><span style="font-weight: 400;"> cost per dose gets to your </span><a href="https://en.wikipedia.org/wiki/Marginal_cost" target="_blank" rel="noopener noreferrer"><i><span style="font-weight: 400;">marginal</span></i></a><span style="font-weight: 400;"> cost of making a single dose.</span></p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/11/yes-the-vaccine-is-really-on-its-way/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/11/yes-the-vaccine-is-really-on-its-way/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/11/GettyImages-1228088737.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/11/yes-the-vaccine-is-really-on-its-way/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">More from this author</span></a><a href="https://stage.unherd.com/2020/11/yes-the-vaccine-is-really-on-its-way/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Yes, the vaccine is really on its way</h5></a><p class="author"><a href="https://stage.unherd.com/2020/11/yes-the-vaccine-is-really-on-its-way/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Tom Chivers</a></p></div></a></div>
<p><span style="font-weight: 400;">The socially optimal outcome is that we charge everyone the marginal cost, $1, so it can reach the maximum number of people. But if we do that, the pharma company will never cover its fixed costs: it will be $1 billion in the red, and probably won’t want to make any more vaccines. </span></p>
<p><span style="font-weight: 400;">On the other hand, if you let pharma companies charge the market value — that is, the amount that people are willing to pay — then it will cover their losses, because people in rich countries want to be vaccinated against this disease. But poorer countries will not be able to afford it. People who would be willing to pay the marginal cost are priced out of a vaccine. </span></p>
<p><span style="font-weight: 400;">The cost that will encourage industry investment R&amp;D, and the cost that maximises the number of people covered by the vaccine, are different. It’s a simple tradeoff. “It’s obvious that, if your financial model is to sell to rich consumers at above cost price, you’re going to do R&amp;D on products that you can do that for,” says Owen Barder, a development economist who has worked on pharma incentives. “The patent model suffers a really big problem.”</span></p>
<p><span style="font-weight: 400;">One obvious solution would be to take the whole business out of pharma companies’ hands, and let governments and philanthropic organisations run the whole thing. But the profit motive is very good at one particular thing: making pharma companies drop a product that isn’t working. “I think the key skill of a pharma company is knowing when to exit,” says Barder. “And, to a gross generalisation, governments are rubbish at exit.” </span></p>
<p><span style="font-weight: 400;">Most candidate drugs don’t work, or don’t work very well. So most of the time you have to abandon research, after spending a lot of money on them. But it is very hard for a government to say “This thing that we’ve spent £100 million on doesn’t work, and we’re going to throw all that money away.” It’s easier to throw another £100 million in and avoid the question. Drug companies, we all agree, are extremely good at making money. And part of being good at making money is not throwing good money after bad. Publicly funded research is great for blue-skies, open-ended questions that help us understand things, but it is less effective than private firms at developing specific products, because of this exit problem.</span></p>
<p><span style="font-weight: 400;">Instead, says Barder, what you need to do is separate the fixed cost from the marginal cost. You need to find some way of encouraging pharma companies to sell their products at a low cost to poor countries, while also incentivising them to keep putting money into R&amp;D.</span></p>
<p><span style="font-weight: 400;">There are several ways of doing this. One example is a financial prize: we (governments, philanthropic agencies, etc) will give whoever comes up with the first vaccine some large amount of money: perhaps $1 billion, on the condition that they then agree to make it in large quantities and sell it at close to marginal cost to the developing world.</span></p>
<p><span style="font-weight: 400;">That’s a useful model, but it has a disadvantage. In the last two weeks, trial results for two Covid vaccines have been announced: </span><a href="https://stage.unherd.com/2020/11/yes-the-vaccine-is-really-on-its-way/" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">the Pfizer one</span></a><span style="font-weight: 400;"> and, this week, </span><a href="https://www.bbc.co.uk/news/live/world-54957220" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">the Moderna one</span></a><span style="font-weight: 400;">. Initial signs suggest that Moderna’s one is a bit better than Pfizer’s: it appears slightly more effective, and it can be stored at normal freezer temperatures for months, while Pfizer’s needs to be kept at -80°C.</span></p>
<p><span style="font-weight: 400;">If we had put in place a prize system, so that the first group to develop a working vaccine got a billion dollars, then (assuming Pfizer’s vaccine gets licensed first) Pfizer would get the whole lot, even though it appears Moderna’s product is slightly superior. Depending on what costs remained, it might well make financial sense for Moderna to abandon the project, because they would not get the reimbursement that would make it viable. But, obviously, if a superior product comes out a week later, you still want to be able to buy it. (And you may want lots of different vaccines anyway, because each will have different advantages and disadvantages.)</span></p>
<p><span style="font-weight: 400;">But there is a better way. The </span><a href="https://www.nhs.uk/conditions/vaccinations/pneumococcal-vaccination/" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">pneumococcus bacterium</span></a><span style="font-weight: 400;"> causes meningitis, pneumonia and septicaemia; </span><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61204-6/fulltext" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">this <em>Lancet</em> paper</span></a><span style="font-weight: 400;"> estimates that it killed about 800,000 children in the year 2000 alone. The pharmaceutical industry — Pfizer, as it happens — </span><a href="https://en.wikipedia.org/wiki/Pneumococcal_conjugate_vaccine#Prevnar" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">developed a vaccine</span></a><span style="font-weight: 400;">, Prevnar. But it was only suitable for the strains of the disease found in Western countries, not in the developing world. Creating a version that worked for the strain found in poorer countries was perfectly possible, but the financial incentives just weren’t there.</span></p>
<p><span style="font-weight: 400;">To solve the problem, in 2004, the economist Michael Kremer — </span><a href="https://stage.unherd.com/2020/08/what-worms-can-teach-us-about-the-ai-apocalypse/" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">he of deworming fame</span></a><span style="font-weight: 400;"> — and the British economist Rachel Glennerster proposed something called an “advanced market commitment”, or AMC. Five national governments and the Gates Foundation </span><a href="https://www.nber.org/system/files/working_papers/w26775/w26775.pdf" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">put aside $1.5 billion dollars</span></a><span style="font-weight: 400;">. They promised the pharma industry that, if they developed a new vaccine for the developing world, then for every dose that the companies provided at the marginal cost of $3.50 a dose, they would reimburse them a further $7.</span></p>
<p><span style="font-weight: 400;">Unlike a prize, an AMC rewards both speed of development and quality of product. If your vaccine is first to market, you can sell it and make money without any competition; but if you know your vaccine is </span><i><span style="font-weight: 400;">better</span></i><span style="font-weight: 400;"> than the one that’s first to market, you can carry on developing it without worrying that it will be rejected because all the money has gone to the earlier, but inferior, product.</span></p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/10/will-a-vaccine-cure-covid/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/10/will-a-vaccine-cure-covid/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/10/GettyImages-1229085466.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/10/will-a-vaccine-cure-covid/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">More from this author</span></a><a href="https://stage.unherd.com/2020/10/will-a-vaccine-cure-covid/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Will a vaccine stop Covid?</h5></a><p class="author"><a href="https://stage.unherd.com/2020/10/will-a-vaccine-cure-covid/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Tom Chivers</a></p></div></a></div>
<p><span style="font-weight: 400;">Better yet, it keeps all the risk on pharma companies. If they know a vaccine isn’t likely to work, then they will abandon it, because it won’t make them money — it won’t meet the requirements. If governments or philanthropic agencies were funding the research directly, they’d have the problem of exiting after spending lots of money on it. The funding bodies never have to pay for a product that doesn’t work (although they do have to pay a premium for the ones that do).</span></p>
<p><span style="font-weight: 400;">With pneumococcus, it was a roaring success. By 2016 the vaccine was being distributed in 60 countries, and more than 150 million children had been vaccinated; Gavi, the body that oversaw the AMC, </span><a href="https://www.gavi.org/investing-gavi/innovative-financing/pneumococcal-amc/about-pneumococcal-amc" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">estimates </span></a><span style="font-weight: 400;">that it will have saved 700,000 lives by the end of the year.</span></p>
<p><span style="font-weight: 400;">To be clear, the AMC model won’t work for everything. In the case of Covid, for instance, the problem wasn’t that companies weren’t investing in R&amp;D — they knew that there was a market. But building a vaccine factory </span><a href="https://stage.unherd.com/2020/04/when-we-get-the-covid-19-vaccine/" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">takes months and millions of dollars</span></a><span style="font-weight: 400;">, and pharma companies, understandably, don’t want to invest millions of dollars in a product that very possibly won’t work; they’d rather build it at small scale until they’ve done the testing, then scale it up afterwards. </span></p>
<p><span style="font-weight: 400;">Most of the time that works fine. But in the Covid case, the costs to society of making a few factories that ended up not being used were negligible compared to the cost of waiting even a few more weeks for a vaccine. So it became worthwhile for the UK government (for instance) to start paying for manufacture of the Oxford-AstraZeneca vaccine even before it had released its results, and why Bill Gates (again: one of history’s greatest heroes) </span><a href="https://www.fiercepharma.com/vaccines/bill-gates-plans-to-help-fund-factories-for-7-covid-19-vaccines-but-expects-only-2-will" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">invested billions of dollars</span></a><span style="font-weight: 400;"> building seven factories for different vaccine types, knowing that some, or even most, would not work.</span></p>
<p><span style="font-weight: 400;">And AMCs wouldn’t work for antibiotics. Antibiotics are a special case: we need lots of new antibiotics so that we can combat antibiotic-resistant microbes, such as MRSA. But we don’t really want people to </span><i><span style="font-weight: 400;">use</span></i><span style="font-weight: 400;"> them, because then microbes will become resistant to the new ones, as well. Most of the time, if a pharma company brings a new drug to market, it will win a significant chunk <em>of</em> that market — if you make a new cancer drug or antidepressant that works better on some group than the existing ones, then it will be prescribed for that group. But with antibiotics, most of the time, doctors will continue to prescribe doxycycline or methicillin, and will save your new drug for when they encounter drug-resistant bacteria.</span></p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/08/when-will-the-covid-19-vaccine-arrive/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/08/when-will-the-covid-19-vaccine-arrive/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/08/GettyImages-1211365746-e1599738700427.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/08/when-will-the-covid-19-vaccine-arrive/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2020/08/when-will-the-covid-19-vaccine-arrive/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>When will the Covid-19 vaccine arrive?</h5></a><p class="author"><a href="https://stage.unherd.com/2020/08/when-will-the-covid-19-vaccine-arrive/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Saloni Dattani</a></p></div></a></div>
<p><span style="font-weight: 400;">So there is very little incentive for pharma companies to invest in antibiotics, because — essentially — your new antibiotic will rarely be prescribed, so it will rarely be sold, so you’ll make very little money. According to Jeremy Knox, policy lead in antibiotic resistance at the Wellcome Trust, there’s an additional problem that, for hard-to-explain reasons, antibiotics command low prices anyway. “So you have this toxic combination of very unpredictable small volume markets and very low prices,” he says: “and both of those things combined means that if you’re a producer you’ll probably forecast making a loss.” An AMC that paid them for each dose sold wouldn’t help, because not many doses will be sold even at low cost.</span></p>
<p><span style="font-weight: 400;">There are models in place that get around this. Jim O’Neill, who was the antibiotics tsar under David Cameron’s government, suggested a lump sum given to each pharma company that brings a novel antibiotic to market. Wellcome and the British Government are also looking at what Knox describes as “the Netflix model”, where bodies like the NHS agree to pay a fixed sum a year to the manufacturers, and are then given as much as they need. So if you only need to use five doses all year, you pay X million; but if you need 5,000 doses, or 5 million, you still pay X million. </span></p>
<p><span style="font-weight: 400;">It means that pharma companies aren’t incentivised to sell as many doses as they can, and the decision to prescribe can stay in the hands of doctors. (It is worth noting that the UK Government, and the health secretary Matt Hancock in particular, have been quick to take up this model; I rarely have nice things to say about Matt Hancock, so I will flag this now.)</span></p>
<p><span style="font-weight: 400;">There is also a funding scheme, </span><a href="https://carb-x.org/about/overview/" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">CARB-X</span></a><span style="font-weight: 400;">, which supports the R&amp;D of new antibiotics. It’s not enough — Knox thinks we need about 10 new antibiotics every decade, and that at the moment we might be lucky to see two or three. But it’s an improvement.</span></p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/11/why-is-france-full-of-anti-vaxxers/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/11/why-is-france-full-of-anti-vaxxers/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/11/GettyImages-93004988-e1605197217800.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/11/why-is-france-full-of-anti-vaxxers/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2020/11/why-is-france-full-of-anti-vaxxers/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>France is infected with anti-vaxxers</h5></a><p class="author"><a href="https://stage.unherd.com/2020/11/why-is-france-full-of-anti-vaxxers/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> John Lichfield</a></p></div></a></div>
<p><span style="font-weight: 400;">Coming back to Owen Jones’s article, it’s worth noting what I think is a factual error. It’s a minor one, but I think it’s instructive. He says that vaccine companies “abandoned” research into a vaccine for Sars in 2003 because it was not “immediately profitable”. But as I understand it, the reason that the pharma industry stopped work on a Sars vaccine was because </span><a href="https://theconversation.com/the-mysterious-disappearance-of-the-first-sars-virus-and-why-we-need-a-vaccine-for-the-current-one-but-didnt-for-the-other-137583" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">Sars (somewhat mysteriously) disappeared</span></a><span style="font-weight: 400;">. If people weren’t getting infected, then you couldn’t tell if your vaccine stopped infections. In fact, Mike Osterholm, the US epidemiologist, </span><a href="https://www.thetimes.co.uk/article/deadliest-enemy-our-war-against-killer-germs-by-michael-t-osterholm-and-mark-olshaker-review-a-pandemic-prophecy-8c05jb3m3" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">says</span></a><span style="font-weight: 400;"> that the pharma industry invested hundreds of millions of dollars in Sars vaccine research, and then when it went away, the US government and philanthropic agencies left them “holding the bag”, and wary about future investments.</span></p>
<p><span style="font-weight: 400;">I think it’s instructive because most of the scientists working at pharma companies want to save and improve lives, just as scientists do at universities or other bodies. But just like the scientists at those other bodies, they have to navigate the incentive structure that surrounds them. For university scientists, it’s publish-or-perish – your work is useless if it doesn’t get you journal articles and citations, regardless of how true it is. For industry scientists, it’s profit. </span></p>
<p><span style="font-weight: 400;">The trick in both cases is to help the incentives align with what we want out of the research they do. In the case of the pharma industry, we want them to keep producing new drugs and vaccines, but also to provide them at a low cost to the people who need them. If we remove the pharma companies’ patents, and stop them making profits, then we might be able to provide </span><i><span style="font-weight: 400;">this</span></i><span style="font-weight: 400;"> drug at a low cost, but we’ll be less likely to see the next one. Instead, we need to come up with clever ways of incentivising them to do what we want, so that we continue to spend more on curing malaria than we do on curing baldness.</span></p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2020/11/should-big-pharma-profit-from-covid/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2020/11/should-big-pharma-profit-from-covid/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2020/11/should-big-pharma-profit-from-covid/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">50311</post-id>				</item>
									<item>
					<title>Will a vaccine stop Covid?</title>
					<link>https://stage.unherd.com/2020/10/will-a-vaccine-cure-covid/?edition=us</link>
											<comments>https://stage.unherd.com/2020/10/will-a-vaccine-cure-covid/?edition=us#comments</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2020/10/GettyImages-1229085466.jpg?w=525</unherd:featured_image>
										<unherd:main_theme></unherd:main_theme>
					<dc:creator>
						<![CDATA[Tom Chivers]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2019/09/chivers.jpg?w=96</unherd:creator_img>
																<unherd:article_ranking></unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[There are about 200 vaccines currently in development for the SARS-Cov2 virus. Credit: Juan Carlos Lucas/NurPhoto/Getty ]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p><strong>Tom Chivers</strong> is a science writer. His second book, <em>How to Read Numbers</em>, is out now.</p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle>TomChivers</unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[ is a science writer. His second book, <em>How to Read Numbers</em>, is out now.]]>
					</unherd:author_bio>
										<pubDate>Wed, 21 Oct 2020 10:56:46 +0000</pubDate>
					<updated>Wed, 21 Oct 2020 20:08:02 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Ebola]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Vaccine]]></category>
					<guid isPermaLink="false">https://old.unherd.com/?p=48523</guid>
																												<description>
								<![CDATA[Even if it's effective, the logistics of delivering it are monumental]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p>If there’s a finish line in sight for the grim marathon that has been Covid-19, it’s a vaccine. It will be – we all hope – the thing that signals a return to some sort of normality, eventually. And there have been some promising headlines recently: notably, the Oxford-AstraZeneca vaccine has <a href="https://www.dailymail.co.uk/news/article-8852159/The-video-world-longed-Covid-vaccines-rolling-production-line.html" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">started production</span></a><span style="font-weight: 400;">, with the UK deputy chief medical officer saying a rollout </span><a href="https://www.thetimes.co.uk/edition/news/hope-for-covid-vaccine-at-new-year-25b52b86s" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">could start before Christmas</span></a><span style="font-weight: 400;">, while Pfizer says that</span><a href="https://edition.cnn.com/2020/10/16/investing/pfizer-vaccine-emergency-use-authorization/index.html" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;"> it hopes to file for FDA emergency use approval</span></a><span style="font-weight: 400;"> for its own vaccine within the next few weeks.</span></p>
<p>I don’t want to downplay these developments. They’re important, and if one or both of those is authorised, then we could start seeing people being vaccinated relatively soon. But I did want to talk about some of the difficulties and complexities involved. It is perfectly possible that one vaccine is already in production, and that another will soon be approved for emergency use, and that still, you, ordinary British person[1. <em>I’d say “you and I”, but since I’m on the Oxford trial, I’ll get the real vaccine if/when it’s declared efficacious, if I haven’t had it already.]</em> will not see either for over a year; and that most of the world will not see one for another year after that.</p>
<p>First, let’s talk about the different kinds of vaccine. All vaccines work on one basic principle, which is presenting the immune system with something (an “antigen”) that looks like the thing you’re vaccinating against, usually a virus. But there are different ways to make that antigen.</p>
<p>There are, depending on how you want to break it down, essentially four different kinds. The traditional method – which goes back to Louis Pasteur – involves getting hold of the actual virus you’re vaccinating against, killing or weakening it somehow, and using that as an antigen. These are known as “killed virus vaccine” and “live attenuated virus vaccines”, but I’ll refer to them both as traditional vaccines.</p>
<p>The second involves using a part of the virus, a “subunit”, as the antigen. In the case of coronaviruses, the part involved is the spike protein, the lumpy bits outside the body of the virus. In modern subunit vaccines, you can use a genetically modified virus to infect yeast cells and get them to produce the protein, so it is faster.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/08/when-will-the-covid-19-vaccine-arrive/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/08/when-will-the-covid-19-vaccine-arrive/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/08/GettyImages-1211365746-e1599738700427.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/08/when-will-the-covid-19-vaccine-arrive/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2020/08/when-will-the-covid-19-vaccine-arrive/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>When will the Covid-19 vaccine arrive?</h5></a><p class="author"><a href="https://stage.unherd.com/2020/08/when-will-the-covid-19-vaccine-arrive/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Saloni Dattani</a></p></div></a></div>
<p>The third and fourth, viral vector vaccines and RNA vaccines, also both use the protein spike as the antigen, but instead of producing it in a factory, they recruit the body to do that for them. Viral vector vaccines use a genetically modified virus to infect the body’s cells and make them produce the spike protein, just as the actual virus co-opts the body’s cells to force them to make copies of itself.</p>
<p>RNA vaccines do much the same, except instead of using a genetically modified virus, they simply use tiny lengths of RNA, which – once snuck inside a cell membrane, in a tiny blob of fat called a lipid nanoparticle – commandeers the cell’s machinery and starts it making the spike protein.</p>
<p>All of these have different strengths and weaknesses. Traditional vaccines are reliable; they’re a mature technology and tend to give good immune responses. But they are slow to make – they need to be grown in insect cells or hens’ eggs, so a batch can take a couple of weeks. The exact process for each one is subtly different, so you can’t easily repurpose a factory. And it takes a lot of infrastructure – a lot of steel in the ground – to make a factory.</p>
<p>Subunit vaccines are pretty well field-tested now; they’ve been around for a few decades. They’re somewhat faster than the traditional ones to make, and the factory hardware is more interchangeable because you can get your yeast to produce any protein you like, but they still need large vats.</p>
<p>Viral vector vaccines, like traditional ones, require the growth of actual virus particles in some biological substrate, such as hens’ eggs or mammalian cells. But unlike traditional vaccines, you don’t need to make a different virus each time – you can just grow the same virus (in the case of the Oxford-AstraZeneca vaccine, a member of a family of viruses called adenoviruses) for each vaccine, and paste in the genetic code for the particular protein you want it to build. They are, however, very much untried – as far as I know, only one has been used in humans before, for <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662269/" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">protection against Ebola</span></a><span style="font-weight: 400;">.</span></p>
<p>RNA vaccines are much faster to produce – it’s “a chemical rather than a biological process”, according to Al Edwards, a professor in biomedical technology at the University of Reading. They also require far smaller doses, so you can get many more out of, say, a 200-litre bioreactor, and, like viral vector vaccines, you can paste in the RNA sequence for whatever protein you need: you can use the same equipment for a vaccine for any given virus. It can also be very small scale, with relatively low-tech equipment; Imperial College is planning to make a small demonstration plant in rural Uganda. But RNA vaccines have literally never been used before, and, inconveniently, while all the other kinds of vaccine can happily be kept at normal fridge temperature (2°C to 8°C), the lipid nanoparticles that are used to get RNA vaccines into the machinery of the cell are very unstable, and need to be kept at -80°C.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/09/do-we-need-a-second-lockdown/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/09/do-we-need-a-second-lockdown/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/09/GettyImages-1254233813.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/09/do-we-need-a-second-lockdown/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2020/09/do-we-need-a-second-lockdown/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Is this the second wave?</h5></a><p class="author"><a href="https://stage.unherd.com/2020/09/do-we-need-a-second-lockdown/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Tom Chivers</a></p></div></a></div>
<p>There are about 200 vaccines currently in development for the SARS-Cov2 virus. All of the above kinds of vaccines are represented. However, the two we mentioned at the top, the Pfizer and Oxford/AstraZeneca vaccines, are the two most advanced – both are in Phase III trials (that is, large trials to show that they are not merely safe in humans, but actually work). They are an RNA vaccine and a viral vector vaccine, respectively. Moderna, Johnson &amp; Johnson, and Novavax also have vaccines in Phase III trials, but are not, I think, quite so far along.</p>
<p>As a bit of an aside, something strange has happened with the Oxford/AstraZeneca vaccine. Two patients got ill. The first was with MS, and the vaccine study <a href="https://stage.unherd.com/thepost/the-paranoid-style-in-vaccine-science/"><span style="font-weight: 400;">declared on its consent form that it was unrelated</span></a><span style="font-weight: 400;">, so the trial continued after a brief pause. The second was transverse myelitis, an inflammation of the sheath around the spinal column; again, the trial paused, and, while it restarted in the UK, Brazil and South Africa, in the US, it did not.</span></p>
<a href="https://stage.unherd.com/2020/10/will-a-vaccine-cure-covid/?edition=us?=refinnar"><div class="ref-ar"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/10/GettyImages-1229085466.jpg?w=300" /><div class="content"><span class="meta">suggested reading</span><h5>Will a vaccine stop Covid?</h5><p class="author"><span>By</span> Tom Chivers</p></div></div></a>
<p>That is extremely unusual, according to <a href="https://www.lshtm.ac.uk/aboutus/people/evans.stephen" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">Stephen Evans</span></a><span style="font-weight: 400;">, a professor of pharmacoepidemiology at the London School of Hygiene and Tropical Medicine. Usually, drug trials are monitored by independent groups called Data and Safety Monitoring Boards (DSMBs). If a patient gets ill, these boards look at the situation – often, as in the AstraZeneca case, pausing the trial to do so – and decide whether the illness was caused by the vaccine, and, if so, whether the risk outweighs the benefit. If it does, they might recommend to the regulator that they end the trial.</span></p>
<p>But normally you only have one DSMB for the whole trial. In this case, there are apparently two – one for the UK, Brazil and South African parts of the trial, and one for the US. And while the UK one decided it was safe to carry on with the trial after a brief pause, the US one has not. The US Food and Drug Administration (FDA) is now <a href="https://uk.reuters.com/article/health-coronavirus-vaccine-astrazeneca/exclusive-fda-widens-us-safety-inquiry-into-astrazeneca-coronavirus-vaccine-sources-idUKL1N2GR1SK" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">investigating it</span></a> <span style="font-weight: 400;">and not allowing it to restart. “It’s a very strange thing to have two different DSMBs for the same vaccine,” says Evans. “I’ve not known it to happen before.”</span></p>
<p><a href="https://www.greenlightbiosciences.com/team/andrey-j-zarur/" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">Andrey Zarur</span></a><span style="font-weight: 400;">, the CEO of the RNA biotech company GreenLight – who have their own RNA vaccine in animal trials, and for whom, full disclosure, I’ve been doing some writing over the past few weeks – thinks that the UK regulators have been very lenient. “AstraZeneca have had very favourable treatment in the UK,” he says. “They say the myelitis is unrelated, but the FDA says BS.” It’s a fairly rare condition, and he thinks it’s likely that it’s connected; he thinks “you may get partial approval” in the UK, but it won’t be approved in the US, at least not soon. </span><span style="font-weight: 400;">Evans is more hopeful, and thinks that the FDA is being “super-cautious”. He notes that </span><a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30160-2/fulltext"><span style="font-weight: 400;">a previous vaccine candidate developed by the Oxford team</span></a><span style="font-weight: 400;"> for the MERS virus also saw a serious adverse event. That one was also declared unrelated, but Evans speculates that the coincidence might be enough to make the FDA more wary.</span></p>
<p>Either way, AstraZeneca are confident enough that they’ll get approval – in the UK, at least – to start production; <a href="https://rs-delve.github.io/reports/2020/10/01/covid19-vaccination-report.html" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">the UK government has ordered 30 million</span></a><span style="font-weight: 400;">, with an option for 70 million more. And if Pfizer does get enough data to apply for emergency use approval, they’ll start manufacturing too, at least at small scale.</span></p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/04/meet-the-man-whose-covid-cure-went-viral/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/04/meet-the-man-whose-covid-cure-went-viral/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/04/GettyImages-1207749740.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/04/meet-the-man-whose-covid-cure-went-viral/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2020/04/meet-the-man-whose-covid-cure-went-viral/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Didier Raoult: the man whose Covid &#039;cure&#039; went viral</h5></a><p class="author"><a href="https://stage.unherd.com/2020/04/meet-the-man-whose-covid-cure-went-viral/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> John Lichfield</a></p></div></a></div>
<p>So let’s talk about manufacturing. All the vaccines currently under development look like they’ll need two doses each. It’s one thing making 10,000 or 20,000 doses for a clinical trial – in order to get the world to herd immunity, even assuming that the vaccines all bestow complete immunity after the booster shot, we are going to need to vaccinate more than four billion people, twice each. Eight billion doses is <i><span style="font-weight: 400;">an awful lot</span></i><span style="font-weight: 400;">. A normal bioreactor for traditional vaccines might be 200 litres and able to make a million or so doses in a period of weeks; you’ll need a lot of them.</span></p>
<p>You can’t simply use a bigger vat, says Edwards. It’s like making a cake: if you can make a cake 20cm across and 10cm deep in your oven, that doesn’t mean you can make a cake 20 metres across and 10 metres deep in a much bigger oven. “It would be burnt on the outside and soggy in the middle.” Making live viral vaccines is a biological process, with lots of steps that depend on precise temperatures and chemistries. “The bigger your batch, the more you have to change your system of production,” he says, “so if you’re making it in a big batch, you have to check you&#8217;re still making the same thing. One disaster is that if you make it a different way, it can have a different effectiveness or even not work.” You can make lots of smaller reactors, but obviously that is expensive and difficult.</p>
<p>That’s true for traditional virus vaccines, but it’s also true for the modern viral vector ones, which similarly have to brew up a virus. “Making an adenovirus particle has never been scaled,” says Zarur. <span style="font-weight: 400;">The only medical treatments which use similar technologies, gene therapies, have only been used on “single-digit thousands” of patients, he says. </span><span style="font-weight: 400;">AstraZeneca </span><a href="https://www.cnbc.com/2020/06/04/astrazeneca-is-set-to-make-two-billion-doses-of-a-coronavirus-vaccine.html" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">says</span></a><span style="font-weight: 400;"> that it can create two billion doses by the end of next year, but Zarur is sceptical: “there just aren’t enough reactors in the world” as it stands.</span></p>
<p>RNA vaccines can be made more easily, and because they need much smaller doses, you can get more doses out of the same-size reactor. But Zarur points out other problems. <a href="https://bioprocessintl.com/bioprocess-insider/facilities-capacity/moderna-how-to-make-1-billion-doses-of-a-covid-19-vaccine/" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">Moderna</span></a><span style="font-weight: 400;"> and </span><a href="https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-potentially-supply-eu-200-million-doses" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">Pfizer</span></a><span style="font-weight: 400;">, both developing RNA vaccines, have each said they can produce around a billion doses by the end of next year. But, Zarur says, that’s an estimate based on how much of their raw materials they can get hold of. “When Moderna says they’re going to make a billion doses by the end of 2021,” he says, “it’s about calling on suppliers and saying how much nucleotide can you make.” And the suppliers of nucleotides might say, we can build enough to make a billion doses. “But those are the same suppliers that Pfizer is calling! Those materials, the nucleotides and the enzymes, are in very short supply.” RNA vaccines, he says, have enormous upsides, but there just isn’t a supply chain in place for them yet.</span></p>
<p>It is, Zarur says, “a twist of fate” that “the vaccines that are in the lead are also the ones with the least developed supply chain”. The Coalition for Epidemic Preparedness Initiatives (CEPI), the global body established to prepare vaccines for new viruses, <a href="https://cepi.net/news_cepi/cepi-survey-assesses-potential-covid-19-vaccine-manufacturing-capacity/" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">estimates</span></a> <span style="font-weight: 400;">that even putting all the pharma companies together, globally there is only capacity to make between two and four billion doses by the end of 2021; even in the most optimistic scenario, we will only have about half of what we need.</span></p>
<p><span style="font-weight: 400;">(It’s worth noting here that the Oxford-AstraZeneca vaccine trial will be declared a success if there are half as many infections among people given the real vaccine as among those given the control — so if there were 100 in the control arm and 50 in the vaccine, that would be enough. This means it may be that “successful” vaccines only prevent 50% of infections. If that were the case, we’d need to vaccinate a lot more than half the world.) </span></p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/07/dont-dismiss-the-anti-vaxxers/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/07/dont-dismiss-the-anti-vaxxers/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/07/GettyImages-1175843013.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/07/dont-dismiss-the-anti-vaxxers/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2020/07/dont-dismiss-the-anti-vaxxers/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>The truth about vaccines</h5></a><p class="author"><a href="https://stage.unherd.com/2020/07/dont-dismiss-the-anti-vaxxers/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Stuart Ritchie</a></p></div></a></div>
<p>Manufacturing the vaccine isn’t the end of the problem. “After you’ve made billions of doses,” says Edwards, “you have the opposite problem: we’ve got factories making tonnes of these vaccines, now you’ve got to get them into little tubes, stick them in a fridge, get them all around the world and put them in needles and stick them in someone’s arm.”</p>
<p>It is a huge logistical challenge. Recently, I spoke to Toby Peters, a professor of cold-chain economy at the University of Birmingham, and Nilay Shah, the head of the chemical engineering department at Imperial College London, about the difficulties of mass rollout of vaccines. At the moment, we vaccinate only a subset of the population at a time: small children, vulnerable people, pregnant women. Now, though, we need to vaccinate everyone, fast. <span style="font-weight: 400;">To get a sense of how much the system needs to be scaled up, at the moment, about 50 million vaccine doses – for measles, polio, things like that – are distributed every month in India.</span> <span style="font-weight: 400;">There are nine different vaccines, so that’s about 6 million people. But, he reckons, we’d need to get that up to about 200 million people a month. The vaccines need to get from the factory to the clinic to the patient without spending more than a day or so at room temperature.</span></p>
<p>This “cold chain” delivery is a significant enough challenge if you’re working in a city, but to get to people living in rural parts of India, or sub-Saharan Africa, you will need infrastructure. You’ll need trained people to deliver it, especially if you’re putting several doses in a single vial, which will save money but will mean the healthcare workers need to know how to safely take the right dose out while keeping the remainder sterile and secure. And the vaccine needs to reach a majority of the population. So, Shah points out, you need to get it to them – it needs to be walking distance at most for everyone. We can’t expect billions of people to travel long distances; in underdeveloped areas, that might mean mobile vaccination stations in trucks.</p>
<p>Peters points out that millions of tonnes of food are transported chilled around the world, and that that cold chain is extremely effective and has huge capacity, so it’s not impossible; but it will require a major effort, not least to find out how many fridges and things are available in the developing world, and second to design a cold-chain system, separate from the existing vaccine cold chain. Even in the UK, this is going to be a non-trivial problem. “One thing that bothers me slightly,” says Edwards, “is that a mass vaccination programme is as difficult as a mass testing program, and that” – this last with admirable understatement – “hasn’t always run as smoothly as we hoped.”</p>
<p>Again, RNA vaccines can be made at a smaller scale, so more locally. But then if you want to keep them for more than 24 hours or so, you need to keep them at -80°C. “You can do that in London or New York,” says Zarur, “but how are you going to get it to Laos or Sao Paolo? And unless you vaccinate those populations, you’re wasting your time.” He is hopeful that the second generation of RNA vaccines, including GreenLight’s, will be made in small, almost popup factories anywhere you can get some cheap chemical ingredients and an electrical supply, and then in the 24 hours you have before it degrades, you can get it to where it needs to be. “You couldn’t get it from Cambridge, Massachusetts to France,” he says. “But you could get it from Mexico City to Chiapas.” But that won’t be true of the first-generation ones, which will require more complex and expensive ingredients.</p>
<p>None of this is to say that it’s not important that vaccines are starting to roll off the shelf. It is. Even if only a few million doses are built at first – even if, as Zarur says, “it’s enough for the football players, the Trumps, and the healthcare workers” – that’s a big deal. As he points out, in the first wave, “healthcare workers were dying in the hallways”, and the shortage of medical professionals caused by illness was part of the reason it killed so many others – people weren’t getting treated properly. And as we vaccinate the most at-risk populations, the susceptible population will be reduced, so the virus will find it harder to infect people, and the death toll will come down, and slowly the situation will improve for all of us.</p>
<p>But it absolutely will not be: we get a vaccine in December and we’re out of this by February. The light is real, but the tunnel it’s at the end of is still pretty long.</p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2020/10/will-a-vaccine-cure-covid/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2020/10/will-a-vaccine-cure-covid/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2020/10/will-a-vaccine-cure-covid/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">48523</post-id>				</item>
									<item>
					<title>When will we get the Covid-19 vaccine?</title>
					<link>https://stage.unherd.com/2020/04/when-we-get-the-covid-19-vaccine/?edition=us</link>
											<comments>https://stage.unherd.com/2020/04/when-we-get-the-covid-19-vaccine/?edition=us#comments</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2020/04/GettyImages-1210114338-e1588070950861.jpg?w=579</unherd:featured_image>
										<unherd:main_theme></unherd:main_theme>
					<dc:creator>
						<![CDATA[Tom Chivers]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2019/09/chivers.jpg?w=96</unherd:creator_img>
																<unherd:article_ranking></unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[Volunteers in Wuhan receive an experimental coronavirus vaccine which is in a phase II human clinical trial Credit: TPG / Getty]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p><strong>Tom Chivers</strong> is a science writer. His second book, <em>How to Read Numbers</em>, is out now.</p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle>TomChivers</unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[ is a science writer. His second book, <em>How to Read Numbers</em>, is out now.]]>
					</unherd:author_bio>
										<pubDate>Tue, 28 Apr 2020 08:31:35 +0000</pubDate>
					<updated>Tue, 28 Apr 2020 11:09:30 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[biochemistry]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Vaccine]]></category>
					<guid isPermaLink="false">https://old.unherd.com/?p=35570</guid>
																												<description>
								<![CDATA[By the time the jab arrives, we might not even need it]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p><span style="font-weight: 400;">There are, I think, three possible futures for the coronavirus pandemic. Either nearly everyone gets it, and the survivors stay immune, and we get </span><a href="https://stage.unherd.com/thepost/can-we-build-a-herd-immunity-to-covid-19/"><span style="font-weight: 400;">herd immunity </span></a><span style="font-weight: 400;">that way; or it becomes endemic in the population, turning up each year like flu; or we get a vaccine.</span></p>
<p><span style="font-weight: 400;">In the shorter term, there are other options: decisions to be made about testing and tracing, about when to open schools and bars and football stadiums, about masks. They’re all important. But we can’t keep people in their homes forever, and unless we eradicate every single case of the disease, it will eventually come back. So, as people say, unless everyone gets it and the disease burns itself out, there’s no going back to normal </span><a href="https://www.bbc.co.uk/news/uk-52308201"><span style="font-weight: 400;">until we get a vaccine</span></a><span style="font-weight: 400;">.</span></p>
<p><span style="font-weight: 400;">So: when will that happen? There are bullish reports from Oxford that a new vaccine is showing early promise; that it has </span><a href="https://www.nytimes.com/2020/04/27/world/europe/coronavirus-vaccine-update-oxford.html" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">protected inoculated macaques</span></a><span style="font-weight: 400;"> from the virus when unvaccinated ones consistently get sick. They think that they could get the first few million doses off the production line and ready for human consumption by September. Other people talk about being able to return to full economic activity in 18 months.</span></p>
<p><span style="font-weight: 400;">Not everyone is so hopeful, though. A report by a biopharma analyst for the investment bank SVB Leerink, titled “Sober Up! 25 Reasons Not to Count on COVID Vaccine for Herd Immunity in 1-2 years”, suggests that it could be years, rather than months – attesting gloomily that “There is absolutely no evidence that a vaccine can protect against human infection with SARS-nCoV2” and that new kinds of RNA- or DNA-based vaccines are so far completely untested.</span></p>
<p><span style="font-weight: 400;">As I </span><a href="https://stage.unherd.com/2020/04/could-anyone-have-predicted-covid-19/"><span style="font-weight: 400;">said last week</span></a><span style="font-weight: 400;">, predictions are hard, especially about the future. I don’t know which of the two extremes is more likely. But I thought I could go through some of the challenges.</span></p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/04/could-anyone-have-predicted-covid-19/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/04/could-anyone-have-predicted-covid-19/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/04/GettyImages-1210398255-e1587552513561.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/04/could-anyone-have-predicted-covid-19/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2020/04/could-anyone-have-predicted-covid-19/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Did anyone predict coronavirus?</h5></a><p class="author"><a href="https://stage.unherd.com/2020/04/could-anyone-have-predicted-covid-19/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Tom Chivers</a></p></div></a></div>
<p><span style="font-weight: 400;">All coronaviruses have a distinctive shape – a ball with spikes coming off it, like an old-fashioned</span><a href="https://assets.realclear.com/images/45/456897_5_.png"><span style="font-weight: 400;"> naval mine</span></a><span style="font-weight: 400;">. The spikes are made of a protein called an S-glycoprotein. Most research into Covid-19 vaccines, says </span><a href="https://www.imperial.ac.uk/people/r.shattock"><span style="font-weight: 400;">Robin Shattock</span></a><span style="font-weight: 400;">, a professor of mucosal infection and immunity at Imperial College London, targets those spikes. That is, they try to mimic either the whole spike or a part of it, so that — when the vaccine is injected into our bloodstream — our immune systems will latch onto that S-glycoprotein and learn its shape. Then, if the real coronavirus turns up, not just a disembodied spike but the whole naval mine, our immune systems will remember the protein and attack it.</span></p>
<p><span style="font-weight: 400;">So your first job is to make a stable version of that protein, separated from the rest of the virus. Then once you have one that looks promising, you test them in animal models.</span></p>
<p><span style="font-weight: 400;">Assuming it’s safe and effective in ferrets or rhesus macaques (the two most useful animal models for this research, since they’re both susceptible to Covid-19), the next stage is to produce a higher-quality version of the vaccine, test that again in animals to make sure it’s safe, then try it on humans.</span></p>
<p><span style="font-weight: 400;">The first human trial will be small, and in young, healthy volunteers. It’s just looking to make sure that it’s safe and gives the sort of immune response you want. Then you do more trials, in larger numbers and in older or less healthy volunteers, and eventually you see if the vaccine actually works — if people who are given it are less likely to become infected.</span></p>
<p><span style="font-weight: 400;">After that, if the vaccine is safe and effective, it will be licensed – in Europe by the European Medicines Agency (EMEA), in the US by the Food and Drug Administration (FDA); once it is licensed, it will be manufactured and then given to the population. And then – fingers crossed – the disease will die out.</span></p>
<p><span style="font-weight: 400;">So far, so straightforward? Not really. </span></p>
<p><span style="font-weight: 400;">One problem that recurs at several stages is that vaccines are different to treatments. If you have some drug that you think will cure a particular cancer, you find people with that cancer, you give some of them the drug and some of them a placebo (or, rather, the usual treatment for that cancer); if they do better on the new drug, it works.</span></p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/04/meet-the-man-whose-covid-cure-went-viral/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/04/meet-the-man-whose-covid-cure-went-viral/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/04/GettyImages-1207749740.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/04/meet-the-man-whose-covid-cure-went-viral/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2020/04/meet-the-man-whose-covid-cure-went-viral/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Didier Raoult: the man whose Covid &#039;cure&#039; went viral</h5></a><p class="author"><a href="https://stage.unherd.com/2020/04/meet-the-man-whose-covid-cure-went-viral/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> John Lichfield</a></p></div></a></div>
<p><span style="font-weight: 400;">But with vaccines, by definition, you’re giving it to people who don’t have the disease, and then you want to see if they </span><i><span style="font-weight: 400;">get </span></i><span style="font-weight: 400;">the disease.</span></p>
<p><span style="font-weight: 400;">In animal models, that’s not such a huge problem, because you can give them the disease yourself — or “challenge” them, in the terminology. It’s still not ideal when — as now — you’re in a huge rush; it takes some time after exposure for your body to develop enough antibodies to be properly immune. “To see if the vaccine works, the minimal time to get to a level where you want to challenge them is about four weeks,” says Shattock. “So those studies typically take a couple of months.”</span></p>
<p><span style="font-weight: 400;">But in humans, usually, you don’t want to deliberately give subjects a potentially deadly disease. “I can’t rule out that it might happen,” says Shattock, “but it’s ethically difficult.” Covid-19 is much less dangerous for young healthy people, but it’s not completely without risk, and there’s the the chance “that if you took 10 people in their 20s and gave them the virus, you might just be unlucky”. One or more could get really ill for reasons you don’t understand; they could die. Kirsty Gelsthorpe, a spokesperson for the Association of the British Pharmaceutical Industry, says that the Oxford group certainly isn’t doing it.</span></p>
<p><span style="font-weight: 400;">Besides, says Shattock, “it’s quite artificial; shoving virus up their nose mimics natural exposure, but it’s not the same”.</span></p>
<p><span style="font-weight: 400;">So usually, you give the vaccine to a bunch of people in the wild, as it were, and you see if they get the disease less than a control group over some period of time. But, Gelsthorpe points out, at the moment, we’re all locked down. Fewer people are getting the disease. So that causes a problem: it’s good news in the sense that not as many people are getting ill, but it slows down research. You don’t know if your vaccine works if no one gets sick in your control group.</span></p>
<p><span style="font-weight: 400;">“That’s why many groups,” says Shattock, “including ourselves, are moving very fast. One, because we want to get it made quickly, but two, because we want to be able to test it while infections are still going on.”</span></p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/03/covid-19-has-exposed-our-financial-fragility/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/03/covid-19-has-exposed-our-financial-fragility/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/03/GettyImages-1207637252.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/03/covid-19-has-exposed-our-financial-fragility/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2020/03/covid-19-has-exposed-our-financial-fragility/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Covid-19 has exposed our financial fragility</h5></a><p class="author"><a href="https://stage.unherd.com/2020/03/covid-19-has-exposed-our-financial-fragility/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Jonathan Tepper</a></p></div></a></div>
<p><span style="font-weight: 400;">There’s another problem. Vaccines are already dealing with a trust problem — anti-vaccination movements around the world have led to significant drops in the takeup of the MMR jab in the West and polio and TB vaccines elsewhere. </span></p>
<p><span style="font-weight: 400;">In the phase I trials — the small-scale ones — you’re looking at safety. Usually, that doesn’t mean whether or not it kills people; serious reactions are vanishingly rare, despite the awful and high-profile </span><a href="https://www.bbc.co.uk/news/magazine-35766627"><span style="font-weight: 400;">Northwick Park incident </span></a><span style="font-weight: 400;">14 years ago, which left six previously healthy men fighting for their lives. Normally,you’re just looking to see if “their arms are so painful that they can’t go to work, or if they have flu-symptoms that make them feel horrible”, says Shattock.</span></p>
<p><span style="font-weight: 400;">Of course, if you have some really nasty disease, you can shift your threshold somewhat. “If you’re facing an Ebola epidemic and 50% of people are dying,” says Shattock, “you’re not going to be worried if your arm is sore for a few days.” And since you only need to give it to the most at-risk people, you can be forgiven if you’re not as vigilant as you might be about long-term side effects: “Everyone in the [Ebola-]affected areas thought ‘This is going to kill me. If I take the vaccine I don’t care if I have side-effects in years to come; I won’t die.”</span></p>
<p><span style="font-weight: 400;">But that’s not true of coronavirus. It’s dangerous, but it’s nowhere near that dangerous, </span><span style="font-weight: 400;">and you have to convince millions of healthy people in their 20s and 30s who aren’t at significant risk to test the vaccine.</span><span style="font-weight: 400;"> “The level of what’s tolerable, vs the perceived risk, is very different,” says Shattock. “Safety will be particularly important. You don’t want people turning up five years later with some weird arthritis and asking if it’s caused by the vaccine. </span></p>
<p><span style="font-weight: 400;">“Vaccines struggle anyway because of the anti-vaccine movement — the difficulty is that they’re so successful no one sees the disease, they only see the side effects. You don’t want anything that will make that worse.” If the coronavirus vaccine kills some healthy people, it could easily reduce trust in other vaccines and lead to major loss of life.</span></p>
<div class="ref-ar"><a href="https://stage.unherd.com/2019/03/the-dangerous-power-of-the-anti-vaxxer-brigade/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2019/03/the-dangerous-power-of-the-anti-vaxxer-brigade/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2019/02/GettyImages-96238858.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2019/03/the-dangerous-power-of-the-anti-vaxxer-brigade/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2019/03/the-dangerous-power-of-the-anti-vaxxer-brigade/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>The dangerous power of the anti-vaxxer brigade</h5></a><p class="author"><a href="https://stage.unherd.com/2019/03/the-dangerous-power-of-the-anti-vaxxer-brigade/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Imogen Shaw </a></p></div></a></div>
<p><span style="font-weight: 400;">But let’s imagine we get our vaccine through the testing, and get it licensed. Then we just need to produce it and ship it out. That should be easy, right?</span></p>
<p><a href="https://acmedsci.ac.uk/fellows/fellows-directory/ordinary-fellows/fellow/Professor-Jeffrey-Almond-0005748"><span style="font-weight: 400;">Jeffery Almond</span></a><span style="font-weight: 400;">, a visiting professor of microbiology at Oxford and for several years the head of research at the French pharmaceutical giant Sanofi, says that the production of a new vaccine usually takes a long time — “10, 12, 15 years” — and that, traditionally, “we always had to engage with manufacturing technology”. What that means is that about half-way through the process of researching the vaccine, they’d have to start designing and building a factory to produce it.</span></p>
<p><span style="font-weight: 400;">“Typically that process took four or five years,” he says. “Designing the building, getting the equipment ordered, installed, validated, operational. Getting it licensed as a production facility. Minimum three years, then you’d have a facility with a capacity of a few tens of millions.”</span></p>
<p><span style="font-weight: 400;">We’ve been unlucky with coronavirus, he says, in that everyone expected the next pandemic to be a flu virus, “like 1918, 1957, 1968, 1976, 2009”. There’s industrial capacity for manufacturing flu vaccines — we make millions of doses every year. But those factories won’t work for coronavirus vaccines, and we need billions of doses. “To get a billion doses by this time next year or Christmas or whatever, when you don’t have industrial capacity, is a hell of a challenge,” says Almond.</span></p>
<p><span style="font-weight: 400;">I can sound a note of optimism here, though. Almond is talking about old-school vaccines, which are made with attenuated viruses grown (in many cases) in </span><a href="https://web.archive.org/web/20100705162154/https://www.ecbt.org/parents/media/pdf/howisflumade.pdf"><span style="font-weight: 400;">chicken eggs</span></a><span style="font-weight: 400;"> or other cultures. There are more modern versions. Some groups, he says, are working on vaccines which target stretches of viral DNA or RNA. “For them the manufacturing is a chemical synthesis of the RNA or DNA,” he says. “It’s intrinsically easier to scale up.”</span></p>
<p><span style="font-weight: 400;">But so far none of these vaccines exists. “We have plenty under development,” Almond says, “but the manufacturing capacity isn’t there, and we don’t really know if it’s going to work. It’s a bit more risky in that the technology is new.”</span></p>
<p><span style="font-weight: 400;">His own former employers, Sanofi, are working on vaccines that you can culture in insect cells, which he says is vastly more scalable than the chicken-egg method, and could easily be applied to coronavirus. When used in conjunction with an adjuvant produced by GSK which would, he says, allow you to “reduce the dose per person to a fifth or a 10th of what you’d need without it”, the Sanofi model “is the most straightforwardly scalable version and the manufacturing is already there”.</span></p>
<p><span style="font-weight: 400;">The Oxford team are using something else entirely — a vaccine that uses another virus, an adenovirus,</span><span style="font-weight: 400;">  </span><span style="font-weight: 400;">as its delivery system. Philip Ridley Smith, the marketing director for the firm </span><a href="https://www.cobrabio.com/" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">Cobra Biologics and Pharmaceutical Services</span></a><span style="font-weight: 400;">, which works with the Oxford researchers, says that they’re building a 200-litre bioreactor to start producing the vaccine. It would be enough to make a million doses a batch, and, says Ridley Smith, the consortium of three manufacturers that make up the Oxford consortium hope to make six million doses a month.</span></p>
<p><span style="font-weight: 400;">For that reason, Shattock is quite hopeful that when the vaccine arrives, it will be quite easy to produce enough to vaccinate everyone in Britain pretty quickly. “Solving it on a national basis is relatively straightforward,” he says. Building enough for a global scale will be the tricky bit, although Ridley Smith points out that many developing nations, such as India and China have excellent manufacturing, if not the same refrigerated supply chains.</span></p>
<p><span style="font-weight: 400;">One trouble will be funding it. Pharma companies are throwing money at this at the moment, but they are in the end commercial enterprises, and vaccines are often not very commercial things: they are given once, and need to be given to people who can’t easily pay for it. Plus, they’ve been burned before — in </span><a href="https://www.thetimes.co.uk/edition/times2/deadliest-enemy-our-war-against-killer-germs-by-michael-t-osterholm-and-mark-olshaker-review-a-pandemic-prophecy-8c05jb3m3" target="_blank" rel="noopener noreferrer"><span style="font-weight: 400;">his book </span><i><span style="font-weight: 400;">Deadliest Enemy</span></i></a><span style="font-weight: 400;">, the epidemiologist Mike Osterholm says that they rushed to get a vaccine for Sars in 2003, urged on by governments and philanthropic bodies; then, when Sars burnt itself out, the governments and philanthropic bodies lost interest. </span></p>
<div class="ref-ar"><a href="https://stage.unherd.com/2020/04/how-likely-are-you-to-die-of-coronavirus/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2020/04/how-likely-are-you-to-die-of-coronavirus/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2020/04/GettyImages-1215689752-scaled.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2020/04/how-likely-are-you-to-die-of-coronavirus/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2020/04/how-likely-are-you-to-die-of-coronavirus/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>How likely are you to die of coronavirus?</h5></a><p class="author"><a href="https://stage.unherd.com/2020/04/how-likely-are-you-to-die-of-coronavirus/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Tom Chivers</a></p></div></a></div>
<p><span style="font-weight: 400;">“At Sanofi we rushed to make a Sars vaccine,” says Almond. “It got to the point we could test it in primates after 11 months, and by then it had gone away, and we’d spent tens of millions of euros on it never to get it back. The industry does it, but it knows it’s losing money, and it can’t do that too much.”</span></p>
<p><span style="font-weight: 400;">“I&#8217;m not sure how scarred pharma was by that,” says Shattock, “but they’ve certainly been bruised by other projects: Ebola, Sanofi with the dengue programme, GSK with malarial vaccines. They’re not seeing big returns.” It may be different with Covid-19 if it’s around for years, especially if it needs yearly doses, but it may not. </span></p>
<p><span style="font-weight: 400;">Osterholm in his book suggests that public-private partnerships — like the US defence contractor model, in which governments put out a specification for a jet fighter, and firms compete to build one in the knowledge that the most suitable will be richly rewarded — may be the best system. That’s probably for future outbreaks, though; this one will be driven by funding from the Gates Foundation, Wellcome, the World Bank, and by goodwill from the pharma companies. “Yes there’s a risk the companies will make a loss,” says Almond, “and on smaller things they might need incentivisation, but on this one they’ll dive in and do the best they can.”</span></p>
<p><span style="font-weight: 400;">So will we see a vaccine soon? </span></p>
<p><span style="font-weight: 400;">Ridley Smith is confident: “We would hope that we’d be able to start getting the vaccines out by September” – although he warns that it will depend on the success of the trial, and on enough people in the control branch getting infected to give them working statistics; ironically, too much success at limiting the disease might mean we can’t get a vaccine. The Oxford researchers have encouraged at-risk workers to volunteer for the trials to maximise the chances of getting good information.</span></p>
<p><span style="font-weight: 400;">Shattock is less so. “If everything went really well, and one of the two UK vaccines work, that could start to be rolled out early next year,” he says. That could happen: “If we were working with no knowledge, it would be a very low percentage chance,” he says. “But because we know a lot about coronaviruses, that increases the chances of success a lot, although many things could still go wrong.” But getting it rolled out globally will take longer; he thinks even 24 months is “very optimistic”. </span></p>
<p><span style="font-weight: 400;">And it’s possible, of course, that in 24 months, we might not even need a vaccine any more. The virus might have run its course. “How important will it be by 2022? I suspect we’ll still need it for vulnerable groups, but we may see that by that stage most of the world has had the virus and we’ll have herd immunity.” </span></p>
<p><span style="font-weight: 400;">The scientific community has got a lot faster at researching and developing viruses, but it may not yet be fast enough to help us with the coronavirus. Let&#8217;s hope this outbreak at least means we&#8217;re better prepared for the next one. </span></p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2020/04/when-we-get-the-covid-19-vaccine/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2020/04/when-we-get-the-covid-19-vaccine/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2020/04/when-we-get-the-covid-19-vaccine/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">35570</post-id>				</item>
									<item>
					<title>Does dirty money make the art world go round?</title>
					<link>https://stage.unherd.com/2019/04/can-culture-clean-money/?edition=us</link>
											<comments>https://stage.unherd.com/2019/04/can-culture-clean-money/?edition=us#respond</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2019/04/GettyImages-969194358.jpg?w=525</unherd:featured_image>
										<unherd:main_theme></unherd:main_theme>
					<dc:creator>
						<![CDATA[Libby Emmons]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2019/09/Libby.jpg?w=96</unherd:creator_img>
																<unherd:article_ranking></unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[The Guggenheim, New York. Credit: Drew Angerer/Getty Images]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p><strong>Libby Emmons</strong> is a writer, award-winning playwright and co-founder of Blue Box Productions, based in Brooklyn.</p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle>li88yinc</unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[ is a writer, award-winning playwright and co-founder of Blue Box Productions, based in Brooklyn.]]>
					</unherd:author_bio>
										<pubDate>Tue, 02 Apr 2019 08:43:08 +0000</pubDate>
					<updated>Mon, 11 Nov 2019 16:55:42 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[Capitalism]]></category>
		<category><![CDATA[Charity]]></category>
		<category><![CDATA[Philanthropy]]></category>
		<category><![CDATA[Purdue Pharma]]></category>
		<category><![CDATA[The Arts]]></category>
					<guid isPermaLink="false">http://old.unherd.com/?p=19371</guid>
																												<description>
								<![CDATA[Philanthropy from certain sources is increasingly deemed too dodgy to touch]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[
<p class="wp-block-paragraph">Can corporate money ever be clean? Following the recent removal of the Sackler name and funding from museums in the US and the UK, it&#8217;s a question that needs to be asked.</p>



<p class="wp-block-paragraph">The Sacklers are the family behind Purdue Pharma, the pharmaceutical giant that developed opioid painkiller OxyContin. This drug is widely used for pain relief and even more widely abused by people who either became addicted through reasonable medical use or those just looking to get high<strong>.</strong> It is currently the scourge of many communities across the western world.</p>



<p class="wp-block-paragraph">While drug use and abuse are not new, the remarkable thing about the Sackler scandal is the allegation that the Purdue Pharma knew about the widespread misuse of the drug. And even pursued it. The company was supposedly also engaged in comprehensive marketing schemes to ensure sufficient OxyContin proliferation to destroy their competition. They had determined that the base clientele of Oxy users were the perfect customers for naloxone, the drug that reverses the effect of opioid overdose. They realised they could increase their profits <a href="https://www.nytimes.com/2019/04/01/health/sacklers-oxycontin-lawsuits.html">by selling treatments for the problem their company was creating</a>. The implication is that <a href="https://www.wsj.com/articles/purdue-pharma-family-had-heavy-hand-in-opioid-marketing-complaint-says-11547600253">the Sackler family was aware of and in favour of</a> these profit making motives.</p>



<p class="wp-block-paragraph">These revelations spurred artist Nan Goldin to <a href="https://news.artnet.com/art-world/nan-goldin-sackler-met-2019-1460413" target="_blank" rel="noreferrer noopener" aria-label="lead a protest (opens in a new tab)">lead a protest</a> with Prescription Addiction Intervention Now (P.A.I.N.) at the Guggenheim Museum in New York against the Sackler family’s funding of the institution. She and her fellow activists stood at the top of the iconic corkscrew curves and leafleted the glorious rotunda with white prescription-sized paper slips.</p>



<p class="wp-block-paragraph">Goldin had been hooked on painkillers, and, having pulled herself out, wanted to make sure that consumers were aware of the dangers of the drug and of the willingness of both Purdue Pharma and, by implication, the Sacklers to perpetrate further addiction under the guise of care. But what Goldin and her fellow activists were also looking for was more than increased awareness.</p>



<p class="wp-block-paragraph">They wanted the Guggenheim to refuse all future funding from the Sackler family foundations, and they wanted the name pulled off buildings and wings built with that money. It was not enough that visitors to galleries and museums funded by the Sacklers should know the corporate misdeeds of its patrons, but that the name and the money itself, should be scrubbed from institutional existence.</p>



<p class="wp-block-paragraph">This is not the first time that activists have questioned the dirty origins of the money that fund America’s greatest cultural institutions. And the same thing has happened in Britain. In 2011, <a href="https://www.telegraph.co.uk/finance/newsbysector/energy/oilandgas/8464338/Artists-fight-against-BPs-Tate-donations.html" target="_blank" rel="noopener noreferrer">there was controversy over BP’s donations to the Tate</a>; and there have been persistent calls from both sides of the Atlantic for arts and humanitarian organisations to boycott any funding from the Koch Brothers. Recently, there has been a move <a href="https://www.sfchronicle.com/business/article/SF-politician-wants-to-remove-Mark-Zuckerberg-s-13429100.php" target="_blank" rel="noopener noreferrer">for the Zuckerberg name to be removed</a> from a hospital that his foundation funded.</p>



<p class="wp-block-paragraph">The argument against the Koch brothers is that they have <a href="https://www.bbc.co.uk/news/world-us-canada-44385053" target="_blank" rel="noopener noreferrer">used their influence and money to advocate for political candidates and policies that</a> are opposed to action against climate change, and that the world is in such dire, existential straits that we cannot spend their money and still survive as a planet.</p>
<p>When BP funding was protested, similar logic was applied. BP is a fossil fuel company. If we keep using these energy sources, they said, we won’t have a planet anymore. Well, sustainable energy sources need to be implemented by energy companies, and when they reach a more profitable state of production and distribution, or perhaps when the fear-mongering surrounding nuclear energy dissipates, they will. Just as we’re not sending whaling ships out there to hunt down baby belugas and scrape the fat off them to enable us to burn a light in the darkness, fossil fuels will decline as other energy resources take their place.</p>



<p class="wp-block-paragraph">Much of the American artistic, cultural, educational and medical infrastructure was funded by robber barons, tycoons of industry, and companies and families that had money to burn (hello, runaway capitalism). The Rockefeller, Carnegie, Ford, and Astor families, to name a few, profited from unfair labour practices, not to mention slavery, the decimation of native tribes, exploitation of natural resources, all of which enabled an ultra-rich class that subsequently felt a noblesse oblige to provide at least some pittance to the lower classes.</p>


<div class="ref-ar"><a href="https://stage.unherd.com/2019/02/ruskins-modern-message/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2019/02/ruskins-modern-message/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2019/02/RuskinPortrain.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2019/02/ruskins-modern-message/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Further reading</span></a><a href="https://stage.unherd.com/2019/02/ruskins-modern-message/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Ruskin&#039;s modern message</h5></a><p class="author"><a href="https://stage.unherd.com/2019/02/ruskins-modern-message/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Melanie McDonagh</a></p></div></a></div>



<p class="wp-block-paragraph">So they did, in the form of contributions to and founding capital in major long-lasting cultural institutions. In New York alone, the funding basis for The Met, Lincoln Center, MoMA, The Museum of Natural History, and plenty of other basic, essential, cultural institutions that the citizenry of this city where I live rely on were funded with filthy money. No questions were asked as the public lined up to see all the unearthed wonders from Egyptian tombs, or sought treatment in clean new hospital wings. The received wisdom was that if the money needed to be cleaned, charitable giving was the way to do it. This is what was meant by the concept of &#8220;giving back&#8221;.</p>



<p class="wp-block-paragraph">The Sackler family, BP, the Koch brothers, Zuckerberg, all have money to give away, and they want to give it. If cultural or educational institutions no longer wish to take it, then that won’t stop these people giving it to some other useful cause, nor will any boycott negatively impact either their bottom lines or their impulse to generate more wealth and power. In the case of the Sacklers, the money may go to settle the myriad lawsuits being brought against them and their complicity in OxyContin addiction and over distribution. This will move the money from Sackler hands to government hands, a net win, since governments have never been guilty of misuse of funds.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2018/05/greed-corrupted-american-dream/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2018/05/greed-corrupted-american-dream/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2018/05/GettyImages-631830448.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2018/05/greed-corrupted-american-dream/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Further reading</span></a><a href="https://stage.unherd.com/2018/05/greed-corrupted-american-dream/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>How greed corrupted the American dream</h5></a><p class="author"><a href="https://stage.unherd.com/2018/05/greed-corrupted-american-dream/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Sarah Churchwell</a></p></div></a></div>



<p class="wp-block-paragraph">Perhaps cultural institutions will crowd source their funding from now on, and in order to make sure that no unclean money filters through their Patreon accounts, they will ask donors to complete intricate forms as to their beliefs, practices and investments.</p>



<p class="wp-block-paragraph">Or maybe development officers will solicit big gifts from companies that are only known for their good works, such as those in&#8230; some industry where everyone is paid equitably throughout the global supply chain and no one at any level is exploited, and each corporate officer has only the best intentions for their entity and has never even once hired an illegal nanny or under tipped or wanted their products to do well to the exclusion or detriment of their competitors.</p>



<p class="wp-block-paragraph">It&#8217;s too bad all the big corporations aren&#8217;t into giving their money away anonymously, for no credit or return, so that society could benefit from their largesse without being confronted with the moral or ethical failures that facilitated it.</p>



<p class="wp-block-paragraph">As things stand, protesters and activists believe that money from unethical pharmaceutical companies, oil companies, social media companies with dodgy privacy reputations, and capitalist investors should be off limits. It is unclear if the motivation here is to punish the donors – or the cultural institutions. Nor is it clear which funders should be forced to defund major cultural assets.</p>
<div class="ref-ar"><a href="https://stage.unherd.com/2019/01/the-politics-of-the-patreon-purge/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2019/01/the-politics-of-the-patreon-purge/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2019/01/GettyImages-479988704.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2019/01/the-politics-of-the-patreon-purge/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Further reading</span></a><a href="https://stage.unherd.com/2019/01/the-politics-of-the-patreon-purge/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>The politics of the Patreon purge</h5></a><p class="author"><a href="https://stage.unherd.com/2019/01/the-politics-of-the-patreon-purge/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Douglas Murray</a></p></div></a></div>



<p class="wp-block-paragraph">In Britain, it&#8217;s <a href="https://www.bbc.co.uk/news/uk-42818467" target="_blank" rel="noopener noreferrer">not so easy to hand back money</a> to philanthropists.<a href="https://www.ft.com/content/cd29a1ee-05bb-11e8-9e12-af73e8db3c71" target="_blank" rel="noopener noreferrer"> The Charity Commission</a> regulations make moral outrage a little harder to pull off if you&#8217;ve already accepted money from a source subsequently deemed tainted.</p>



<p class="wp-block-paragraph">But what do we really think will happen if we deny the fruits of humanity&#8217;s labours? We have sacrificed ourselves, our resources, our work. Lives were lost in the effort to further the human cause upon this earth, and now we wish to reap no reward from those devastating efforts. Let’s not lose our ground just because we hate what it cost to achieve it.</p>



<p class="wp-block-paragraph">To target the tarnished legacy of our forebears is to negate the work they did on our behalf, work so that we could have clean water and plumbing, electricity at the touch of a switch, plentiful food, infrastructure, education, and yes, glorious, perpetual, beautiful, soul shocking, art. Art, that reward for our struggle, that means to connect with each other and with humanity from across all time, is the prayer that we say all together.</p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2019/04/can-culture-clean-money/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2019/04/can-culture-clean-money/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2019/04/can-culture-clean-money/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">19371</post-id>				</item>
									<item>
					<title>How Big Pharma kills off competition</title>
					<link>https://stage.unherd.com/2018/11/big-pharma-kills-off-competition/?edition=us</link>
											<comments>https://stage.unherd.com/2018/11/big-pharma-kills-off-competition/?edition=us#comments</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2018/11/GettyImages-879167778.jpg?w=525</unherd:featured_image>
										<unherd:main_theme></unherd:main_theme>
					<dc:creator>
						<![CDATA[Jonathan Tepper]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2020/03/tepperj.png?w=96</unherd:creator_img>
																<unherd:article_ranking></unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[Credit: Getty]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p class="font_8"><strong><span class="color_15">J</span>onathan Tepper</strong> is the co-author of <em>The Myth of Capitalism: Monopolies and the Death of Competition </em>and Chief Investment Officer at Prevatt Capital. His website is <a href="https://www.jonathan-tepper.com/" target="_blank" rel="noopener" data-saferedirecturl="https://www.google.com/url?q=https://www.jonathan-tepper.com&amp;source=gmail&amp;ust=1671056589184000&amp;usg=AOvVaw05mPDoenqSW4sdE1q2TCl1">www.jonathan-tepper.com</a>.</p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle></unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[ is the co-author of <em>The Myth of Capitalism: Monopolies and the Death of Competition </em>and Chief Investment Officer at Prevatt Capital. His website is <a href="https://www.jonathan-tepper.com/" target="_blank" rel="noopener" data-saferedirecturl="https://www.google.com/url?q=https://www.jonathan-tepper.com&amp;source=gmail&amp;ust=1671056589184000&amp;usg=AOvVaw05mPDoenqSW4sdE1q2TCl1">www.jonathan-tepper.com</a>.</p>]]>
					</unherd:author_bio>
										<pubDate>Fri, 16 Nov 2018 11:13:58 +0000</pubDate>
					<updated>Fri, 03 Dec 2021 17:15:28 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[Intellectual property]]></category>
		<category><![CDATA[Monopoly]]></category>
		<category><![CDATA[Myth of Capitalism]]></category>
		<category><![CDATA[pharmaceuticals]]></category>
					<guid isPermaLink="false">http://old.unherd.com/?p=17320</guid>
																												<description>
								<![CDATA[Endlessly extended patents and fierce regulation lock out startups and keep the big players on top]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p>When people think of monopolies, they usually think of something like Google with its 90% market share in search, Microsoft with its 90% share in operating systems, or Comcast with its dominance of US cable. But monopolies in markets often come from patents and intellectual property – and in the case of pharmaceuticals, they often cover an individual drug.</p>
<p>Patents give drug makers a period of time with no competition where they can be rewarded for their innovations, encouraging drug companies to invest in costly research and development that might take years to pay off. The logic behind patents is sound, and drug companies devote billions of dollars to find extraordinary cures that extend our lives.</p>
<p>But intellectual property, once an unremarkable area of law, has exploded since the 1980s. From 1900 to 1982, the number of patents increased by around 138%. After 1982, the number of patents extended increased by an astounding 416% by 2014. Not only did the number of patents explode, the areas they cover has expanded in ways the Founding Fathers never intended.</p>
<p>Over the past few decades, copyright protection has been extended to unpublished works, the requirement to register one’s copyright has been dropped, and copyright terms have grown from 28 years to the life of the author plus 70 years. This is the dark side of patents, when they are often used as a tool to gouge customers. In the case of drug companies, patents allow them to rip off patients. The longer the drug lacks competition, the longer companies can charge extortionate prices.</p>
<p>The cost to society is immense. The United States spends over $3 trillion annually on health care, and 10% is spent on drugs. The average American spends more than $1,000 a year on prescription medications, 40% more than the next highest country, Canada, and double what Germany spends.</p>
<p><div class="ref-ar"><a href="https://stage.unherd.com/2018/07/clash-titons-amazon-takes-big-pharma/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2018/07/clash-titons-amazon-takes-big-pharma/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2018/07/GettyImages-459987396.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2018/07/clash-titons-amazon-takes-big-pharma/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Further Reading</span></a><a href="https://stage.unherd.com/2018/07/clash-titons-amazon-takes-big-pharma/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Clash of the Titans: Amazon takes on big pharma</h5></a><p class="author"><a href="https://stage.unherd.com/2018/07/clash-titons-amazon-takes-big-pharma/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Nigel Cameron</a></p></div></a></div></p>
<p>The broadest study done on the reasons for the increase in costs appeared in the <a href="https://www.ncbi.nlm.nih.gov/pubmed/27552619" target="_blank" rel="noopener">Journal of the American Medical Association</a>: “The most important factor that allows manufacturers to set high drug prices is market exclusivity, protected by monopoly rights awarded upon Food and Drug Administration (FDA) approval and by patents.” Generic drugs are the main reason why drug prices have fallen, but access to them is generally delayed by numerous business and legal strategies.</p>
<p>When patents are about to expire, for example, the pharmaceutical industry seeks endless extensions through &#8216;reformulation&#8217; of their drugs or minor modifications to the methods of delivery. Reformulation involves changing the drug just enough to obtain additional patent protection, while keeping enough characteristics the same, so that previous clinical testing results can be relied on to obtain FDA approval. There is no new innovation, no new discoveries or any greater benefit to patients, yet companies can continue to charge high prices.</p>
<p>For example, the <a href="https://en.wikipedia.org/wiki/Orphan_Drug_Act_of_1983" target="_blank" rel="noopener">Orphan Drug Act of 1983</a> regulated the approval of drugs for rare diseases and gave a drug companies even greater exclusivity. In theory, this would encourage drug companies to find cures for diseases that might not have a big market. The problem is that Orphan Drugs are not in fact rare. They make up 20% of all global prescription drug sales. Incredibly, 44% of new drugs approved in 2014 had orphan status, and due to pricing they are almost all the most expensive drugs. Now pharmaceutical companies are taking advantage of these incentives to gouge patients, insurers and the government.</p>
<p>Even once patents expire, regulations and bureaucracy provide another even greater barrier to entry for challengers who might want to bring new medicines to market. All new drugs are approved by the FDA to make sure that they work and are not harmful. This is an essential job. Generic drugs, though, are not new or unknown. They are identical to a brand name drug that is off patent in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Yet the current FDA approval process for generics is extremely onerous.</p>
<p><div class="ref-ar"><a href="https://stage.unherd.com/2017/11/cosy-relationship-big-pharma-doctors-killing-people/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2017/11/cosy-relationship-big-pharma-doctors-killing-people/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2017/08/GettyImages-832255342.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2017/11/cosy-relationship-big-pharma-doctors-killing-people/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Further Reading</span></a><a href="https://stage.unherd.com/2017/11/cosy-relationship-big-pharma-doctors-killing-people/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>The cosy relationship between big pharma and doctors is killing people</h5></a><p class="author"><a href="https://stage.unherd.com/2017/11/cosy-relationship-big-pharma-doctors-killing-people/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Charlotte Pickles</a></p></div></a></div></p>
<p>Drug makers can charge what the market will bear because the magic of competition is missing. On average, a generic takes between three and four years to be approved. Given how long this process takes, it is no surprise the FDA’s backlog of generic drugs stands at an all-time high. In 2014, nearly 1,600 applications for generic drugs were submitted to the FDA. By the end of the year, not a single drug was approved due to a backlog of over 4,700 generics from previous years. Fast-forward to July of 2016, and 4,036 generic drugs awaited FDA approval, yet very few were even processed.</p>
<p>The bipartisan Creating and Restoring Equal Access to Equivalent Samples Act (CREATES), which has been submitted to Congress, should remove roadblocks to the approval of lower-cost generic drugs. However, lobbying &#8211; the industry spends millions of dollars a year – means it has almost no chance of passing and has failed every time it has been introduced.</p>
<p>The ugly truth about regulation is that while big businesses often complain about regulation, they tend to benefit from it. Regulations that are burdensome enough kill small companies but not enough to kill large ones are, in fact, ideal. To big companies, startups are like a horrible cancer attacking them, and they are willing to put up with anything painful that will kill them.</p>
<p><div class="ref-ar"><a href="https://stage.unherd.com/2018/01/lateral-thinking-can-save-us-economic-stagnation/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2018/01/lateral-thinking-can-save-us-economic-stagnation/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2018/01/3FB8BE68-ADD9-4969-89BA-E7A89AFE9DC4.jpeg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2018/01/lateral-thinking-can-save-us-economic-stagnation/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Further Reading</span></a><a href="https://stage.unherd.com/2018/01/lateral-thinking-can-save-us-economic-stagnation/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Only lateral thinking can save us from economic stagnation</h5></a><p class="author"><a href="https://stage.unherd.com/2018/01/lateral-thinking-can-save-us-economic-stagnation/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Peter Franklin</a></p></div></a></div></p>
<p>You can compare its effect with cancer treatment. Chemotherapy has the capacity to kill nearly every cell—tumor or normal. The most common way it does so is to damage DNA, the genetic blueprint of the cell. The damaged cells do not die right away—only when they try to replicate with the damaged DNA do the cells die. Sometimes replicating with damaged DNA triggers cell suicide, called apoptosis.</p>
<p>Normal tissues can repair damage because they have the resources and DNA blueprint to repair damage, even if it means slowing growth. Cancers, on the other hand, grow at the expense of any DNA repair. When they try to grow with damaged DNA, they then undergo cell death, through apoptosis or necrosis. Hence, the basis of selectivity of chemotherapy.</p>
<p>Bigger companies favour regulation because, like the normal tissues, they can divert energy to repair and maintenance (lawyers, compliance officers, lobbyists, etc). Big companies are not in the exponential phases of growth like many startups are. (Interestingly, most toxicity in normal tissues come from tissues that grow rapidly: intestines, skin, hair, bone marrow.) These smaller companies need to grow and do not have the budgets to hire an army of lawyers and compliance officers. These fixed costs are a bigger drag on the profitability of small firms than large firms. Hence excessive regulation selectively kills off the small startups attacking big corporations. It is a formidable barrier to entry for any industry.</p>
<p>Today, small businesses are feeling the scorching heat from the chemotherapy of regulation. US companies in 2016 were subject to 104.6 million words of regulation. (The King James Bible comes in around 783,137 words.)</p>
<p><div class="ref-ar"><a href="https://stage.unherd.com/2017/07/us-governments-ex-goldman-sachs-staffers-top-positions-keeps-adopting-policies-favour-wall-street-coincidence/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2017/07/us-governments-ex-goldman-sachs-staffers-top-positions-keeps-adopting-policies-favour-wall-street-coincidence/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2017/07/1024px-Wall_Street_5899300483.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2017/07/us-governments-ex-goldman-sachs-staffers-top-positions-keeps-adopting-policies-favour-wall-street-coincidence/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Further Reading</span></a><a href="https://stage.unherd.com/2017/07/us-governments-ex-goldman-sachs-staffers-top-positions-keeps-adopting-policies-favour-wall-street-coincidence/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>&#039;Government Sachs&#039; keeps adopting policies that favour Wall Street</h5></a><p class="author"><a href="https://stage.unherd.com/2017/07/us-governments-ex-goldman-sachs-staffers-top-positions-keeps-adopting-policies-favour-wall-street-coincidence/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Reihan Salam</a></p></div></a></div></p>
<p>Researchers have found that a 10% increase in the regulatory restrictions on a particular industry is associated with a decrease of about 0.5 % of the total number of small firms within that industry, with large firms mostly unaffected. The correlation between regulation and higher profits holds across countries. The economist Fabio Schiantarelli looked at OECD countries, and found that high barriers to entry contributed to higher markups. It also explains the loss of dynamism in the economy with fewer startups.This is exactly what has been happening in the US, as industries have concentrated.</p>
<p>If you doubt that regulations can effectively kill any new entrants, consider what has happened to the banking industry. The extensive new regulations introduced with the Dodd-Frank Act have created a protected class of financial firms, with only seven new banks formed between 2009 and 2013. Jamie Dimon, the CEO of JP Morgan has said that Dodd-Frank creates a “moat” around the big banks, while doing nothing to break up America&#8217;s largest banks or end the status of banks that are too big to fail. Instead, it has simply kept lawyers, accountants, and consultants busy while choking off competition.</p>
<p>For big businesses across many industires, it&#8217;s exactly as one Goldman Sachs lobbyist told Politico in 2010: “We are not against regulation. We’re for regulation. We partner with regulators.”</p>
<p><em>This is the third of three extracts from “</em>The Myth of Capitalism: Monopolies and the Death of Competition”<em> a new book co-authored by Jonathan Tepper and Denise Hearn.</em></p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2018/11/big-pharma-kills-off-competition/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2018/11/big-pharma-kills-off-competition/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2018/11/big-pharma-kills-off-competition/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">17320</post-id>				</item>
									<item>
					<title>Clash of the Titans: Amazon takes on big pharma</title>
					<link>https://stage.unherd.com/2018/07/clash-titons-amazon-takes-big-pharma/?edition=us</link>
											<comments>https://stage.unherd.com/2018/07/clash-titons-amazon-takes-big-pharma/?edition=us#respond</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2018/07/GettyImages-459987396.jpg?w=525</unherd:featured_image>
										<unherd:main_theme></unherd:main_theme>
					<dc:creator>
						<![CDATA[Nigel Cameron]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2018/01/nc-pic-stars.jpg?w=96</unherd:creator_img>
																<unherd:article_ranking></unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[Credit: Peter Macdiarmid/Getty Images]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p>Nigel Cameron writes about technology, society, and the future. In 2007 he founded the Washington think tank The Center for Policy on Emerging Technologies. His most recent book is Will Robots Take Your Job?</p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle>nigelcameron</unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[Nigel Cameron writes about technology, society, and the future. In 2007 he founded the Washington think tank The Center for Policy on Emerging Technologies. His most recent book is Will Robots Take Your Job?]]>
					</unherd:author_bio>
										<pubDate>Mon, 09 Jul 2018 05:11:25 +0000</pubDate>
					<updated>Mon, 09 Jul 2018 05:11:25 +0000</updated>
							<category><![CDATA[Amazon]]></category>
		<category><![CDATA[Bezos]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[Competition]]></category>
					<guid isPermaLink="false">http://old.unherd.com/?p=15038</guid>
																												<description>
								<![CDATA[]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p>Amazon founder Jeff Bezos’ core innovation isn’t selling stuff online, it’s fixating on making customers happy – and not being much bothered about turning a profit. Plainly it works. He’s already the world’s<a href="https://www.independent.co.uk/news/world/richest-billionaires-combined-wealth-jeff-bezos-bill-gates-warren-buffett-mark-zuckerberg-carlos-a8163621.html"> richest man.</a>[1. Amazon’s <a href="https://www.bloomberg.com/gadfly/articles/2018-04-26/amazon-earnings-being-jeff-bezos-is-good-so-are-gross-margins">latest profit</a> was a meagre 3.8% on a turnover of $51 billion. For comparison, Facebook is more like <a href="https://www.theguardian.com/technology/2018/jan/31/facebook-profit-mark-zuckerberg">33%</a>.]</p>
<p>And he has the rare luxury of investors committed to the long term, so he’s free to build market share, cut costs and prices, and diversify into fresh sectors. He’s already <a href="https://en.wikipedia.org/wiki/Blue_Origin">building rockets</a>, selling <a href="https://stage.unherd.com/2018/02/jeff-bezos-eats-whole-foods-whats/">high-end groceries,</a> and publishing the <em><a href="https://www.businessinsider.de/how-the-washington-post-changed-after-jeff-bezos-acquisition-2016-5?r=US&amp;IR=T">Washington Post</a></em> newspaper; and <a href="https://aws.amazon.com/what-is-cloud-computing/?sc_channel=PS&amp;sc_campaign=acquisition_DE&amp;sc_publisher=google&amp;sc_medium=english_cloud_computing_hv_b&amp;sc_content=sitelink&amp;sc_detail=amazon%20web%20services&amp;sc_category=cloud_computing&amp;sc_segment=what_is_cloud_computing&amp;sc_matchtype=e&amp;sc_country=DE&amp;s_kwcid=AL!4422!3!70693883912!e!!g!!amazon%20web%20services&amp;ef_id=WQckgwAAAV3yhRKk:20180705155153:s">Amazon Web Services</a> is the world’s largest supplier of cloud computing storage to governments.</p>
<p>It&#8217;s no surprise then that his latest move, a jump into the highly profitable market in prescription drugs, has everyone’s attention. By snapping up start-up <a href="https://www.vox.com/policy-and-politics/2018/6/28/17514482/amazon-pillpack-delivery-startup">PillPack</a> he wiped $11 billion off the shares of Walgreens, CVS, and RiteAid, the three major US prescription retailers.</p>
<p><div class="ref-ar"><a href="https://stage.unherd.com/2018/02/jeff-bezos-eats-whole-foods-whats/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2018/02/jeff-bezos-eats-whole-foods-whats/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2018/02/PA-34271132.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2018/02/jeff-bezos-eats-whole-foods-whats/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2018/02/jeff-bezos-eats-whole-foods-whats/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Jeff Bezos eats Whole Foods. What’s he up to?</h5></a><p class="author"><a href="https://stage.unherd.com/2018/02/jeff-bezos-eats-whole-foods-whats/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Nigel Cameron</a></p></div></a></div></p>
<p>It&#8217;s a huge industry: Americans, particularly older Americans, take a lot of pills. According to a recent report by Sandra Boodman in the <a href="https://www.washingtonpost.com/national/health-science/the-other-big-drug-problem-older-people-taking-too-many-pills/2017/12/08/3cea5ca2-c30a-11e7-afe9-4f60b5a6c4a0_story.html?utm_term=.81f9e6a340bd" target="_blank" rel="noopener"><em>Washington Post</em> </a>&#8220;Researchers estimate that 25 percent of people ages 65 to 69 take at least five prescription drugs to treat chronic conditions, a figure that jumps to nearly 46 percent for those between 70 and 79.&#8221;</p>
<p>Hence PillPack’s product. Once a month they send people who take drugs long-term a batch of “pillpacks” – little envelopes printed with the time and day for every pill or batch of pills you need to take.</p>
<p>Handy though it is, it’s hard to believe that’s why Bezos paid a rumoured $1 billion for the company.</p>
<p>As with the Whole Foods purchase, Amazon is jumping into a completely new market by buying a going concern ­– which is especially useful in this instance given the high regulatory barriers to entry in the pharmacy world. In its five short years PillPack has done the heavy lifting – it’s already licensed to operate in 49 of the 50 states.</p>
<p><div class="inner-body-quote" data-type="quote">
	<div class="quote-open"></div>
	<div class="quote"><div class="inner">If Amazon&#8217;s market clout can arm-wrestle big pharma into more competitive pricing then that’s a good thing.
	<div class="quote-close"></div></div>
	</div>
	
	<div class="attribution">- </div>
</div></p>
<p>Amazon’s enormous retail market – a staggering 64% of US households have signed up for Prime – gives them a big advantage. As with Whole Foods, we should expect discounts for Prime members who sign on to PillPack and vice versa. And given that Amazon’s users tend to be younger, while PillPack’s are older, the acquisition brings big new demographic opportunities.</p>
<p>This will soon go well beyond the traditional mail-order drug market, and that’s why it’s scaring the big retailers. Amazon has been pioneering same-day delivery – and now offers it in <a href="https://www.businessinsider.de/why-amazon-prime-now-is-perfect-for-specific-situations-2018-4?r=US&amp;IR=T">two-hours</a> in many locations. Expect a whole new market for urgent, one-off, prescriptions – where the mail-order providers have never been able to compete. No need to drive to Walgreens and hang around for an hour to get your migraine painkiller or your kid’s antibiotics. When the doctor hits send with the prescription, Amazon gets to work and your pills could beat you home.</p>
<p>Yet it’s likely Bezos has his sights set even higher. The US drug market itself is enormous: <a href="https://www.reuters.com/article/us-usa-drugspending-quintilesims/u-s-prescription-drug-spending-as-high-as-610-billion-by-2021-report-idUSKBN1800BU">$580 billion</a> in 2017 and notorious for bloated prices. One reason? The industry has consistently used its political punch in Washington to avoid competition. President Obama submitted to their trade group PhRMA’s demand that the “Obamacare” reforms leave their prices <a href="https://www.politico.com/story/2016/07/obamacare-prescription-drugs-pharma-225444">alone</a> (there would have been government buying power to pull them down).</p>
<p><div class="ref-ar"><a href="https://stage.unherd.com/2018/07/time-topple-technopoly/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2018/07/time-topple-technopoly/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2018/04/GettyImages-944224644.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2018/07/time-topple-technopoly/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">Suggested reading</span></a><a href="https://stage.unherd.com/2018/07/time-topple-technopoly/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Time to topple the technopoly</h5></a><p class="author"><a href="https://stage.unherd.com/2018/07/time-topple-technopoly/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Charlotte Pickles</a></p></div></a></div></p>
<p>President Trump is the latest leader to curry public favour by asking them to lower their prices while doing nothing about it (a new report in <a href="https://www.politico.com/story/2018/07/03/drugmakers-trump-drug-prices-668260">Politico </a>notes that hundreds of drug prices have actually just been increased).</p>
<p>It&#8217;s worth remembering how Bezos began his empire: by selling books online and using <a href="https://www.businessinsider.com/amazon-war-against-publishers-like-hachette-2014-5?IR=T">cut-throat tactics</a> to force publishers to go along with him. In the book trade he operated what economists call a monopsony; a monopoly buyer who can dictate prices to suppliers just as a standard monopolist dictates them to consumers. Book publishers, mostly small companies with few political friends, had little choice but to give in.</p>
<p><div class="inner-body-quote" data-type="quote">
	<div class="quote-open"></div>
	<div class="quote"><div class="inner">It’s likely Bezos has his sights set even higher. The US drug market itself is enormous: $580 billion in 2017 and notorious for bloated prices
	<div class="quote-close"></div></div>
	</div>
	
	<div class="attribution">- </div>
</div></p>
<p>So here’s the big question: is his plan to go after the drug companies next? And if he does – with his enormous market base, two-thirds of all American households – will he succeed?</p>
<p>It will be a much more equal fight than that against the book sellers. At a market value of <a href="https://blogs.wsj.com/moneybeat/2018/06/04/amazons-latest-milestone-an-800-billion-market-value/">$800 billion</a>, Amazon is worth around the same as the <a href="https://en.wikipedia.org/wiki/List_of_largest_biotechnology_and_pharmaceutical_companies">four largest pharmaceutical companies</a> together. If his market clout can arm-wrestle them into more competitive pricing then that’s a good thing.</p>
<p>But one thing is clear, PhRMA is not the book trade. Any anti-competitive antics from Amazon won’t just be met in the market place but in the corridors of power where pharmaceutical lobbying is constant. It will be a battle royale, and the winner will be consumers.</p>
<p>&nbsp;</p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2018/07/clash-titons-amazon-takes-big-pharma/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2018/07/clash-titons-amazon-takes-big-pharma/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2018/07/clash-titons-amazon-takes-big-pharma/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">15038</post-id>				</item>
									<item>
					<title>Rip-off healthcare is ripe for the Trump treatment</title>
					<link>https://stage.unherd.com/2018/05/rip-off-healthcare-ripe-trump-treatment/?edition=us</link>
											<comments>https://stage.unherd.com/2018/05/rip-off-healthcare-ripe-trump-treatment/?edition=us#respond</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2018/05/GettyImages-597987748.jpg?w=535</unherd:featured_image>
										<unherd:main_theme></unherd:main_theme>
					<dc:creator>
						<![CDATA[Justin Webb]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2019/09/justin.jpg?w=96</unherd:creator_img>
																<unherd:article_ranking></unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[A protest against the price of EpiPens. Credit: Drew Angerer / Getty]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[<p><strong>Justin Webb</strong> presents the Americast podcast and Today on Radio Four. His Panorama documentary “Trump the Sequel&#8221;, is available now on  Iplayer</p>
]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle>JustinOnWeb</unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[ presents the Americast podcast and Today on Radio Four. His Panorama documentary “Trump the Sequel", is available now on  Iplayer]]>
					</unherd:author_bio>
										<pubDate>Tue, 08 May 2018 06:00:38 +0000</pubDate>
					<updated>Tue, 08 May 2018 06:00:38 +0000</updated>
							<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[Donald Trump]]></category>
					<guid isPermaLink="false">https://old.unherd.com/?p=13900</guid>
																												<description>
								<![CDATA[]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p>Just suppose for a moment that Donald Trump’s Republicans lose control of the House of Representatives in the <a href="https://media.cq.com/electionguide/">midterm elections this November</a>. The conventional view of this entirely plausible result:<span class="Apple-converted-space"> </span>Chaos!<span class="Apple-converted-space">  </span>Clearouts! U-turns! That’s what happens when presidents’ parties lose midterm elections during their first term in office.<span class="Apple-converted-space"> </span>It’s not fatal – far from it – but it does require a new start. <span class="Apple-converted-space"> </span></p>
<p>Careful students of American politics will have spotted a flaw in this argument:<span class="Apple-converted-space"> we already have </span>all of these things in the Trump Administration. Even before a single midterm ballot is cast. This is the most fissiparous White House since the British burnt it down. Folks are cleared out, or clear out themselves, almost every day.<span class="Apple-converted-space"> </span>Policies come and go. Trade wars are declared and suspended with dizzying speed. Walls, once promised, remain unbuilt;<span class="Apple-converted-space"> i</span>nfrastructure is unimproved.<span class="Apple-converted-space">   </span></p>
<p><div class="inner-body-quote" data-type="quote">
	<div class="quote-open"></div>
	<div class="quote"><div class="inner">The President attacked pharmaceutical companies and their ability to gouge money out of America’s chaotic and wasteful healthcare system
	<div class="quote-close"></div></div>
	</div>
	
	<div class="attribution">- </div>
</div></p>
<p>I wonder, therefore, whether a Republican loss this November might have the opposite effect on the White House.<span class="Apple-converted-space"> </span>Faced with a disorganised but noisy opposition from Congress, what if Trump’s response were to focus on<i> being Trump</i>; what if the President were to double down on measures that could truly be described as radical and populist and by doing so bought off significant numbers of otherwise troublesome opponents.<span class="Apple-converted-space"> </span>In other words, what if the Trump post-midterms White House were to make a proper break with both parties? <span class="Apple-converted-space"> </span></p>
<p>There are two big items he could press which might garner support from a wide cross-section of the 116<sup>th</sup> United States Congress and form the basis of a Trump 2020 re-election bid. <span class="Apple-converted-space">   </span></p>
<p>The first – the break-up of Big Tech –<span class="Apple-converted-space"> </span>is already the subject of much debate among conservative Americans as well as left-wingers upset at what has become of the once-adored tech industry they regarded as their own. From <a href="https://www.theregister.co.uk/2017/07/31/bannon_vs_google_and_facebook/">Steve Bannon</a>, the President’s former right-hand man, to <a href="https://www.thenation.com/article/elizabeth-warrens-big-fight-against-monopolies/">Elizabeth Warren</a>, the left-wing Democrats&#8217; darling, the cry goes out: “Break up Facebook! And Google!<span class="Apple-converted-space"> </span>And the other tech companies whose market dominance feels to so many capitalists like a proper case for anti-trust action.&#8221;</p>
<p>Such a move feels like it would be a good fit for Trump – but it would take enormous political acumen and focus. And the Supreme Court would make the ultimate call as they did with Big Oil. So maybe not.<span class="Apple-converted-space">   </span></p>
<p><div class="ref-ar"><a href="https://stage.unherd.com/2017/11/cosy-relationship-big-pharma-doctors-killing-people/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2017/11/cosy-relationship-big-pharma-doctors-killing-people/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2017/08/GettyImages-832255342.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2017/11/cosy-relationship-big-pharma-doctors-killing-people/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">You might also like...</span></a><a href="https://stage.unherd.com/2017/11/cosy-relationship-big-pharma-doctors-killing-people/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>The cosy relationship between big pharma and doctors is killing people</h5></a><p class="author"><a href="https://stage.unherd.com/2017/11/cosy-relationship-big-pharma-doctors-killing-people/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Charlotte Pickles</a></p></div></a></div></p>
<p>But there&#8217;s another populist cause that could be more fruitful and have much more impact on the lives of ordinary Americans. It’s less eye-catching than breaking up Big Tech but to tackle this problem would be audacious and, again, could find support from both sides of the Congressional aisle. There are rumblings he&#8217;s going to have a stab at a package of reform in a speech<span class="Apple-converted-space"> this month. But some think it might be a better idea to just tear that up and go for something really radical.</span></p>
<p>To act in this area would be a case of Trump delivering on something he already promised. During his presidential campaign of 2016, he claimed: “<a href="https://www.reuters.com/article/us-usa-trump-drugpricing-idUSKBN14V24J">They are getting away with murder!</a>” <span class="Apple-converted-space"> </span>He was not – on this occasion &#8211; referring to Mexicans or Muslims or even the Clintons. He was referring to the bosses of the pharmaceutical companies and their ability to gouge money out of America’s chaotic and wasteful healthcare system. As Trump put it: “Pharma has a lot of lobbies, a lot of lobbyists, a lot of power. And there’s very little bidding on drugs.”</p>
<p>Another prominent politician said days later that Trump was “<a href="https://www.huffingtonpost.co.uk/entry/bernie-sanders-trump-big-pharma_us_58768db1e4b092a6cae4daba">exactly right</a>”. That politician was the Democratic presidential hopeful Bernie Sanders. <span class="Apple-converted-space">   </span></p>
<p><div class="inner-body-quote" data-type="quote">
	<div class="quote-open"></div>
	<div class="quote"><div class="inner">US healthcare is transparent is an utterly broken market in the control of the drug companies, the hospital companies, the insurance companies and the doctors themselves
	<div class="quote-close"></div></div>
	</div>
	
	<div class="attribution">- </div>
</div></p>
<p>In fact, dealing with the pricing of drugs and medical devices could be political rocket fuel for Trump. America’s real problem with healthcare is not the unfairness that so obsesses foreign commentators; no, the real problem is the opacity of the system and the waste and suffering that causes.</p>
<p>Almost nothing about US healthcare is transparent. It is an utterly broken market in the control of the drug companies, the hospital companies, the insurance companies and the doctors themselves.</p>
<p>I know this broken market well. In 2009, in Washington DC, my little boy, Sam, was diagnosed with Type 1 diabetes – an incurable and potentially fatal condition. Amid all the personal chaos and confusion of our family coming to terms with this, the US healthcare system sprang into life. First, there was a hospital stay.<span class="Apple-converted-space"> </span>Then, insulin was prescribed (he has to inject it whenever he eats), and eventually an insulin pump provided along with a bewildering array of test-kits and monitoring devices.</p>
<p><div class="ref-ar"><a href="https://stage.unherd.com/2018/03/really-want-generals-get-taste-running-america/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><a href="https://stage.unherd.com/2018/03/really-want-generals-get-taste-running-america/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><img decoding="async" src="https://stage.unherd.com/wp-content/uploads/2018/03/PA-33170959.jpg?w=300" /></a><div class="content"><a href="https://stage.unherd.com/2018/03/really-want-generals-get-taste-running-america/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span class="meta">By the same author...</span></a><a href="https://stage.unherd.com/2018/03/really-want-generals-get-taste-running-america/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><h5>Do we really want generals to get a taste for running America?</h5></a><p class="author"><a href="https://stage.unherd.com/2018/03/really-want-generals-get-taste-running-america/?edition=us&#038;ref=refinnar" class="text-decoration-none border-0"><span>By</span> Justin Webb</a></p></div></a></div></p>
<p>So who paid for all this? And how fair were the prices?</p>
<p>This was never clear – precisely because of that opacity. I paid quite a bit up-front myself. I remember, in those dazed first days after Sam came out of hospital, trips to the pharmacist that left me hundreds of dollars poorer.<span class="Apple-converted-space"> </span>Then it got pricier still, but was taken out of my hands.<span class="Apple-converted-space"> </span>The pump salesmen (yep, they exist) competed with each other to sell us their device.<span class="Apple-converted-space"> </span>But this time we didn’t pay: the insurance company paid. Only, they didn’t pay either.<span class="Apple-converted-space"> </span>My company (the BBC) had bought an insurance policy for all its staff. So the BBC paid.<span class="Apple-converted-space"> </span>Only, they didn’t pay either. <span class="Apple-converted-space">  </span></p>
<p>Insurance costs are tax deductible for companies so, in the end, you guessed it: the taxpayer paid! And bigly:<span class="Apple-converted-space"> </span>the <a href="https://www.taxpolicycenter.org">Brookings Institution Tax Policy Center</a> says the combined tax deductions for employees and employers add up to a whopping $260 billion annually. It’s the single largest tax expenditure of the federal government.<span class="Apple-converted-space">   </span></p>
<p>The point is that this system encourages – essentially, it <i>demands</i> – an utterly dysfunctional allocation of resources. It is in nobody’s interests to keep costs down. It is in nobody’s interests to keep treatments proportionate and sensibly applied.<span class="Apple-converted-space">   </span></p>
<p>The results are poisonous. Yes, there are sudden outrageous increases in drug prices – the <a href="https://www.fiercepharma.com/financials/mylan-s-epipen-crashes-q3-new-competition-higher-rebates">recent controversy over the EpiPen</a> was an example – but there&#8217;s also the problem of an entire system that bleeds Americans dry over the long-term. And for which insurers carry much of the blame.</p>
<p><div class="inner-body-quote" data-type="quote">
	<div class="quote-open"></div>
	<div class="quote"><div class="inner">Trump could demand transparency and regulate so that everyone knew at every stage of the process who was paying and how much
	<div class="quote-close"></div></div>
	</div>
	
	<div class="attribution">- </div>
</div></p>
<p>The headlines focus on the costs borne by individuals, such as the hikes in insurance premiums that users of Obamacare are suffering right now. But most Americans are insured through their employers. <a href="https://www.kff.org/report-section/ehbs-2015-section-one-cost-of-health-insurance/">According to the Kaiser Family Foundatio</a><a href="https://www.kff.org/health-costs/report/2017-employer-health-benefits-survey/">n</a>, employer costs for family health coverage went from $4,200 in 1999 to $12,600 in 2015.</p>
<p>This increase, way above inflation, drove employers to seek more in subsidy from the government but it also kept wages down as they struggled to cope with higher insurance policy costs. It was, in other words, one of the key drivers of the middle-class wage stagnation that has so obsessed America and so hurt the life chances of a generation. <span class="Apple-converted-space">  </span></p>
<p>And the insurers are doing pretty well out of it all. The one that paid Sam’s healthcare costs, was <a href="https://investorplace.com/2018/04/aetna-stock-big-reward/">Aetna</a>. Their stock value has gone up by well over 400% in the past ten years.<span class="Apple-converted-space">   </span></p>
<p>Trump could attack this. He could demand transparency and regulate so that everyone knew at every stage of the process who was paying and how much. It would start an explosive nationwide debate.<span class="Apple-converted-space"> </span>It would put the drug companies and the insurers in the dock, which is where many believe they belong. It could radically reduce costs.<span class="Apple-converted-space">   </span></p>
<p><div class="inner-body-quote" data-type="quote">
	<div class="quote-open"></div>
	<div class="quote"><div class="inner">It would be disruptive; it would discombobulate, it would confuse friends and enemies alike. It would be pure Trump
	<div class="quote-close"></div></div>
	</div>
	
	<div class="attribution">- </div>
</div></p>
<p>The downside? Well, politically, there are those lobbyists that Trump himself referred to and who are already tooling up for battle. They would argue that Big Pharma pays big tax and does big business in America. Does Trump want that to carry on?<span class="Apple-converted-space">    </span></p>
<p>Again my personal story is relevant. Sam’s insulin pump was provided by a small and massively successful company called <a href="https://www.forbes.com/companies/insulet/">Insulet</a>. It rose from nothing to become a multi-billion dollar outfit. It did that on the back of the ability to charge what it would regard as a decent whack to those Americans who chose the product.<span class="Apple-converted-space"> </span>Without that whack: no R&amp;D, no Insulet, no pump.<span class="Apple-converted-space">     </span></p>
<p>This is probably why Donald Trump has held back so far. But the day is fast approaching when someone in the White House (or someone on Fox News) mentions that campaign speech in which Trump eviscerated Big Pharma and wonders aloud: “Why don’t we do this?” <span class="Apple-converted-space"> </span></p>
<p>It would be disruptive; it would discombobulate, it would confuse friends and enemies alike. It would be pure Trump. And it might be a good idea too. <span class="Apple-converted-space">     </span></p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2018/05/rip-off-healthcare-ripe-trump-treatment/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2018/05/rip-off-healthcare-ripe-trump-treatment/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2018/05/rip-off-healthcare-ripe-trump-treatment/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">13900</post-id>				</item>
									<item>
					<title>The cosy relationship between big pharma and doctors is killing people</title>
					<link>https://stage.unherd.com/2017/11/cosy-relationship-big-pharma-doctors-killing-people/?edition=us</link>
											<comments>https://stage.unherd.com/2017/11/cosy-relationship-big-pharma-doctors-killing-people/?edition=us#comments</comments>
										<unherd:featured_image>https://stage.unherd.com/wp-content/uploads/2017/08/GettyImages-832255342.jpg?w=484</unherd:featured_image>
										<unherd:main_theme></unherd:main_theme>
					<dc:creator>
						<![CDATA[]]>
					</dc:creator>
					<unherd:creator_img>https://stage.unherd.com/wp-content/uploads/2019/09/justin.jpg?w=96</unherd:creator_img>
																<unherd:article_ranking></unherd:article_ranking>
																<unherd:image_caption>
							<![CDATA[Credit: Getty]]>
						</unherd:image_caption>
						<unherd:twitter_bio>
							<![CDATA[]]>
						</unherd:twitter_bio>
						<unherd:twitter_handle></unherd:twitter_handle>
															<unherd:author_bio>
						<![CDATA[ presents the Americast podcast and Today on Radio Four. His Panorama documentary “Trump the Sequel", is available now on  Iplayer]]>
					</unherd:author_bio>
										<pubDate>Fri, 10 Nov 2017 08:53:13 +0000</pubDate>
					<updated>Wed, 04 Nov 2020 17:56:41 +0000</updated>
							<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[Capitalism]]></category>
		<category><![CDATA[Opioid Epidemic]]></category>
		<category><![CDATA[Regulation]]></category>
					<guid isPermaLink="false">https://old.unherd.com/?p=9074</guid>
																												<description>
								<![CDATA[]]>
							</description>
																		
																			<content:encoded>
								<![CDATA[<p>In America, almost 100 people are dying from opioids every day.</p>
<p>Some experts predict that half a million more people will die over the next decade . Others think it will be closer to 650,000[1. Max Blau, <a href="https://www.statnews.com/2017/06/27/opioid-deaths-forecast/">‘STAT forecast: Opioids could kill nearly 500,000 Americans in the next decade’</a>, STAT, 27 June 2017] – the population of Miami, or Atlanta, or Sacramento. President Trump has rightly declared the crisis a “public health emergency”.</p>
<p>Last week Trump’s commission on ‘Combatting Drug Addiction and the Opioid Crisis’ published its recommendations. The report has had a lukewarm reception, not least as the question of funding remains unanswered. Yet much of what it does say – from cracking down on the illegal importation of opioids to expanding drug courts and removing barriers to treatment – is sensible (we’ll park the report’s proposal for a ‘just say no’ media campaign for now).</p>
<p>The problem with the report lies in what it doesn’t say. Because while it traces the role of big pharma in the development of the opioid epidemic, and it seeks greater oversight of prescribing, it fails to adequately link the two. In reality, the financial relationship between pharmaceutical companies and doctors is killing people.</p>
<p><figure id="attachment_9086" aria-describedby="caption-attachment-9086" style="width: 1024px" class="wp-caption alignnone"><img loading="lazy" decoding="async" class="size-large wp-image-9086" src="https://stage.unherd.com/wp-content/uploads/2017/11/New-York-newspaper-ad-opioid-Richard-B.-LevineSIPA-USAPA-Images-1024x683.jpg" alt="" width="1024" height="683" /><figcaption id="caption-attachment-9086" class="wp-caption-text">The crisis has reached such proportions that health departments are urging people to carry Naloxone, an antidote for an opioid overdose, in case they come across an overdosed addict. Credit: Richard B. Levine/SIPA USA/PA Images</figcaption></figure></p>
<p><strong>Like big tobacco before, big pharma is being called to account </strong></p>
<p>The opioid epidemic can be traced back to false advertising by big pharma in the 1990s, who peddled opioid-based painkillers as having lower risk of addiction than existing pain pills.[2. Barry Meier, <a href="https://www.nytimes.com/2007/05/10/business/11drug-web.html">‘In Guilty Plea, OxyContin Maker to Pay $600 million’</a>, The New York Times, 10 May 2007] More specifically, Purdue Pharma executives gave false information about their narcotic OxyContin, and doctors duly prescribed it – between 1996 and 2001 annual prescriptions increased almost 20-fold.[3. .<a href="https://www.cnbc.com/id/18591525">‘Purdue Pharma, Execs to Pay $634.5 Million Fine in OxyContin Case’</a>, CNBC, 5 August 2010] Over that period, OxyContin made Purdue Pharma almost $2.8 billion.[4. Barry Meier, <a href="https://www.nytimes.com/2007/05/10/business/11drug-web.html">‘In Guilty Plea, OxyContin Maker to Pay $600 million’</a>, The New York Times, 10 May 2007]</p>
<p>In 2007, Purdue Pharma finally agreed to pay $634.5 million in fines for those misleading claims, and three top executives pleaded guilty to criminal charges. 41 states are now suing the producers and distributors of opioid painkillers,[5. Yuki Noguchi, <a href="https://www.npr.org/sections/thetwo-way/2017/09/19/552135830/41-states-to-investigate-pharmaceutical-companies-over-opioids">‘41 States To Investigate Pharmaceutical Companies Over Opioids’</a>, NPR, 19 September 2017] reminiscent of the mass litigation against tobacco companies. If these companies are also found to have made misleading claims, to have behaved negligently in doling out obscene volumes of highly-addictive pills (Vox reports that enough pills were prescribed in 2016 to almost fill a bottle for every US adult), massive settlements will follow.</p>
<p>But as the lawsuits snowball, there’s a danger we’re missing a longer-term opportunity to protect patients.</p>
<p><div class="inner-body-quote" data-type="quote">
	<div class="quote-open"></div>
	<div class="quote"><div class="inner">375,000 opioid-related payments were made by drug companies to more than 68,000 doctors in a 29-month period. That’s one in 12 physicians, and one in five family doctors
	<div class="quote-close"></div></div>
	</div>
	
	<div class="attribution">- </div>
</div></p>
<p><strong>Financial incentives, even small ones, sway doctors</strong></p>
<p>Three quarters of people whose heroin use began in the 2000s report they started with prescription drugs.[6. Theodore Cicero, <a href="https://jamanetwork.com/journals/jamapsychiatry/fullarticle/1874575"><em>The Changing Face of Heroin Use in the United States: A Retrospective Analysis of the Past 50 Years</em></a>, JAMA, July 2014] Why are prescription drugs such a wide gateway? Because, the researchers find, “many users viewed these drugs as safer to use than other illicit substances”:</p>
<blockquote><p>“prescription opioids are legal, are prescribed by a physician, and are thus considered trustworthy and predictable (eg, the dose is clearly specified on a distinctive tablet or pill)”.</p></blockquote>
<p>In short, doctors – those we trust to help us when we’re at our most vulnerable – say prescription drugs are OK. How is a patient to know that, in fact, there is little evidence that opioid drugs are even effective at alleviating pain? Or that one in every 550 patients on opioid medication dies from an opioid-related cause – increasing to as many as one in just 32 for very high doses?[7. Thomas Frieden and Debra Houry, <a href="https://www.nejm.org/doi/full/10.1056/NEJMp1515917#t=article">‘Reducing the Risks of Relief — The CDC Opioid-Prescribing Guideline’,</a> The New England Journal of Medicine, 27 April 2016] The information asymmetry between patient and doctor is vast, while our lives are quite literally in that health professional’s hands.</p>
<p>Which is why the Trump administration should be looking at the benefits, in cash and kind, that doctors receive from pharmaceutical companies aggressively pushing their drugs.</p>
<p>I’m talking about the culture of lunching, speech-giving, and honorariums (not legitimate research). Because research has found even a $20 lunch can influence a doctor’s prescribing habits – and the higher the value of benefits, the higher the rates at which the promoted drug is prescribed.[8. Colette De Jong, et al, <a href="https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2528290">‘Pharmaceutical Industry–Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries’</a>, JAMA Internal Medicine, August 2016] And it’s pervasive: analysis by <em>ProPublica</em> found that in 2014 three quarters of doctors across five common medical specialties received at least one payment (and they too found a correlation between payments and prescriptions).</p>
<p>For some doctors that’s being treated to a burger and fries by a local pharma rep, but for some it&#8217;s tens, even hundreds, of thousands of dollars in speaker fees, ‘consultancy’, exclusive dinners in high end restaurants, even golfing junkets. It may be illegal to pay doctors to prescribe a specific drug, but paying them to promote it is a different matter.</p>
<p>Research published in September looked at payments relating to opioid drugs specifically.[9. .<a href="https://news.brown.edu/articles/2017/08/opioids-influence">‘Opioid makers made payment to one in 12 U.S. doctors’</a>, Brown University, 9 August 2017] It found 375,000 opioid-related payments were made to more than 68,000 doctors in a 29-month period. That’s one in 12 physicians, and one in five family doctors, profiting (the average payment was $15, the median $50) from drugs at the centre of this public health emergency. And while the research is not proving cause and effect, the $46 million spent by pharmaceutical companies should be deep cause for concern.</p>
<p><figure id="attachment_9089" aria-describedby="caption-attachment-9089" style="width: 1024px" class="wp-caption alignnone"><img loading="lazy" decoding="async" class="size-large wp-image-9089" src="https://stage.unherd.com/wp-content/uploads/2017/11/Opioid-pill-bottle-Graeme-RoyThe-Canadian-PressPA-Images-1024x681.jpg" alt="" width="1024" height="681" /><figcaption id="caption-attachment-9089" class="wp-caption-text">Big pharma is spending millions of dollars to promote their highly addictive opioid-based prescription drugs to doctors. Research has shown that doctors receiving payments in cash or kind are more likely to prescribe the promoted drugs, despite their dangers. Credit: Graeme Roy/The Canadian Press/PA Images</figcaption></figure></p>
<p><strong>No, all regulation isn’t bad, it protects consumers </strong></p>
<p>Corporate abuse – in this case, the deliberate misbranding of opioid drugs – is a clear violation of regulatory, even criminal, standards (as shown in the Purdue Pharma case). But enforcing those standards, while vital, is not sufficient to protect patients. Nor is simply letting people look up in a database whether their doctor takes payments from drug companies. Patients have been able to do that through the Sunshine Act (part of the Affordable Care Act), but there’s no evidence of better behaviour.</p>
<p>There’s a read across to banking. In 2012 the then head of the UK Financial Services Authority Martin Wheatley gave a speech on the damaging effect of incentives in retail banking – his analogy works as well for health services:[10. Martin Wheatley, <a href="https://commodity.com/brokers/regulators/" target="_blank" rel="noopener noreferrer">&#8216;The incentivisation of sales staff &#8211; are consumers getting a fair deal?&#8217;</a>, FSA, 5 September 2012]</p>
<blockquote><p>“This is not like when you go to a fast food restaurant and the server asks ‘do you want fries with that?’, or ‘do you want to go large?’. We all know they ask these questions because they are encouraged to make the most of every sale, and when customers are standing at the counter, they are more likely to say yes. But then we also know what to expect – chiefly lots of salt, calories and a bigger waistline. But far fewer of us actually have such a clear understanding of financial services. We also mostly trust those selling or giving advice to be acting in our best interests… The cost of going large may cost us a few pence – the cost of buying the wrong mortgage could see you lose your home.”</p></blockquote>
<p>Regulators in banking understood that financial incentives skew staff behaviour, and that even if consumers know incentives are being used, the imbalance of knowledge makes further action necessary. They acted and banks changed their behaviour.</p>
<p>The takeaway for the health sector is that transparency is not enough.</p>
<p>Opioid prescriptions have been falling since their 2010 peak, but as the projection of half a million deaths over the next decade shows, it’s not enough to slow the path of destruction. And heroin-related deaths have more than quadrupled since 2010 – a cheaper, more easily accessible opioid for patients who have already become addicts.</p>
<p>The President’s commission’s plans for enforcement, education and treatment will hopefully help. But without addressing the cosy culture between pharma and physicians, greased by millions of dollars in payments and hospitality, patients are going to continue to lose out. That’s about preventing the next scandal.</p>
<style>
				a.appcomments {
					background: #FFF;
					border: 1px solid #446c76 !important;
					font-family: benton-sans,sans-serif;
					font-weight: 600;
					font-style: normal;
					font-size: 12px;
					color: #446c76 !important;
					padding: 12px 50px;
					text-transform: uppercase;
					letter-spacing: 1.5px;
					text-decoration: none;
					width: 100%;
					display: block;
					text-align: center !important;
				 }
			</style>
			<a href="https://stage.unherd.com/2017/11/cosy-relationship-big-pharma-doctors-killing-people/?edition=us?appcomments" class="appcomments">view comments</a>]]>
							</content:encoded>
																<unherd:comments_embed_url>https://stage.unherd.com/2017/11/cosy-relationship-big-pharma-doctors-killing-people/?edition=us?appcommentsnew</unherd:comments_embed_url>
											<wfw:commentRss>https://stage.unherd.com/2017/11/cosy-relationship-big-pharma-doctors-killing-people/?edition=us/feed/</wfw:commentRss>
															<post-id xmlns="com-wordpress:feed-additions:1">9074</post-id>				</item>
						</channel>
</rss>
